Synthesis of biguanidines and triazines, and biguanidino-aluminium complexes as intermediates

ABSTRACT

Synthesis of biguanidines and triazines, and biguanidino-aluminium complexes as intermediates Compounds of formula (I) or salts thereof, in which R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , X and Y are defined as in claim  1 , can be prepared by a process characterized in that a compound of the formula (II) or a salt thereof, is reacted to a compound of the formula (III) or a salt thereof, and an aluminium (III) source, optionally, in the presence of a protic additive or solvent selected from the group consisting of alcohols or amines. The compounds (I) are suitable to be used for the preparation of heterocyclic compounds corresponding to (I) where the group Al(X)(Y) is replaced with an optionally substituted carbon atom, or s-triazine derivatives thereof.

The invention is related to the technical field of chemical processes for the preparation of heterocyclic compounds, particularly to the preparation of symmetrical triazines (s-triazines), and intermediates therefor, by ring-formation of the triazine ring. The s-triazines preferably are active ingredients in the pharmaceutical, agrochemical or fine chemicals field or are intermediates thereof.

It is well documented in the literature that biguanidine salts may be prepared from the reaction of cyanamide and guanidine salts or cyanoguanidine and ammonium salts at high temperatures in solution or as a melt. Even in the simplest of cases these syntheses are however often unspecific, lead to low yield and give mixtures from which the product is difficult to obtain. This is primarily due to the fact that the temperature required for reaction, often very much in excess of 120° C., is such that the biguanidine product itself reversibly decomposes to give the related guanidine and cyanamide derivatives which may themselves further take part in the reaction. In addition from the side products produced these decompositions may be extremely exothermic and as such preclude operating such a reaction on a technical scale. An example of which is that, in some cases it has been documented that under virtually identical reaction conditions some amines yield unpredictably only the mono-guanidine product in low yield (J. Amer. Chem. Soc. 81, 3728, 1959, see example on page 3735 with 2-cyclohexylethylamine). Alternatively, for those cases where fusion or boiling in strong acid are not appropriate the use of copper salts (e.g. copper sulfate) is known to promote the formation of the biguanidine as the bisguanidino copper complex, albeit in only poor to modest yields (Ber. 62B, 1398 (1929) and J. Amer. Chem. Soc. 81, 3728, example on page 3735 with 2-pyrid-2-ylethylamine). Furthermore such complexes, including those, for example, of nickel, cobalt and chromium, are so stable that they have been considered to be pseudoaromatic in character (J. Indian Chem. Soc. 54, 127 (1977)). As such, expectedly and unfortunately, excess H₂S gas or related sulfur derivates must be used in order to liberate the biguanidine from the strongly bound biguanidino heavy metal complex such as the copper complex (Inorg. Synth. 7, 56 (1963)). Such syntheses are therefore of little technical value.

Nevertheless, substituted biguanidines and the triazines derived from them have found widespread application as pharmaceuticals, biocides and agrochemicals. Thus the formation and reaction of biguanidines under mild, clean, high yielding conditions is of great importance and a remaining technical challenge.

Remarkably and surprisingly it has been found that aluminium derivatives are particularly suitable for the formation of biguanidines from amines and cyanoguanidines. The reaction is mild, proceeds cleanly, most often under conditions which would not have been expected, based on literature precedent, to lead to addition products, and is of a general nature with respect to the amine (Scheme 1).

The ligands X and Y of the aluminium complex shown in formula (I) may be furnished from the aluminium source, the solvent or other added components of the reaction mixture. Formula (I) shows only one of the possible resonance structures of the aluminium complex. For instance, the positive charge can also be located at the N-atom linked to the group R⁵ or at the N-atom of the group NR³R⁴. The formula (I) shall represent all resonance structures or tautomers of the aluminium complex, which are in equilibrium with the one shown in formula (I) explicitly or can easily be formed therefrom in the reaction mixture. The same shall be valid also for other chemical formulae considered below.

In case of R⁶ or R⁵ or both being hydrogen atoms in formula (III) the starting material is represented by formulae (IIIA) or (IIIB) or (IIIC), respectively, and the reaction can proceed to compounds of formula (I) which are not in a salt form; see compounds of formula (IA), (IB) or (IC) in Schemes 1a, 1b or 1c, respectively (in each case only one of the resonance or tautomeric structures for the aluminium complexes is shown).

Especially, in case of formula (IC) the hydrogen atom in the complex formed can move and then forms tautomers where the saturated hydrogen atom is linked to any of the N-atoms in the compound, mainly to the N-atoms in the ring. The main tautomers in case of R⁵ and R⁶ both being hydrogen atoms are the following:

The tautomers together and addition salts thereof (HX added) are also represented by formula (Ia) (non-salt form) or (Ib) (salt form, aluminium complex as anion) or (Ic) (salt form=HX addition salt=aluminium complex as internal salt with higher coordination having four ligands at the Al-atom):

The compounds of the general formula (I) in which R⁵ and R⁶ are both hydrogen shall also represent tautomers (Ia) in the non-salt form and salt forms (Ib) and (Ic) and respective resonance structures, and addition complexes of higher coordination (see e.g. complexes with 5 ligands further below), unless specific tautomers or complex structures are specifically considered. The same applies in cases when R⁵ or R⁶ or both being different from hydrogen, accordingly.

The invention is thus directed or related to novel aluminium complexes of formula (I), or salts, dimers or polymers thereof (in short “salts thereof”),

in which

-   -   R¹ is (C₁-C₁₈)alkyl, (C₂-C₁₈)alkenyl or (C₂-C₁₈)alkynyl,         -   wherein each of the last-mentioned three radicals is             unsubstituted or substituted, preferably unsubstituted or             substituted by one or more radicals selected from the group             consisting of halogen, hydroxy, nitro, carbamoyl, sulfo and             radicals of the formulae         -   —O—R^(1a), —S—R^(1b), —S(═O)—R^(1c), —S(═O)₂—R^(1d),             —NR^(1e)R^(1f), —C(═O)—NHR^(1g), —C(═O)—NR^(1h)R^(1i),             —NHC(═O)—NR^(1j)R^(1k) and A^(1a),         -   wherein R^(1a), R^(1b), R^(1c), R^(1d), R^(1e), R^(1f),             R^(1g), R^(1h), R^(1i), R^(1j), and R^(1k), independently of             one another, are (C₁-C₆)alkyl, (C₁-C₆)haloalkyl,             (C₁-C₆)alkoxy-(C₁-C₆)alkyl or a radical of the formula             A^(1b),     -    or is a group of the formula A¹ or B¹,     -   R² is H, (C₁-C₁₈)alkyl, (C₂-C₁₈)alkenyl or (C₂-C₁₈)alkynyl,         -   wherein each of the last-mentioned three radicals is             unsubstituted or substituted, preferably unsubstituted or             substituted by one or more radicals selected from the group             consisting of halogen, hydroxy, nitro, carbamoyl, sulfo and             radicals of the formulae         -   —O—R^(2a), —S—R^(2b), —S(═O)—R^(2c), —S(═O)₂—R^(2d),             —NR^(2e)R^(2f), —C(═O)—NHR^(2g), —C(═O)—NR^(2h)R^(2i),             —NHC(═O)—NR^(2j)R^(2k) and A^(2a),         -   wherein R^(2a), R^(2b), R^(2c), R^(2d), R^(2e), R^(2f),             R^(2g), R^(2h), R^(2i), R^(2j), and R^(2k), independently of             one another, are (C₁-C₆)alkyl, (C₁-C₆)haloalkyl,             (C₁-C₆)alkoxy-(C₁-C₆)alkyl or a radical of the formula             A^(2b),     -    or is a group of the formula A²,     -   R³ is H, (C₁-C₁₈)alkyl, (C₂-C₁₈)alkenyl or (C₂-C₁₈)alkynyl,         -   wherein each of the last-mentioned three radicals is             unsubstituted or substituted, preferably unsubstituted or             substituted by one or more radicals selected from the group             consisting of halogen, hydroxy, nitro, carbamoyl, sulfo and             radicals of the formulae         -   —O—R^(3a), —S—R^(3b), —S(═O)—R^(3c), —S(═O)₂—R^(3d),             —NR^(3e)R^(3f), —C(═O)—NHR^(3g), —C(═O)—NR^(3h)R^(3i),             —NHC(═O)—NR^(3j)R^(3k) and A^(3b),         -   wherein R^(3a), R^(3b), R^(3c), R^(3d), R^(3e), R^(3f),             R^(3g), R^(3h), R^(3i), R^(3j), and R^(3k), independently of             one another, are (C₁-C₆)alkyl, (C₁-C₆)haloalkyl,             (C₁-C₆)alkoxy-(C₁-C₆)alkyl or a radical of the formula             A^(3b),     -    or is a group of the formula A³,     -   R⁴ is H, (C₁-C₁₈)alkyl, (C₂-C₁₈)alkenyl or (C₂-C₁₈)alkynyl,         -   wherein each of the last-mentioned three radicals is             unsubstituted or substituted, preferably unsubstituted or             substituted by one or more radicals selected from the group             consisting of halogen, hydroxy, nitro, carbamoyl, sulfo and             radicals of the formulae         -   —O—R^(4a), —S—R^(4b), —S(═O)—R^(4c), —S(═O)₂—R^(4d),             —NR^(4e)R^(4f), —C(═O)—NHR^(4g), —C(═O)—NR^(4h)R^(4i),             —NHC(═O)—NR^(4j)R^(4k) and A^(4a),         -   wherein R^(4a), R^(4b), R^(4c), R^(4d), R^(4e), R^(4f),             R^(4g), R^(4h), R^(4i), R^(4j), and R^(4k), independently of             one another, are (C₁-C₆)alkyl, (C₁-C₆)haloalkyl,             (C₁-C₆)alkoxy-(C₁-C₆)alkyl or a radical of the formula             A^(4b),     -    or is a group of the formula A⁴,     -   R⁵ is H, (C₁-C₁₈)alkyl, (C₂-C₁₈)alkenyl or (C₂-C₁₈)alkynyl,         -   wherein each of the last-mentioned three radicals is             unsubstituted or substituted, preferably unsubstituted or             substituted by one or more radicals selected from the group             consisting of halogen, hydroxy, nitro, carbamoyl, sulfo and             radicals of the formulae         -   —O—R^(5a), —S—R^(5b), —S(═O)—R^(5c), —S(═O)₂—R^(5d),             —NR^(5e)R^(5f), —C(═O)—NHR^(5g), —C(═O)—NR^(5h)R^(5i),             —NHC(═O)—NR^(5j)R^(5k) and A^(5a),         -   wherein R^(5a), R^(5b), R^(5c), R^(5d), R^(5e), R^(5f),             R^(5g), R^(5h), R^(5i), R^(5j), and R^(5k), independently of             one another, are (C₁-C₆)alkyl, (C₁-C₆)haloalkyl,             (C₁-C₆)alkoxy-(C₁-C₆)alkyl or a radical of the formula             A^(5b),     -    or is a group of the formula A⁵,     -   R⁶ is H, (C₁-C₁₈)alkyl, (C₂-C₁₈)alkenyl or (C₂-C₁₈)alkynyl,         -   wherein each of the last-mentioned three radicals is             unsubstituted or substituted, preferably unsubstituted or             substituted by one or more radicals selected from the group             consisting of halogen, hydroxy, nitro, carbamoyl, sulfo and             radicals of the formulae         -   —O—R^(6a), —S—R^(6b), —S(═O)—R^(6c), —S(═O)₂—R^(6d),             —NR^(6e)R^(6f), —C(═O)—NHR^(6g), —C(═O)—NR^(6h)R^(6i),             —NHC(═O)—NR^(6j)R^(6k) and A^(6a),         -   wherein R^(6a), R^(6b), R^(6c), R^(6d), R^(6e), R^(6f),             R^(6g), R^(6h), R^(6i), R^(6j), and R^(6k), independently of             one another, are (C₁-C₆)alkyl, (C₁-C₆)haloalkyl,             (C₁-C₆)alkoxy-(C₁-C₆)alkyl or a radical of the formula             A^(6b),     -    or is a group of the formula A⁶, or     -   R¹ and R² or R³ and R⁴ together with the N-atom linked to each         other form a N-heterocyclic ring having 3 to 7 ring atoms and         optionally having one or more additional hetero atoms selected         from the group consisting of N, O and S and which is         unsubstituted or substituted, preferably unsubstituted or         substituted by one or more radicals selected from the group         consisting of halogen, hydroxy, nitro, carbamoyl, sulfo,         (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy-(C₁-C₆)alkyl,         (C₁-C₆)alkoxy, (C₁-C₆)haloalkoxy, (C₁-C₆)alkoxy-(C₁-C₆)alkoxy,         (C₁-C₆)alkylthio, (C₁-C₆)alkylsulfinyl,         (C₁-C₆)haloalkylsulfinyl, (C₁-C₆)alkylsulfonyl,         (C₁-C₆)haloalkylsulfonyl, di-[(C₁-C₄)alkyl]-amino,         (C₁-C₄)alkylamino-carbonyl, di-[(C₁-C₄)alkyl]-amino-carbonyl,         (C₁-C₄)alkylamino-carbonylamino,         di-[(C₁-C₄)alkyl]-aminocarbonylamino and oxo,     -   A¹, A^(1a), A^(1b), A², A^(2a), A^(2b), A³, A^(3a), A^(3b), A⁴,         A^(4a), A^(4b), A⁵, A^(5a), A^(5b), A⁶, A^(6a), and A^(6b),         independently of one another, are (C₃-C₉)cycloalkyl,         (C₄-C₉)cycloalkenyl, (C₅-C₉)cycloalkinyl, aryl or heterocyclyl         as a basic cyclic moiety, wherein the basic cyclic moiety is         unsubstituted or substituted, preferably         -   (a) is unsubstituted or substituted by one or more radicals             selected from the group consisting of halogen, hydroxy,             nitro, carbamoyl, sulfo, (C₁-C₆)alkyl, (C₁-C₆)haloalkyl,             (C₁-C₆)alkoxy-(C₁-C₆)alkyl, (C₁-C₆)alkoxy,             (C₁-C₆)haloalkoxy, (C₁-C₆)alkoxy-(C₁-C₆)alkoxy,             (C₁-C₆)alkylthio, (C₁-C₆)alkylsulfinyl,             (C₁-C₆)haloalkylsulfinyl, (C₁-C₆)alkylsulfonyl,             (C₁-C₆)haloalkylsulfonyl, di-[(C₁-C₄)alkyl]-amino,             (C₁-C₄)alkylamino-carbonyl,             di-[(C₁-C₄)alkyl]-amino-carbonyl,             (C₁-C₄)alkylamino-carbonylamino and             di-[(C₁-C₄)alkyl]-amino-carbonylamino and, in case of             heterocyclyl, also oxo attached to heteroring atoms N or S             or in alpha-position of an N-atom as heteroring atom,         -   or         -   (b) is substituted by or substituted additionally to one or             more of the substituents mentioned in (a) by a bridge linked             geminal (a 1,1-position), vicinal (a 1,2-position) or in a             1,3-position at the basic cyclic moiety thus forming another             carbocyclic or heterocyclic ring together with the part of             the basic cyclic moiety between the atoms linked to the             bridge,             -   preferably by a bridge linked in a vicinal position of                 the basic cyclic moiety thus forming a carbocyclic or                 heterocyclic ring condensed with the basic cyclic                 moiety,         -    wherein the carbocyclic or heterocyclic ring formed is             saturated, partly unsaturated, unsaturated, aromatic or             heteroaromatic and wherein the bridge is further             unsubstituted or substituted,             -   preferably is further unsubstituted or substituted by                 one or more radicals selected from the group consisting                 of halogen, hydroxy, nitro, carbamoyl, sulfo,                 (C₁-C₆)alkyl, (C₁-C₆)haloalkyl,                 (C₁-C₆)alkoxy-(C₁-C₆)alkyl, (C₁-C₆)alkoxy,                 (C₁-C₆)haloalkoxy, (C₁-C₆)alkoxy-(C₁-C₆)alkoxy,                 (C₁-C₆)alkylthio, (C₁-C₆)alkylsulfinyl,                 (C₁-C₆)haloalkylsulfinyl, (C₁-C₆)alkylsulfonyl,                 (C₁-C₆)haloalkylsulfonyl, di-[(C₁-C₄)alkyl]-amino,                 (C₁-C₄)alkylamino-carbonyl,                 di-[(C₁-C₄)alkyl]-amino-carbonyl,                 (C₁-C₄)alkylamino-carbonylamino and                 di-[(C₁-C₄)alkyl]-aminocarbonylamino,     -   B¹ is a group as defined for R¹ further linked to the amino         group of the group of the formula (I*)

-   -   -   wherein R²*, R³*, R⁴*, R⁵*, X* and Y* are independently as             defined in formula (I) for R², R³, R⁴, R⁵, X and Y,             respectively,

    -   X and Y each, independently of one another, are selected from         the group consisting of         -   (i) amino,         -   (ii) a group of the formula NR⁷R⁸ in which R⁷ is a radical             selected from the group consisting of radicals as defined             for and independently of R¹, and in which R⁸ is a radical             selected from the group consisting of radicals as defined             for and independently of R², preferably a group of the             formula NR⁷R⁸ which is defined as the group NR¹R² in formula             (I),         -   (iii) hydroxy,         -   (iv) (C₁-C₆)alkoxy, (C₁-C₆)haloalkoxy,             (C₁-C₆)alkoxy-(C₁-C₆)alkoxy and (C₁-C₆)alkylthio,         -   (v) (C₁-C₆)alkoxy, (C₁-C₆)haloalkoxy,             (C₁-C₆)alkoxy-(C₁-C₆)alkoxy and (C₁-C₆)alkylthio, wherein             each of the latter 4 radicals is substituted by one or more             radicals selected from the group consisting of             (C₃-C₆)cycloalkyl, (C₃-C₆)cycloalkoxy,             -   wherein each of the last-mentioned 2 radicals is                 unsubstituted or substituted by one or more radicals                 selected from the group consisting of halogen, hydroxy;                 carbamoyl, (C₁-C₆)alkyl, (C₁-C₆)haloalkyl,                 (C₁-C₆)alkoxy-(C₁-C₆)alkyl, (C₁-C₆)alkoxy,                 (C₁-C₆)haloalkoxy and (C₁-C₆)alkoxy-(C₁-C₆)alkoxy,         -    aryl and aryloxy,             -   wherein each of the last-mentioned 2 radicals is                 unsubstituted or substituted by one or more radicals                 selected from the group consisting of halogen, hydroxy,                 nitro, carbamoyl, sulfo, (C₁-C₆)alkyl, (C₁-C₆)haloalkyl,                 (C₁-C₆)alkoxy-(C₁-C₆)alkyl, (C₁-C₆)alkoxy,                 (C₁-C₆)haloalkoxy, (C₁-C₆)alkoxy-(C₁-C₆)alkoxy,                 (C₁-C₆)alkylthio, (C₁-C₆)alkylsulfinyl,                 (C₁-C₆)haloalkylsulfinyl, (C₁-C₆)alkylsulfonyl,                 (C₁-C₆)haloalkylsulfonyl, di-[(C₁-C₄)alkyl]-amino,                 (C₁-C₄)alkylamino-carbonyl,                 di-[(C₁-C₄)alkyl]-amino-carbonyl,                 (C₁-C₄)alkylamino-carbonylamino and                 di-[(C₁-C₄)alkyl]-aminocarbonylamino,         -   (vi) (C₃-C₆)cycloalkoxy which is unsubstituted or             substituted             -   by one or more radicals selected from the group                 consisting of halogen, hydroxy, carbamoyl, (C₁-C₆)alkyl,                 (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy-(C₁-C₆)alkyl,                 (C₁-C₆)alkoxy, (C₁-C₆)haloalkoxy and                 (C₁-C₆)alkoxy-(C₁-C₆)alkoxy,         -   (vii) aryloxy which is unsubstituted or substituted,             -   preferably unsubstituted or substituted by one or more                 radicals selected from the group consisting of halogen,                 hydroxy, nitro, carbamoyl, sulfo, (C₁-C₆)alkyl,                 (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy-(C₁-C₆)alkyl,                 (C₁-C₆)alkoxy, (C₁-C₆)haloalkoxy,                 (C₁-C₆)alkoxy-(C₁-C₆)alkoxy, (C₁-C₆)alkylthio,                 (C₁-C₆)alkylsulfinyl, (C₁-C₆)haloalkylsulfinyl,                 (C₁-C₆)alkylsulfonyl, (C₁-C₆)haloalkylsulfonyl,                 di-[(C₁-C₄)alkyl]-amino, (C₁-C₄)alkylamino-carbonyl,                 di-[(C₁-C₄)alkyl]-amino-carbonyl,                 (C₁-C₄)alkylamino-carbonylamino and                 di-[(C₁-C₄)alkyl]-aminocarbonylamino,         -    and         -   (viii) acyloxy, acylthio or acylamino, preferably acyloxy,         -   more preferably are each selected from the above groups             (ii), (iv), (v), (vi), (vii) and (viii), more preferably             from the above groups (ii), (iv) and (v),         -   or

    -   X and Y together are a divalent group of the formula —U¹-D*-U²—         in which         -   D* is a hydrocarbon bridge, optionally interrupted by one or             more divalent groups of the formula U³ defined below,             -   or, preferably,             -   is a linear alkylene bridge, a linear (C₂-C₁₀)alkenylene                 bridge, a linear (C₂-C₁₀)alkynylene bridge, a                 (C₃-C₉)cycloalkylene bridge, a phenylene bridge or a                 bridge consisting of a combination of two or more of                 said linear acyclic and cyclic moieties having in total                 4 to 24 carbon atoms, wherein the bridge in each case is                 unsubstituted or substituted, preferably unsubstituted                 or substituted by one or more radicals selected from the                 group consisting of halogen, hydroxy, nitro, carbamoyl,                 sulfo, (C₁-C₆)alkyl, (C₁-C₆)haloalkyl,                 (C₁-C₆)alkoxy-(C₁-C₆)alkyl, (C₁-C₆)alkoxy,                 (C₁-C₆)haloalkoxy, (C₁-C₆)alkoxy-(C₁-C₆)alkoxy,                 (C₁-C₆)alkylthio, (C₁-C₆)alkylsulfinyl,                 (C₁-C₆)haloalkylsulfinyl, (C₁-C₆)alkylsulfonyl,                 (C₁-C₆)haloalkylsulfonyl, di-[(C₁-C₄)alkyl]-amino,                 (C₁-C₄)alkylamino-carbonyl,                 di-[(C₁-C₄)alkyl]-amino-carbonyl,                 (C₁-C₄)alkylamino-carbonylamino and                 di-[(C₁-C₄)alkyl]-aminocarbonylamino, and         -   U¹, U² and U³, independently of each other are selected from             the group consisting of NH, NR′, O and S, wherein R′ is             (C₁-C₆)alkyl, hydroxy-(C₁-C₆)alkyl or             (C₁-C₆)alkoxy-(C₁-C₆)alkyl,         -   or

    -   X is a radical as defined above and Y is an organic ligand based         on a compound of the formula Y′—H, Y′—R^(L) or         R^(L)—U³-D**-U⁴—R^(LL) wherein D** is a divalent group as         defined for the group D* above, Y′ is a radical as defined for         Y, U³ is a divalent group as defined for U¹ above, U⁴ is a         divalent group as defined for U² above, each of R^(L) and R^(LL)         is a radical group selected from the group consisting of         (C₁-C₆)alkyl, hydroxy-(C₁-C₆)alkyl or         (C₁-C₆)alkoxy-(C₁-C₆)alkyl, and wherein the organic ligand is         coordinated to the aluminium atom of the complex by a free         electron pair of a hetero atom contained therein and selected         from the group consisting of N, O and S,         -   or

    -   X and Y together are a radical of the formula —U′-D*-U²—R^(LLL)         in which U¹, U² and D* are as defined above, and R^(LLL) is a         radical selected from the group consisting of (C₁-C₆)alkyl,         hydroxy-(C₁-C₆)alkyl or (C₁-C₆)alkoxy-(C₁-C₆)alkyl, and wherein         the radical —U′-D*-U²—R^(LLL) is additionally coordinated to the         aluminium atom of the complex by a free electron pair located at         a hetero atom contained in the radical (position represented by         Y), preferably located at the heteroatom of the divalent group         U².

In the present patent specification, including the accompanying claims, the aforementioned substituents have the following meanings:

Halogen means fluorine, chlorine, bromine or iodine. In case of a radical “halogen” means a fluorine, chlorine, bromine or iodine atom.

The term “halo” before the name of a radical means that this radical is partially or completely halogenated, that is to say substituted by F, Cl, Br or I in any combination. The expression “(C₁-C₆)alkyl” means an unbranched or branched non-cyclic saturated hydrocarbon radical having 1, 2, 3, 4, 5 or 6 carbon atoms (indicated by a range of C-atoms in the parenthesis), such as, for example a methyl, ethyl, propyl, isopropyl, 1-butyl, 2-butyl, 2-methylpropyl or tert-butyl radical. The same applies to alkyl groups in composite radicals such as “alkoxyalkyl”.

Alkyl radicals and also in composite groups, unless otherwise defined, preferably have 1 to 4 carbon atoms.

“(C₁-C₆)Haloalkyl” means an alkyl group mentioned under the expression “(C₁-C₆)alkyl” in which one or more hydrogen atoms are replaced by the same number of identical or different halogen atoms, such as monohaloalkyl, perhaloalkyl, CF₃, CHF₂, CH₂F, CHFCH₃, CF₃CH₂, CF₃CF₂, CHF₂CF₂, CH₂FCHCl, CH₂Cl, CCl₃, CHCl₂ or CH₂CH₂Cl.

“[(C₁-C₄)alkoxy](C₁-C₆)alkyl” means (C₁-C₆)alkyl which is substituted by (C₁-C₄)alkoxy. “(C₁-C₆)Alkoxy” means an alkoxy group whose carbon chain has the meaning given under the expression “(C₁-C₆)alkyl”. “Haloalkoxy” is, for example, OCF₃, OCHF₂, OCH₂F, CF₃CF₂O, OCH₂CF₃ or OCH₂CH₂Cl.

“(C₂-C₆)Alkenyl” means an unbranched or branched non-cyclic carbon chain having a number of carbon atoms which corresponds to this stated range and which contains at least one double bond which can be located in any position of the respective unsaturated radical. “(C₂-C₆)alkenyl” accordingly denotes, for example, the vinyl, allyl, 2-methyl-2-propenyl, 2-butenyl, pentenyl, 2-methylpentenyl or the hexenyl group. “(C₂-C₆)alkynyl” means an unbranched or branched non-cyclic carbon chain having a number of carbon atoms which corresponds to this stated range and which contains one triple bond which can be located in any position of the respective unsaturated radical. “(C₂-C₆)alkynyl” accordingly denotes, for example, the propargyl, 1-methyl-2-propynyl, 2-butynyl or 3-butynyl group.

yclohexadienyl.

A hydrocarbon radical or bridge is a monovalent or divalent group, respectively, which consists of carbon and hydrogen atoms and which is a linear or branched acyclic or a cyclic group or a group consisting of acyclic and cyclic moieties, and which group is saturated, partly unsaturated, fully unsaturated or aromatic or which group consists of two or more of said structural moieties linked to each other.

Cycloalkyl is a carbocyclic saturated ring system having preferably 3-8 carbon atoms, for example cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl. In the case of substituted cycloalkyl, cyclic systems with substituents are included, where the substituents are bonded by a double bond on the cycloalkyl radical, for example an alkylidene group such as methylidene. In the case of substituted cycloalkyl, polycyclic aliphatic systems are also included, for example bicyclo[1.1.0]butan-1-yl, bicyclo[1.1.0]butan-2-yl, bicyclo[2.1.0]pentan-1-yl, bicyclo[2.1.0]pentan-2-yl, bicyclo[2.1.0]pentan-5-yl, adamantan-1-yl and adamantan-2-yl.

Cycloalkenyl is a carbocyclic, nonaromatic, partially unsaturated ring system having preferably 4-8 carbon atoms, for example 1-cyclobutenyl, 2-cyclobutenyl, 1-cyclopentenyl, 2-cyclopentenyl, 3-cyclopentenyl, or 1-cyclohexenyl, 2-cyclohexenyl, 3-cyclohexenyl, 1,3-cyclohexadienyl or 1,4-cyclohexadienyl. In the case of substituted cycloalkenyl, the explanations for substituted cycloalkyl apply correspondingly.

Haloalkyl, -alkenyl and -alkynyl are, respectively, alkyl, alkenyl and alkynyl substituted partly or fully by identical or different halogen atoms, preferably from the group of fluorine, chlorine and bromine, in particular from the group of fluorine and chlorine, for example monohaloalkyl, perhaloalkyl, CF₃, CHF₂, CH₂F, CF₃CF₂, CH₂FCHCl, CCl₃, CHCl₂, CH₂CH₂Cl; haloalkoxy is, for example OCF₃, OCHF₂, OCH₂F, CF₃CF₂O, OCH₂CF₃ and OCH₂CH₂Cl; the same applies to haloalkenyl and other halogen-substituted radicals.

Aryl is a mono-, bi- or polycyclic aromatic system, for example phenyl, naphthyl, tetrahydronaphthyl, indenyl, indanyl, pentalenyl, fluorenyl and the like, preferably phenyl.

A heterocyclic radical or ring (heterocyclyl) can be saturated, partially unsaturated, unsaturated or heteroaromatic; unless defined otherwise, it preferably contains one or more, in particular 1, 2 or 3, heteroatoms in the heterocyclic ring, preferably from the group of N, O and S; it is preferably an aliphatic heterocyclyl radical having from 3 to 7 ring atoms or a heteroaromatic radical having 5 or 6 ring atoms. The heterocyclic radical may, for example, be a heteroaromatic radical or ring (heteroaryl), for example a mono-, bi- or polycyclic aromatic system in which at least one ring contains one or more heteroatoms. It is preferably a heteroaromatic ring having a heteroatom from the group of N, O and S, for example pyridyl, pyrrolyl, thienyl or furyl; it is also preferably a corresponding heteroaromatic ring having 2 or 3 heteroatoms, for example pyrimidinyl, pyridazinyl, pyrazinyl, triazinyl, thiazolyl, thiadiazolyl, oxazolyl, isoxazolyl, pyrazolyl, imidazolyl and triazolyl. It is also preferably a partially or fully hydrogenated heterocyclic radical having one heteroatom from the group of N, O and S, for example oxiranyl, oxetanyl, oxolanyl (=tetrahydrofuryl), oxanyl, pyrrolinyl, pyrrolidyl or piperidyl.

It is also preferably a partially or fully hydrogenated heterocyclic radical having 2 heteroatoms from the group of N, O and S, for example piperazinyl, dioxolanyl, oxazolinyl, isoxazolinyl, oxazolidinyl, isoxazolidinyl and morpholinyl.

Possible substituents for a substituted heterocyclic radical include the substituents specified below, and additionally also oxo. The oxo group may also occur on the ring heteroatoms which may exist in various oxidation states, for example in the case of N and S.

Preferred examples of heterocyclyl are a heterocyclic radical having from 3 to 6 ring atoms from the group of pyridyl, thienyl, furyl, pyrrolyl, oxiranyl, 2-oxetanyl, 3-oxetanyl, oxolanyl (=tetrahydrofuryl), pyrrolidyl, piperidyl, especially oxiranyl, 2-oxetanyl, 3-oxetanyl or oxolanyl, or is a heterocyclic radical having two or three heteroatoms, for example pyrimidinyl, pyridazinyl, pyrazinyl, triazinyl, thienyl, thiazolyl, thiadiazolyl, oxazolyl, isoxazolyl, pyrazolyl, triazolyl, piperazinyl, dioxolanyl, oxazolinyl, isoxazolinyl, oxazolidinyl, isoxazolidinyl or morpholinyl.

When a base structure is substituted “by one or more radicals” from a list of radicals (=group) or a generically defined group of radicals, this in each case includes simultaneous substitution by a plurality of identical and/or structurally different radicals.

Substituted radicals, such as a substituted alkyl, alkenyl, alkynyl, aryl, phenyl, benzyl, heterocyclyl and heteroaryl radical, are, for example, a substituted radical derived from the unsubstituted base structure, where the substituents are, for example, one or more, preferably 1, 2 or 3, radicals from the group of halogen, alkoxy, alkylthio, hydroxyl, amino, nitro, carboxyl, cyano, azido, alkoxycarbonyl, alkylcarbonyl, formyl, carbamoyl, mono- and dialkylaminocarbonyl, substituted amino such as acylamino, mono- and dialkylamino, alkylsulfinyl, alkylsulfonyl and, in the case of cyclic radicals, also alkyl, haloalkyl, alkylthioalkyl, alkoxyalkyl, optionally substituted mono- and dialkylaminoalkyl and hydroxyalkyl; in the term “substituted radicals”, such as substituted alkyl, etc., substituents include, in addition to the saturated hydrocarbon radicals mentioned, corresponding unsaturated and aromatic radicals, such as optionally substituted alkenyl, alkynyl, alkenyloxy, alkynyloxy, phenyl, phenoxy, etc. In the case of substituted cylic radicals having aliphatic moieties in the ring, cyclic systems with those substituents which are bonded on the ring by a double bond are also included, for example substituted by an alkylidene group such as methylidene or ethylidene.

It should be noted that in the present case those of the above groups which can easily react under the reaction conditions with the cyanoguanidine of formula (III) or with the amino group of the compound (II) in the process for preparing a compound of the formula (I) are not preferred or need to be masked by a “protective group” if such a functional group shall be implemented.

The substituents mentioned by way of example (“first substituent level”) may, when they contain hydrocarbon moieties, optionally be further substituted there (“second substituent level”), for example by one of the substituents as defined for the first substituent level. Corresponding further substituent levels are possible. The term “substituted radical” preferably includes only one or two substituent levels.

Preferred substituents for the substituent levels are, for example,

amino, hydroxyl, halogen, nitro, cyano, mercapto, carboxyl, carbonamide, SF₅, aminosulfonyl, alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, monoalkylamino, dialkylamino, N-alkanoylamino, alkoxy, alkenyloxy, alkynyloxy, cycloalkoxy, cycloalkenyloxy, alkoxycarbonyl, alkenyloxycarbonyl, alkynyloxycarbonyl, aryloxycarbonyl, alkanoyl, alkenylcarbonyl, alkynylcarbonyl, arylcarbonyl, alkylthio, cycloalkylthio, alkenylthio, cycloalkenylthio, alkynylthio, alkylsulfinyl, alkylsulfonyl, monoalkylaminosulfonyl, dialkylaminosulfonyl, N-alkylaminocarbonyl, N,N-dialkyl-aminocarbonyl, N-alkanoylaminocarbonyl, N-alkanoyl-N-alkylaminocarbonyl, aryl, aryloxy, benzyl, benzyloxy, benzylthio, arylthio, arylamino and benzylamino.

In the case of radicals with carbon atoms, preference is given to those having from 1 to 6 carbon atoms, preferably from 1 to 4 carbon atoms, in particular 1 or 2 carbon atoms. In general, preferred substituents are those from the group of halogen, e.g. fluorine and chlorine, (C₁-C₄)alkyl, preferably methyl or ethyl, (C₁-C₄)haloalkyl, preferably trifluoromethyl, (C₁-C₄)alkoxy, preferably methoxy or ethoxy, (C₁-C₄)haloalkoxy, nitro and cyano. Preference is given to the substituents methyl, methoxy, fluorine and chlorine.

Substituted amino, such as mono- or disubstituted amino, is a radical from the group of the substituted amino radicals which are N-substituted, for example, by one or two identical or different radicals from the group of alkyl, alkoxy, acyl and aryl; preferably mono- and dialkylamino, mono- and diarylamino, acylamino, N,N-diacylamino, N-alkyl-N-arylamino, N-alkyl-N-acylamino and N-heterocycles; preference is given to alkyl radicals having from 1 to 4 carbon atoms; aryl is preferably phenyl or substituted phenyl; acyl is as defined below, preferably (C₁-C₄)alkanoyl. The same applies to substituted hydroxylamino or hydrazino.

Optionally substituted phenyl is preferably phenyl which is unsubstituted or mono- or polysubstituted, preferably up to trisubstituted, by identical or different radicals from the group of halogen, (C₁-C₄)alkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkyl, (C₁-C₄)haloalkoxy and nitro, for example o-, m- and p-tolyl, dimethylphenyls, 2-, 3- and 4-chlorophenyl, 2-, 3- and 4-trifluoro- and -trichlorophenyl, 2,4-, 3,5-, 2,5- and 2,3-dichlorophenyl, o-, m- and p-methoxyphenyl.

The invention also provides all stereoisomers which are encompassed by formula (I) and mixtures thereof. Such compounds of the formula (I) contain one or more asymmetric carbon atoms or else double bonds which are not stated specifically in the general formulae (I). The possible stereoisomers defined by their specific three-dimensional shape, such as enantiomers, diastereomers, Z- and E-isomers, are all encompassed by the formula (I) and can be obtained from mixtures of the stereoisomers by customary methods or else prepared by stereoselective reactions in combination with the use of stereochemically pure starting materials.

The expression “one or more radicals selected from the group consisting of” in the definition is to be understood as meaning in each case one or more identical or different radicals selected from the stated group of radicals, unless specific limitations are defined expressly.

Acyl is a radical of an organic acid which arises in a formal sense by removal of a hydroxyl group on the acid function, and the organic radical in the acid may also be bonded to the acid function via a heteroatom. Examples of acyl are the —CO—R radical of a carboxylic acid HO—CO—R and radicals of acids derived therefrom, such as those of thiocarboxylic acid, optionally N-substituted iminocarboxylic acids or the radical of carbonic monoesters, N-substituted carbamic acid, sulfonic acids, sulfinic acids, N-substituted sulfonamide acids, phosphonic acids or phosphinic acids.

Acyl is, for example, formyl, alkylcarbonyl such as [(C₁-C₄)alkyl]carbonyl, phenylcarbonyl, alkyloxycarbonyl, phenyloxycarbonyl, benzyloxycarbonyl, alkylsulfonyl, alkylsulfinyl, N-alkyl-1-iminoalkyl and other radicals of organic acids. The radicals may each be substituted further in the alkyl or phenyl moiety, for example in the alkyl moiety by one or more radicals from the group of halogen, alkoxy, phenyl and phenoxy; examples of substituents in the phenyl moiety are the substituents already mentioned above in general for substituted phenyl.

Acyl is preferably an acyl radical in the narrower sense, i.e. a radical of an organic acid in which the acid group is bonded directly to the carbon atom of an organic radical, for example formyl, alkylcarbonyl such as acetyl or [(C₁-C₄)alkyl]carbonyl, optionally substituted phenylcarbonyl, such as benzoyl, alkylsulfonyl, such as methylsulfonyl, alkylsulfinyl, optionally substituted arylsulfonyl, such as phenylsulfonyl or p-tolylsulfonyl and other radicals of organic acids.

The invention also provides all stereoisomers which are encompassed by formula (I) and mixtures thereof. Such compounds of the formula (I) contain one or more asymmetric carbon atoms or else double bonds which are not stated specifically in the general formulae (I). The possible stereoisomers defined by their specific three-dimensional shape, such as enantiomers, diastereomers, Z- and E-isomers, are all encompassed by the formula (I) and can be obtained from mixtures of the stereoisomers by customary methods or else prepared by stereoselective reactions in combination with the use of stereochemically pure starting materials.

Compounds of the stated formula (I) according to the invention in which individual radicals have one of the preferred meanings which have already been stated or are stated hereinbelow and particularly those shown in the Table examples, or in particular those in which two or more of the preferred meanings which have already been stated or which are stated hereinbelow are combined, are of particular interest, mainly because of the ease of preparation or efficacy in the process of forming the aluminium complexes or in the process of forming triazines from the aluminium complexes.

Of particular interest are compounds of formula (I) where a radical selected from the group of radicals R¹, R², R³, R⁴, R⁵, R⁶, X and Y is preferably defined as set forth below.

In the following preferred definitions it is generally to be understood that where symbols are not specifically defined for a specific group of compounds they are to be defined as defined for the compounds in formula (I) or the respective generic formula or for preferred compounds of formula (I) or the respective preferred formula in the description.

-   -   R¹ preferably is (C₁-C₁₂)alkyl, (C₂-C₁₂)alkenyl or         (C₂-C₁₂)alkynyl, more preferably (C₁-C₆)alkyl, (C₂-C₆)alkenyl or         (C₂-C₆)alkynyl,         -   wherein each of the last-mentioned six radicals is             unsubstituted or substituted, preferably unsubstituted or             substituted by one or more radicals selected from the group             consisting of         -   halogen, hydroxy, nitro, carbamoyl, sulfo and radicals of             the formulae —O—R^(1a), —S—R^(1b), —S(═O)—R^(1c),             —S(═O)₂—R^(1d), —NR^(1e)R^(1f), —C(═O)—NHR^(1g),             —C(═O)—NR^(1h)R^(1i), —NHC(═O)—NR^(1j)R^(1k) and A^(1a),         -   more preferably by one or more radicals selected from the             group consisting of halogen, hydroxy and radicals of the             formulae —O—R^(1a), —S—R^(1b), —S(═O)—R^(1c),             —S(═O)₂—R^(1d), —NR^(1e)R^(1f) and A^(1a),         -   more preferably by one or more radicals selected from the             group consisting of halogen, hydroxy and radicals of the             formula —O—R^(1a) and A^(1a),         -   wherein R^(1a), R^(1b), R^(1c), R^(1d), R^(1e), R^(1f),             R^(1g), R^(1h), R^(1i), R^(1j), and R^(1k), independently of             one another, are (C₁-C₆)alkyl, (C₁-C₆)haloalkyl,             (C₁-C₆)alkoxy-(C₁-C₆)alkyl or a radical of the formula             A^(1b), preferably are (C₁-C₄)alkyl, (C₁-C₄)haloalkyl,             (C₁-C₄)alkoxy-(C₁-C₄)alkyl or a radical of the formula             A^(1b),         -   more preferably are (C₁-C₄)alkyl or a radical of the formula             A^(1b),     -   or is a group of the formula A¹ or B¹, preferably of the formula         A¹,     -   or     -   R¹ and R² together with the N-atom linked to each other form a         N-heterocyclic ring having 5 or 6 ring atoms and optionally         having 1, 2 or 3 additional hetero atoms selected from the group         consisting of N, O and S and which is unsubstituted or         substituted by one or more radicals selected from the group         consisting of halogen, hydroxy, nitro, carbamoyl, sulfo,         (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy-(C₁-C₆)alkyl,         (C₁-C₆)alkoxy, (C₁-C₆)haloalkoxy, (C₁-C₆)alkoxy-(C₁-C₆)alkoxy,         (C₁-C₆)alkylthio, (C₁-C₆)alkylsulfinyl,         (C₁-C₆)haloalkylsulfinyl, (C₁-C₆)alkylsulfonyl,         (C₁-C₆)haloalkylsulfonyl, di-[(C₁-C₄)alkyl]-amino,         (C₁-C₄)alkylamino-carbonyl di-[(C₁-C₄)alkyl]-amino-carbonyl,         (C₁-C₄)alkylamino-carbonylamino,         di-[(C₁-C₄)alkyl]-aminocarbonylamino and oxo,         -   preferably unsubstituted or substituted by one or more             radicals selected from the group consisting of halogen,             hydroxy, nitro, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl,             (C₁-C₄)alkoxy-(C₁-C₄)alkyl, (C₁-C₄)alkoxy,             (C₁-C₄)haloalkoxy, (C₁-C₄)alkoxy-(C₁-C₄)alkoxy,             (C₁-C₄)alkylthio, (C₁-C₄)alkylsulfonyl,             (C₁-C₄)haloalkylsulfonyl and oxo,         -   more preferably unsubstituted or substituted by one or more             radicals selected from the group consisting of halogen,             (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₁-C₄)alkoxy,             (C₁-C₄)alkylsulfonyl, (C₁-C₄)haloalkylsulfonyl and oxo,     -   A¹, A^(1a) and A^(1b), independently of one another, are         (C₃-C₉)cycloalkyl, (C₄-C₉)cycloalkenyl, (C₅-C₉)cycloalkinyl,         aryl or heterocyclyl as a basic cyclic moiety, wherein the basic         cyclic moiety is unsubstituted or substituted, preferably         -   (a) is unsubstituted or substituted by one or more radicals             selected from the group consisting of halogen, hydroxy,             nitro, carbamoyl, sulfo, (C₁-C₆)alkyl, (C₁-C₆)haloalkyl,             (C₁-C₆)alkoxy-(C₁-C₆)alkyl, (C₁-C₆)alkoxy,             (C₁-C₆)haloalkoxy, (C₁-C₆)alkoxy-(C₁-C₆)alkoxy,             (C₁-C₆)alkylthio, (C₁-C₆)alkylsulfinyl,             (C₁-C₆)haloalkylsulfinyl, (C₁-C₆)alkylsulfonyl,             (C₁-C₆)haloalkylsulfonyl, di-[(C₁-C₄)alkyl]-amino,             (C₁-C₄)alkylamino-carbonyl di-[(C₁-C₄)alkyl]-amino-carbonyl,             (C₁-C₄)alkylamino-carbonylamino and             di-[(C₁-C₄)alkyl]-amino-carbonylamino and, in case of             heterocyclyl, also oxo attached to heteroring atoms N or S             or in alpha-position of an N-atom as heteroring atom,             -   more preferably is unsubstituted or substituted in the                 cyclic moiety by one or more radicals selected from the                 group consisting of halogen, hydroxy, nitro, sulfo,                 (C₁-C₄)alkyl, (C₁-C₄)haloalkyl,                 (C₁-C₄)alkoxy-(C₁-C₄)alkyl, (C₁-C₄)alkoxy,                 (C₁-C₄)haloalkoxy, (C₁-C₄)alkoxy-(C₁-C₄)alkoxy,                 (C₁-C₄)alkylthio, (C₁-C₄)alkylsulfinyl,                 (C₁-C₄)haloalkyl-sulfinyl, (C₁-C₄)alkylsulfonyl and                 (C₁-C₄)haloalkylsulfonyl, more preferably is                 unsubstituted or substituted in the cyclic moiety by one                 or more radicals selected from the group consisting of                 halogen, hydroxy, nitro, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl,                 (C₁-C₄)alkoxy-(C₁-C₄)alkyl, (C₁-C₄)alkoxy,                 (C₁-C₄)haloalkoxy, (C₁-C₄)alkoxy-(C₁-C₄)alkoxy,                 (C₁-C₄)alkylthio, (C₁-C₄)alkylsulfonyl and                 (C₁-C₄)haloalkylsulfonyl, more preferably is                 unsubstituted or substituted in the cyclic moiety by one                 or more radicals selected from the group consisting of                 halogen, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₁-C₄)alkoxy,                 (C₁-C₄)haloalkoxy, (C₁-C₄)alkylthio and                 (C₁-C₄)alkylsulfonyl,         -   or         -   (b) is substituted by or substituted additionally to one or             more of the substituents mentioned in (a) by a bridge linked             geminal (a 1,1-position), vicinal (a 1,2-position) or in a             1,3-position at the basic cyclic moiety thus forming another             carbocyclic or heterocyclic ring together with the part of             the basic cyclic moiety between the atoms linked to the             bridge,             -   preferably by a bridge linked in a vicinal position of                 the basic cyclic moiety thus forming a carbocyclic or                 heterocyclic ring condensed with the basic cyclic                 moiety,         -   wherein the carbocyclic or heterocyclic ring formed is             saturated, partly unsaturated, unsaturated having 3 to 9             ring atoms or is aromatic or heteroaromatic having 5 or 6             ring atoms and wherein the bridge is further unsubstituted             or substituted,         -   preferably wherein the bridge forming a ring is further             unsubstituted or substituted by one or more radicals             selected from the group consisting of halogen, hydroxy,             nitro, carbamoyl, sulfo, (C₁-C₆)alkyl, (C₁-C₆)haloalkyl,             (C₁-C₆)alkoxy-(C₁-C₆)alkyl, (C₁-C₆)alkoxy,             (C₁-C₆)haloalkoxy, (C₁-C₆)alkoxy-(C₁-C₆)alkoxy,             (C₁-C₆)alkylthio, (C₁-C₆)alkylsulfinyl,             (C₁-C₆)haloalkylsulfinyl, (C₁-C₆)alkylsulfonyl,             (C₁-C₆)haloalkylsulfonyl, di-[(C₁-C₄)alkyl]-amino,             (C₁-C₄)alkylamino-carbonyl,             di-[(C₁-C₄)alkyl]-amino-carbonyl,             (C₁-C₄)alkylamino-carbonylamino and             di-[(C₁-C₄)alkyl]-amino-carbonylamino and, in case of             heterocyclyl, also oxo attached to heteroring atoms N or S             or in alpha-position of an N-atom as heteroring atom,         -   or is further benzocondensated wherein the additional             annellated benzene ring is unsubstituted or further             substituted by one or more radicals as defined for             substitution of the bridge which is benzocondensated,         -   more preferably the bridge forming a ring is further             unsubstituted or substituted by one or more radicals             selected from the group consisting of halogen, hydroxy,             nitro, sulfo, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl,             (C₁-C₄)alkoxy-(C₁-C₄)alkyl, (C₁-C₄)alkoxy,             (C₁-C₄)haloalkoxy, (C₁-C₄)alkoxy-(C₁-C₄)alkoxy,             (C₁-C₄)alkylthio, (C₁-C₄)alkylsulfinyl,             (C₁-C₄)haloalkyl-sulfinyl, (C₁-C₄)alkylsulfonyl and             (C₁-C₄)haloalkylsulfonyl,         -   more preferably the bridge forming a ring is further             unsubstituted or substituted by one or more radicals             selected from the group consisting of halogen, hydroxy,             nitro, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl,             (C₁-C₄)alkoxy-(C₁-C₄)alkyl, (C₁-C₄)alkoxy,             (C₁-C₄)haloalkoxy, (C₁-C₄)alkoxy-(C₁-C₄)alkoxy,             (C₁-C₄)alkylthio, (C₁-C₄)alkylsulfonyl and             (C₁-C₄)haloalkylsulfonyl,         -   more preferably the bridge forming a ring is further             unsubstituted or substituted by one or more radicals             selected from the group consisting of halogen, (C₁-C₄)alkyl,             (C₁-C₄)haloalkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy,             (C₁-C₄)alkylthio and (C₁-C₄)alkylsulfonyl,     -   B¹ is a group as defined for R¹ further linked to the amino         group of the group of the formula (I*),

-   -   -   wherein R²*, R³*, R⁴*, R⁵*, X* and Y* are independently as             defined in formula (I) for R², R³, R⁴, R⁵, X and Y,             respectively.

Examples for R¹ are

(C₁-C₁₂)alkyl, (C₂-C₁₂)alkenyl or (C₂-C₁₂)alkynyl, more preferably (C₁-C₆)alkyl, (C₂-C₆)alkenyl or (C₂-C₆)alkynyl,

-   -   wherein each of the last-mentioned six radicals is unsubstituted         or substituted, preferably unsubstituted or substituted by one         or more radicals selected from the group consisting of halogen,         hydroxy, nitro, carbamoyl, sulfo, (C₁-C₆)alkoxy,         (C₁-C₆)haloalkoxy, (C₁-C₆)alkoxy-(C₁-C₆)alkoxy,         (C₁-C₆)alkylthio, (C₁-C₆)alkylsulfinyl,         (C₁-C₆)haloalkylsulfinyl, (C₁-C₆)alkylsulfonyl,         (C₁-C₆)haloalkylsulfonyl, di-[(C₁-C₄)alkyl]-amino,         (C₁-C₄)alkylamino-carbonyl, di-[(C₁-C₄)alkyl]-amino-carbonyl,         (C₁-C₄)alkylamino-carbonylamino and         di-[(C₁-C₄)alkyl]-amino-carbonylamino, (C₃-C₆)cycloalkyl,         (C₅-C₆)cycloalkenyl, phenyl, naphthyl, heterocyclyl,         benzocondensated heterocycyl, benzo-(C₅-C₆)cycloalkyl,         benzo-(C₅-C₆)cycloalkenyl, (C₃-C₆)cycloalkoxy,         benzo-(C₅-C₆)cycloalkoxy, (C₅-C₆)cycloalkenyloxy,         benzo-(C₅-C₆)cycloalkenyloxy, phenoxy, naphthoxy, phenylthio,         heterocyclyloxy, benzocondensated heterocyclyloxy,         heterocyclylthio, benzocondensated heterocyclylthio         -   wherein each of the last-mentioned 19 radicals is             unsubstituted or substituted in the cyclic moiety by one or             more radicals selected from the group consisting of halogen,             hydroxy, nitro, carbamoyl, sulfo, (C₁-C₄)alkyl,             (C₁-C₄)haloalkyl, (C₁-C₄)alkoxy-(C₁-C₄)alkyl, (C₁-C₄)alkoxy,             (C₁-C₄)haloalkoxy, (C₁-C₄)alkoxy-(C₁-C₄)alkoxy,             (C₁-C₄)alkylthio, (C₁-C₄)alkylsulfinyl,             (C₁-C₄)haloalkylsulfinyl, (C₁-C₄)alkylsulfonyl,             (C₁-C₄)haloalkylsulfonyl, di-[(C₁-C₄)alkyl]-amino,             (C₁-C₄)alkylamino-carbonyl di-[(C₁-C₄)alkyl]-amino-carbonyl,             (C₁-C₄)alkylamino-carbonylamino and             di-[(C₁-C₄)alkyl]-amino-carbonylamino and, in case of             heterocyclyl, also oxo attached to heteroring atoms N or S             or in alpha-position of an N-atom as heteroring atom,             or are (C₃-C₆)cycloalkyl, benzo-(C₅-C₆)cycloalkyl,             (C₅-C₆)cycloalkenyl, benzo-(C₅-C₆)cycloalkenyl, phenyl,             naphthyl, heterocyclyl, benzocondensated heterocyclyl,     -   wherein each of the last-mentioned 8 radicals is unsubstituted         or substituted in the cyclic moiety by one or more radicals         selected from the group consisting of halogen, hydroxy, nitro,         carbamoyl, sulfo, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl,         (C₁-C₄)alkoxy-(C₁-C₄)alkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy,         (C₁-C₄)alkoxy-(C₁-C₄)alkoxy, (C₁-C₄)alkylthio,         (C₁-C₄)alkylsulfinyl, (C₁-C₄)haloalkylsulfinyl,         (C₁-C₄)alkylsulfonyl, (C₁-C₄)haloalkylsulfonyl,         di-[(C₁-C₄)alkyl]-amino, (C₁-C₄)alkylamino-carbonyl         di-[(C₁-C₄)alkyl]-amino-carbonyl,         (C₁-C₄)alkylamino-carbonylamino and         di-[(C₁-C₄)alkyl]-amino-carbonylamino and, in case of         heterocyclyl, also oxo attached to heteroring atoms N or S or in         alpha-position of an N-atom as heteroring atom.

“Heterocyclyl” for the above radicals or substitutents preferably is a heterocyclic saturated, partly saturated, unsaturated or heteroaromatic ring having 3 to 9 ring atoms, preferably 5 or 6 ring atoms in case of a saturated ring or having 5 to 9, preferably 5 or 6 ring atoms in case of partly saturated, unsaturated or heteroaromatic ring, preferably a ring having 1, 2, 3 or 4 hetero ring atoms selected from the group consisting of N, O and S.

Preferably optionally substituted heterocyclyl is saturated heterocyclyl or heteroaryl or benzocondensated derivatives thereof which may be further substituted.

Preferably heteroaryl is: pyrrole, imidazole, triazole, tetrazole, thiophene, thiazole, thiadiazole, oxazole, oxadiazole, pyridine, pyrimidine, piperazine, triazine, tetrazine, benzocondensated derivatives thereof and bicyclic combinations thereof.

Preferably R¹ is (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, phenyl, naphthyl, phenyl(C₁-C₆)alkyl, such as benzyl or phenethyl, (C₂-C₆)alkenyl, phenyl(C₂-C₆)alkenyl, (C₂-C₆)alkynyl, phenyl(C₂-C₆)alkynyl, (C₃-C₆)cycloalkyl, benzo(C₅-C₆)cycloalkyl, such as tetrahydronaphthyl, indanyl, indenyl, fluorenyl, heteroaryl,

wherein the radicals are unsubstituted or substituted in the cyclic moiety, preferably unsubstituted or substituted by one or more radicals mentioned as substituents for A¹ above.

Preferably R¹ and R² together with the N-atom linked to each other are a saturated heterocyclic ring having 5 or 6 ring atoms and can have 1 or 2 additional hetero atoms selected from the group consisting of N, O and S and which is unsubstituted or substituted, for example pyrrolidino, morpholino, piperidino, dihydroindolino, dihydroisoindolino, tetrahydroquinolino, tetrahydroisoquinolino, which all may be further substituted, preferably unsubstituted or substituted by one or more radicals mentioned as substituents for A¹ above.

Preferably R²

-   -   is H, (C₁-C₁₂)alkyl, (C₂-C₁₂)alkenyl or (C₂-C₁₂)alkynyl, more         preferably H, (C₁-C₆)alkyl,     -   (C₂-C₆)alkenyl or (C₂-C₆)alkynyl, more preferably H and         (C₁-C₄)alkyl, in particular H,         -   wherein each of the carbon-containing radicals is             unsubstituted or substituted, preferably unsubstituted or             substituted by one or more radicals selected from the group             consisting of halogen, hydroxy, nitro, carbamoyl, sulfo and             radicals of the formulae         -   —O—R^(2a), —S—R^(2b), —S(═O)—R^(2c), —S(═O)₂—R^(2d),             —NR^(2e)R^(2f), —C(═O)—NHR^(2g), —C(═O)—NR^(2h)R^(2i),             —NHC(═O)—NR^(2j)R^(2k) and A^(2a),         -   more preferably by one or more radicals selected from the             group consisting of halogen, hydroxy and radicals of the             formulae         -   —O—R^(2a), —S—R^(2b), —S(═O)—R^(2c), —S(═O)₂—R^(2d) and             A^(2a),         -   more preferably by one or more radicals selected from the             group consisting of halogen, hydroxy and radicals of the             formula —O—R^(2a) and A^(2a),         -   wherein R^(2a), R^(2b), R^(2c), R^(2d), R^(2e), R^(2f),             R^(2g), R^(2h), R^(2i), R^(2j), and R^(2k), independently of             one another, are (C₁-C₆)alkyl, (C₁-C₆)haloalkyl,             (C₁-C₆)alkoxy-(C₁-C₆)alkyl or a radical of the formula             A^(2b),         -   preferably are (C₁-C₄)alkyl, (C₁-C₄)haloalkyl,             (C₁-C₄)alkoxy-(C₁-C₄)alkyl or a radical of the formula             A^(2b),         -   more preferably are (C₁-C₄)alkyl or a radical of the formula             A^(2b),     -   or is a group of the formula A²,         -   wherein A², A^(2a) and A^(2b), independently of one another,             are as defined for A¹, A^(1a) and A_(1b), above, preferably             wherein         -   A², A^(2a) and A^(2b) independently of one another, are             (C₃-C₆)cycloalkyl, phenyl, heterocyclyl, wherein each of the             last-mentioned 3 radicals is unsubstituted or substituted in             the cyclic moiety, preferably is unsubstituted or             substituted in the cyclic moiety by one or more radicals             selected from the group consisting of halogen, hydroxy,             nitro, carbamoyl, sulfo, (C₁-C₆)alkyl, (C₁-C₆)haloalkyl,             (C₁-C₆)alkoxy-(C₁-C₆)alkyl, (C₁-C₆)alkoxy,             (C₁-C₆)haloalkoxy, (C₁-C₆)alkoxy-(C₁-C₆)alkoxy,             (C₁-C₆)alkylthio, (C₁-C₆)alkylsulfinyl,             (C₁-C₆)haloalkylsulfinyl, (C₁-C₆)alkylsulfonyl,             (C₁-C₆)haloalkylsulfonyl, di-[(C₁-C₄)alkyl]-amino,             (C₁-C₄)alkylamino-carbonyl di-[(C₁-C₄)alkyl]-amino-carbonyl,             (C₁-C₄)alkylamino-carbonylamino and             di-[(C₁-C₄)alkyl]-amino-carbonylamino and, in case of             heterocyclyl, also oxo attached to heteroring atoms N or S             or in alpha-position of an N-atom as heteroring atom,         -   more preferably is unsubstituted or substituted in the             cyclic moiety by one or more radicals selected from the             group consisting of halogen, hydroxy, nitro, sulfo,             (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₁-C₄)alkoxy-(C₁-C₄)alkyl,             (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy,             (C₁-C₄)alkoxy-(C₁-C₄)alkoxy, (C₁-C₄)alkylthio,             (C₁-C₄)alkylsulfinyl, (C₁-C₄)haloalkyl-sulfinyl,             (C₁-C₄)alkylsulfonyl and (C₁-C₄)haloalkylsulfonyl,         -   more preferably is unsubstituted or substituted in the             cyclic moiety by one or more radicals selected from the             group consisting of halogen, hydroxy, nitro, (C₁-C₄)alkyl,             (C₁-C₄)haloalkyl, (C₁-C₄)alkoxy-(C₁-C₄)alkyl, (C₁-C₄)alkoxy,             (C₁-C₄)haloalkoxy, (C₁-C₄)alkoxy-(C₁-C₄)alkoxy,             (C₁-C₄)alkylthio, (C₁-C₄)alkylsulfonyl and             (C₁-C₄)haloalkylsulfonyl,         -   more preferably is unsubstituted or substituted in the             cyclic moiety by one or more radicals selected from the             group consisting of halogen, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl,             (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₁-C₄)alkylthio and             (C₁-C₄)alkylsulfonyl,             or R² together with R¹ and the N-atom linking them are as             defined for NR¹R² above.

Examples for R² are H or radicals as preferably defined for R¹, particularly H, (C₁-C₄)alkyl, (C₂-C₄)alkenyl or (C₂-C₄)alkynyl, (C₁-C₄)haloalkyl, phenyl, naphthyl, phenyl(C₁-C₄)alkyl, such as benzyl or phenethyl, or (C₃-C₆)cycloalkyl, wherein each of the last-mentioned 6 radicals is unsubstituted or substituted in the cyclic moiety, preferably unsubstituted or substituted by one or more radicals as defined for substituents at the cyclic groups A², A^(2a) or A^(2b).

R³, R⁴, R⁵ and R⁶, independently of each other and of R¹ and R², are preferably as defined for R² or preferably defined for R².

More preferred R³, R⁴, R⁵ and R⁶, independently of each other, are H or (C₁-C₄)alkyl, particularly H.

R³ and R⁴, together with the N-atom may form a ring and then, independently of NR¹R² are a cyclic group as defined above for R¹ and R² together with the N-atom forming a ring.

X and Y, independently of one another, preferably are each selected from the group consisting of

-   -   (i) amino,     -   (ii) a group of the formula NR⁷R⁸ in which R⁷ is a radical         selected from the group consisting of radicals as defined for         and independently of R¹, and in which R⁸ is a radical selected         from the group consisting of radicals as defined for and         independently of R², preferably a group of the formula NR⁷R⁸         which is defined as the group NR¹R² in formula (I),     -   (iii) hydroxy,     -   (iv) (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy,         (C₁-C₄)alkoxy-(C₁-C₄)alkoxy and (C₁-C₄)alkylthio,     -   (v) (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy,         (C₁-C₄)alkoxy-(C₁-C₄)alkoxy and (C₁-C₄)alkylthio, wherein each         of the latter 4 radicals is substituted by one or more radicals         selected from the group consisting of (C₃-C₆)cycloalkyl,         (C₃-C₆)cycloalkoxy,         -   wherein each of the last-mentioned 2 radicals is             unsubstituted or substituted by one or more radicals             selected from the group consisting of halogen, hydroxy,             carbamoyl, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl,             (C₁-C₄)alkoxy-(C₁-C₄)alkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy             and (C₁-C₄)alkoxy-(C₁-C₄)alkoxy,     -    aryl and aryloxy, preferably phenyl or phenoxy,         -   wherein each of the last-mentioned 4 radicals is             unsubstituted or substituted by one or more radicals             selected from the group consisting of halogen, hydroxy,             nitro, carbamoyl, sulfo, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl,             (C₁-C₄)alkoxy-(C₁-C₄)alkyl, (C₁-C₄)alkoxy,             (C₁-C₄)haloalkoxy, (C₁-C₄)alkoxy-(C₁-C₄)alkoxy,             (C₁-C₄)alkylthio, (C₁-C₄)alkylsulfinyl,             (C₁-C₄)haloalkylsulfinyl, (C₁-C₄)alkylsulfonyl,             (C₁-C₄)haloalkylsulfonyl, di-[(C₁-C₄)alkyl]-amino,             (C₁-C₄)alkylamino-carbonyl,             di-[(C₁-C₄)alkyl]-amino-carbonyl,             (C₁-C₄)alkylamino-carbonylamino and             di-[(C₁-C₄)alkyl]-aminocarbonylamino,     -   (vi) (C₃-C₆)cycloalkoxy which is unsubstituted or substituted         -   by one or more radicals selected from the group consisting             of halogen, hydroxy, carbamoyl, (C₁-C₄)alkyl,             (C₁-C₄)haloalkyl, (C₁-C₄)alkoxy-(C₁-C₄)alkyl, (C₁-C₄)alkoxy,             (C₁-C₄)haloalkoxy and (C₁-C₄)alkoxy-(C₁-C₄)alkoxy,     -    and     -   (vii) aryloxy, preferably phenoxy, wherein each of the         last-mentioned two radicals is unsubstituted or substituted by         one or more radicals         -   selected from the group consisting of halogen, hydroxy,             nitro, carbamoyl, sulfo, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl,             (C₁-C₄)alkoxy-(C₁-C₄)alkyl, (C₁-C₄)alkoxy,             (C₁-C₄)haloalkoxy, (C₁-C₄)alkoxy-(C₁-C₄)alkoxy,             (C₁-C₄)alkylthio, (C₁-C₄)alkylsulfinyl,             (C₁-C₄)haloalkylsulfinyl, (C₁-C₄)alkylsulfonyl,             (C₁-C₄)haloalkylsulfonyl, di-[(C₁-C₄)alkyl]-amino,             (C₁-C₄)alkylamino-carbonyl,             di-[(C₁-C₄)alkyl]-amino-carbonyl,             (C₁-C₄)alkylamino-carbonylamino and             di-[(C₁-C₄)alkyl]-aminocarbonylamino,     -    and     -   (viii) acyloxy, acylthio or acylamino, preferably acyloxy,         wherein the last-mentioned four groups having 1 to 12 carbon         atoms, preferably 1 to 8 carbon atoms, and wherein acyl in each         group preferably is formyl, (C₁-C₆)alkylcarbonyl,         (C₁-C₆)alkylsulfonyl or optionally substituted arylsulfonyl,         more preferably, acyl is acetyl, n- or i-propionyl, n-, iso-,         sec- or tert.-butylcarbonyl, or methylsulfonyl, ethylsulfonyl,         n-propylsulfonyl, n-butylsulfonyl or phenylsulfonyl         -   the latter of which is unsubstituted or substituted by one             or more radicals selected from the group consisting of             halogen, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl,             (C₁-C₄)alkoxy-(C₁-C₄)alkyl, (C₁-C₄)alkoxy,             (C₁-C₄)haloalkoxy, (C₁-C₄)alkoxy-(C₁-C₄)alkoxy and             (C₁-C₄)alkylthio, preferably selected from the group             consisting of methyl and ethyl,     -   more preferably X and Y are each selected from the above groups         (ii), (iv), (v), (vi), (vii) and (viii), more preferably from         the above groups (ii), (iv) and (v),     -   or

X and Y together are a divalent group of the formula

-   -   —O-D*-O—, —S-D*-S—, —NH-D*-NH—, —O-D*-NH—, —O-D*-S—,     -   —N(CH₃)-D*-N(CH₃)—, —NH-D*-N(CH₃)—, —N(C₂H₅)-D*-N(C₂H₅)— or     -   —NH-D*-N(C₂H₅)—, wherein D* in each of the last-mentioned 9         divalent groups is a linear alkylene bridge, a linear         (C₂-C₁₀)alkenylene bridge, a linear (C₂-C₁₀)alkynylene bridge, a         (C₃-C₉)cycloalkylene bridge, a phenylene bridge or a bridge         consisting of a combination of two or more of said linear         acyclic and cyclic moieties having in total 4 to 18 carbon         atoms, wherein the bridge in each case is unsubstituted or         substituted by one or more radicals selected from the group         consisting of halogen, hydroxy, nitro, carbamoyl, sulfo,         (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₁-C₄)alkoxy-(C₁-C₄)alkyl,         (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₁-C₄)alkoxy-(C₁-C₄)alkoxy,         (C₁-C₄)alkylthio, (C₁-C₄)alkylsulfinyl,         (C₁-C₄)haloalkylsulfinyl, (C₁-C₄)alkylsulfonyl,         (C₁-C₄)haloalkylsulfonyl, di-[(C₁-C₄)alkyl]-amino,         (C₁-C₄)alkylamino-carbonyl, di-[(C₁-C₄)alkyl]-amino-carbonyl,         (C₁-C₄)alkylamino-carbonylamino and         di-[(C₁-C₄)alkyl]-aminocarbonylamino,     -    or     -   X is a radical as defined above and Y is an organic ligand based         on a compound of the formula Y′—H, Y′—R^(L) or         R^(L)—O-D**-O—R^(LL), R^(L)—S-D**-S—R^(LL),         R^(L)—NH-D**-NH—R^(LL), R^(L)—O-D**-NH—R^(LL),         R^(L)—O-D**-S—R^(LL), R^(L)—N(CH₃)-D**-N(CH₃)—R^(LL),         R^(L)—NH-D**-N(CH₃)—R^(LL), R^(L)—N(C₂H₅)-D**-N(C₂H₅)—R^(LL) or         R^(L)—NH-D**-N(C₂H₅)—R^(LL),     -    wherein D** in each of the 9 last-mentioned compounds is a         divalent group as defined for the group D* above, Y′ is a         radical as defined for Y, and each of R^(L) and R^(LL) is a         radical group selected from the group consisting of         (C₁-C₆)alkyl, hydroxy-(C₁-C₆)alkyl or         (C₁-C₆)alkoxy-(C₁-C₆)alkyl, and wherein the organic ligand is         coordinated to the aluminium atom of the complex by a free         electron pair of a hetero atom contained therein and selected         from the group consisting of N, O and S,     -    or     -   X and Y together are a radical of the formula —O-D**-O—R^(LLL),         —S-D**-S—R^(LLL), —NH-D**-NH—R^(LLL), —O-D**-NH—R^(LLL),         —NH-D**-O—R^(LLL), —O-D**-S—R^(LLL), —S-D**-O—R^(LLL),         —N(CH₃)-D**-N(CH₃)—R^(LLL), —NH-D**-N(CH₃)—R^(LLL),         —N(CH₃)-D**-NH—R^(LLL), —N(C₂H₅)-D**-N(C₂H₅)—R^(LLL),         —NH-D**-N(C₂H₅)—R^(LLL) or —N(C₂H₅)-D**-NH—R^(LLL), wherein D*         in the 13 last-mentioned radicals is as defined above, and         R^(LLL) is a radical selected from the group consisting of         (C₁-C₄)alkyl, hydroxy-(C₁-C₄)alkyl or         (C₁-C₄)alkoxy-(C₁-C₄)alkyl, and wherein the radical is         additionally coordinated to the aluminium atom of the complex by         a free electron pair located at a hetero atom contained in the         radical (position represented by Y), preferably located at the         heteroatom attached to the group R^(LLL) in the divalent group.

More preferred are compounds (I) in which X and Y, independently of one another, are each selected from the group consisting of

-   -   (i) amino,     -   (ii) a group of the formula NR⁷R⁸ which is defined as the group         NR¹R² in formula (I),     -   (iii) hydroxy,     -   (iv) (C₁-C₆)alkoxy and (C₁-C₄)alkoxy-(C₁-C₄)alkoxy, preferably         (C₁-C₄)alkoxy and (C₁-C₄)alkoxy-(C₁-C₄)alkoxy in which the         O-Atom of the alkoxy group linked directly to the aluminium atom         is two carbon atoms away from the O-atom of the terminal alkoxy         group; more preferably isopropoxy, 2-butoxy, 2-methoxy-ethoxy,         2-ethoxy-ethoxy, 2-methoxy-1-methyl-ethoxy,         2-ethoxy-1-methyl-ethoxy,     -   (v) (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy,         (C₁-C₄)alkoxy-(C₁-C₄)alkoxy and (C₁-C₄)alkylthio, wherein each         of the latter 4 radicals is substituted by one or more radicals         selected from the group consisting of (C₃-C₆)cycloalkyl,         (C₃-C₆)cycloalkoxy,         -   wherein each of the last-mentioned 2 radicals is             unsubstituted or substituted by one or more radicals             selected from the group consisting of (C₁-C₄)alkyl and             (C₁-C₄)alkoxy,     -   (vi) (C₃-C₆)cycloalkoxy which is unsubstituted or substituted         -   by one or more radicals selected from the group consisting             of (C₁-C₄)alkyl and (C₁-C₄)alkoxy,     -    and     -   (vii) phenoxy which is unsubstituted or substituted by one or         more radicals selected from the group consisting of halogen,         nitro, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl,         (C₁-C₄)alkoxy-(C₁-C₄)alkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy,         (C₁-C₄)alkoxy-(C₁-C₄)alkoxy, (C₁-C₄)alkylthio,         (C₁-C₄)alkylsulfinyl, (C₁-C₄)alkylsulfonyl,         di-[(C₁-C₄)alkyl]-amino,     -    and     -   (viii) acyloxy, acylthio or acylamino, preferably acyloxy,         wherein the last-mentioned four groups having 1 to 12 carbon         atoms, preferably 1 to 8 carbon atoms, and wherein acyl in each         group preferably is formyl, (C₁-C₆)alkylcarbonyl or         (C₁-C₆)alkylsulfonyl or phenylsulfonyl,         -   the latter of which is unsubstituted or substituted by one             or more radicals selected from the group consisting of             halogen, (C₁-C₄)alkyl and (C₁-C₄)alkoxy,     -    more preferably, acyl is acetyl, n- or i-propionyl, n-, iso-,         sec- or tert.-butylcarbonyl, or methylsulfonyl, ethylsulfonyl,         n-propylsulfonyl, n-butylsulfonyl, phenylsulfonyl, o-, m- or         p-tolylsulfonyl,     -   more preferably X and Y are each selected from the above groups         (ii), (iv), (v), (vi), (vii) and (viii), more preferably from         the above groups (ii), (iv) and (v),     -   or

X and Y together are a divalent group of the formula

-   -   —O-D*-O—, —S-D*-S—, —NH-D*-NH—, —O-D*-NH—, wherein D* in each of         the last-mentioned 4 divalent groups is a linear alkylene         bridge, a linear (C₂-C₆)alkenylene bridge, a linear         (C₂-C₆)alkynylene bridge, a (C₃-C₆)cycloalkylene bridge, a         1,2-phenylene bridge or a bridge consisting of a combination of         two or more of said linear acyclic and cyclic moieties having in         total 4 to 12 carbon atoms, wherein the bridge in each case is         unsubstituted or substituted by one or more radicals selected         from the group consisting of halogen, hydroxy, (C₁-C₄)alkyl,         (C₁-C₄)alkoxy-(C₁-C₄)alkyl, (C₁-C₄)alkoxy,         (C₁-C₄)alkoxy-(C₁-C₄)alkoxy, (C₁-C₄)alkylsulfonyl and         di-[(C₁-C₄)alkyl]-amino; or     -   X is a radical as defined above and Y is an organic ligand based         on a compound of the formula Y′—H, Y′—R^(L) or         R^(L)—O-D**-O—R^(LL), R^(L)—S-D**-S—R^(LL),         R^(L)—NH-D**-NH—R^(LL), R^(L)—O-D**-NH—R^(LL),         R^(L)—O-D**-S—R^(LL), R^(L)—N(CH₃)-D**-N(CH₃)—R^(LL),         R^(L)—NH-D**-N(CH₃)—R^(LL), R^(L)—N(C₂H₅)-D**-N(C₂H₅)—R^(LL) or         R^(L)—NH-D**-N(C₂H₅)—R^(LL),         -   wherein D** in each of the 9 last-mentioned compounds is a             divalent group as defined for the group D* above, Y′ is a             radical as defined for Y, and each of R^(L) and R^(LL) is a             radical group selected from the group consisting of             (C₁-C₆)alkyl, hydroxy-(C₁-C₄)alkyl or             (C₁-C₄)alkoxy-(C₁-C₄)alkyl, and wherein the organic ligand             is coordinated to the aluminium atom of the complex by a             free electron pair of a hetero atom contained therein and             selected from the group consisting of N, O and S,         -   or     -   X and Y together are a radical of the formula —O-D**-O—R^(LLL),         —S-D**-S—R^(LLL), —NH-D**-NH—R^(LLL), —O-D**-NH—R^(LLL),         —NH-D**-O-D**S—R^(LLL), —S-D**-O—R^(LLL),         —N(CH₃)-D**-N(CH₃)—R^(LLL), —NH-D**-N(CH₃)—R^(LLL),         —N(CH₃)-D**-NH—R^(LLL), —N(C₂H₅)-D**-N(C₂H₅)—R^(LLL),         —NH-D**-N(C₂H₅)—R^(LLL) or —N(C₂H₅)-D**-NH—R^(LLL), wherein D*         in the 13 last-mentioned radicals is as defined above, and         R^(LLL) is a radical selected from the group consisting of         (C₁-C₄)alkyl, hydroxy-(C₁-C₄)alkyl or         (C₁-C₄)alkoxy-(C₁-C₄)alkyl, and wherein the radical is         additionally coordinated to the aluminium atom of the complex by         a free electron pair located at a hetero atom contained in the         radical (position represented by Y), preferably located at the         heteroatom attached to the group R^(LLL) in the divalent group.

Further preferred are compounds (I) in which

R¹, X and Y are as defined above,

R² is hydrogen,

R³ is hydrogen,

R⁴ is hydrogen,

R⁵ is hydrogen and

R⁶ is hydrogen.

From Al²⁷-NMR studies it has been shown that the stereochemical structure of the aluminium complex depends on the ligands X and Y and ligands present in solutions of compounds (I) that in the case that X and Y or other ligands with oxygen atoms are linked to the aluminium atom that the aluminium atom is tetrahedral 4-coordinated or also 5-coordinated, as is known from other cases in aluminium chemistry (see Scheme 2, showing the case for R³ to R⁶ each being H).

In mono-coordinating solvents such as simple alcohols, for example: methanol, ethanol, isopropanol, 1-butanol, 2-butanol etc. the complex may be variably monomeric or dimeric in nature, depending on the complex concentration in solution or whether the complex is in the solid form (Scheme 3, showing case for R³ to R⁶ each being H):

In the presence of more complex solvents which are capable of offering a second coordination site, for example alkoxyalcohols, the complex has been shown (e.g. by H¹-NMR and IR) to be monomeric (Scheme 4), and thus being chiral at the aluminium centre. For example, in the presence of 2-ethoxyethanol the aluminium complex formed is shown in Scheme 4, wherein X=O, R″=Et and R′=R=H and 1-methoxy-2-propanol X=O, R″=R=Me, R″=H, and R⁴ to R⁶ in formula (I) are H (only one diastereoisomer at the aluminium centre is shown).

Each structure shown in schemes 1 through 4 is a non limiting graphical representation of all tautomeric isomers of that structure. Furthermore, if the coordinating solvent is chiral then diastereomeric mixtures of complexes may be formed in varying ratios.

Another object of the invention is a process for the preparation of bisguanidine-aluminium complexes of the formula (I) or salts thereof,

-   -   in which R¹ to R⁶ and X and Y are as defined above,         characterized in that a compound (an amine) of the formula (II)         or a salt thereof,

in which R¹ and R² are defined as in the compound of formula (I) to be prepared, is reacted to a compound of the formula (III) or a salt thereof,

in which R³, R⁴, R⁵ and R⁶ are defined as in the compound of formula (I) to be prepared, and an aluminium(III) source, optionally, in the presence of a protic additive or solvent selected from the group consisting of alcohols or amines, preferably an aluminium(III) source selected from

-   -   (i) aluminium salts of the formula (IV),

-   -   in which     -   X and Y are as defined in the compound of formula (I) to be         prepared, and Z, independently of X, is a leaving group selected         from the group of radicals as defined for X or Y, or     -   (ii) aluminium salts of the formula (IV′),

-   -   in which     -   X′, Y′ and Z′ each are selected from the group consisting of         radicals as defined for X, Y or Z, respectively and radicals         which generate said group X, Y or Z, respectively in the         presence of a protic additive or solvent X—H, Y—H or Z—H,         respectively, with the proviso that 1, 2 or 3 of the radicals         X′, Y′ and Z′ are selected from said radicals which generate         radicals X, Y and Z, respectively,     -   in combination with a protic additive or solvent X—H, Y—H or Z—H         wherein each of X, Y and Z are defined as set forth for X and Y         in formula (I), and addition salts thereof.

Preferably, the amines of formula (II) are monoamines. If the amines of formula (II) contain another primary or secondary amino group this group may react like the first amino group with the compound of formula (III). In such a case, preferably in case of a diamine with two primary amino groups and where both amino groups react, the compound of formula (I) is obtained where R¹ is a group of the formula (B1). Suitable radicals X, Y and Z in compounds (IV) are selected from the group consisting of radicals (i), (ii), (iii), (iv), (v), (vi) and (vii) set forth above for X and Y of the compounds of formula (I).

Suitable radicals X′, Y′ and Z′ in formula (IV′) which generate a radical X, Y and Z in the presence of a protic additive or solvent are

H, halogen, (C₁-C₁₈)alkyl which is unsubstituted or substituted, preferably which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C₁-C₆)alkoxy, (C₃-C₆)cycloalkyl, aryl and substituted aryl, or is aryl which is unsubstituted or substituted, preferably which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C₁-C₆)alkyl and (C₁-C₆)alkoxy,

and the protic additive or solvent is selected from the type X—H, Y—H or Z—H where X, Y and Z are as defined for X or Y, or preferably defined for X or Y, in the compound (I). Such protic additives are of the type HO-alkyl, HO-aryl, HO-alkylaryl, NH₃ or HNR¹R² to generate groups X, Y and Z of the type —O-alkyl, —O-aryl, —O-alkylaryl, -amino or —NR¹R², respectively.

Suitable radicals X′, Y′ and Z′ in formula (IV′) which generate a radical X, Y and Z in the presence of a protic additive or solvent preferably are

H, halogen, cyano, (C₁-C₆)alkyl which is unsubstituted or substituted, preferably which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C₁-C₆)alkoxy, (C₃-C₆)cycloalkyl, phenyl and substituted phenyl (preferably phenyl substituted by one or more radicals selected from the group consisting of halogen, (C₁-C₆)alkyl and (C₁-C₆)alkoxy),

or are phenyl which is unsubstituted or substituted, preferably which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C₁-C₆)alkyl and (C₁-C₆)alkoxy.

Suitable radicals X′, Y′ and Z′ in formula (IV′) which generate a radical X, Y and Z in the presence of a protic additive or solvent are also those selected from the group consisting of radicals (i), (ii), (iii), (iv), (v), (vi) and (vii) set forth above for X and Y of the compounds of formula (I) if they are used in combination with a protic additive or solvent of the type X—H, Y—H or Z—H if the group X, Y and Z in the protic additive or solvent is more nucleophilic than X′, Y′ or Z′ in the compound of formula (IV′) or if the protic additive or solvent is present in a large excess so that an exchange of the ligands occurs.

Suitable compounds of formula (IV) are aluminium trimethoxide [Al(OCH₃)₃]aluminium triethoxide [Al(OC₂H₅)₃], aluminium tri(n-propoxide) [Al(O-n-C₃H₇)₃], aluminium tri(i-propoxide) [Al(O-i-C₃H₇)₃], aluminium tri(n-butoxide) [Al(O-n-C₄H₉)₃], aluminium tri(sec-butoxide) [Al(O-sec-C₄H₉)₃], aluminium tri(i-butoxide) [Al(O-i-C₄H₉)₃], aluminium tri(tert-butoxide) [Al(O-tert-C₄H₉)₃], aluminium tri(2-methoxy-ethoxide) [Al(O—CH₂CH₂—O—CH₃)₃], aluminium tri(2-ethoxy-ethoxide) [Al(O—CH₂CH₂—O—C₂H₅)₃], aluminium tri(2-methoxy-1-methyl-ethoxide) [Al(O—CH(CH₃)CH₂—O—CH₃)₃], aluminium tri(2-ethoxy-1-methyl-ethoxide) {Al[O—CH(CH₃)CH₂—O—C₂H₅]₃}, or aluminium compounds with mixed radicals such as Al(OCH₃)₂(OC₂H₅), Al(OCH₃)(OC₂H₅)₂, Al(OCH₃)(O-n-C₃H₇)₂, Al(OCH₃)₂(O-n-C₃H₇), Al(OC₅H₅)(O-n-C₃H₇)₂, Al(OC₂H₅)₂ (O-n-C₃H₇), Al(OCH₃)(O-i-C₃H₇)₂, Al(OCH₃)₂(O-i-C₃H₇), Al(OC₂H₅)(O-i-C₃H₇)₂, Al(OC₂H₅)₂ (O-i-C₃H₇).

The above compounds (IV) are also suitable aluminium(III) sources of the formula (IV′) in the presence of a protic additive or solvent selected from alcohols and/or amines of the type X—H, Y—H or Z—H.

Additionally suitable compounds (IV′) which are used in the presence of a protic additive or solvent selected from alcohols and/or amines of the type X—H, Y—H or Z—H are aluminium compounds such as trimethylaluminium [Al(CH₃)₃], triethylaluminium [Al(C₂H₅)₃], triphenylaluminium [Al(C₆H₅)₃], aluminium hydrides and addition salts thereof such as aluminiumhydride [AlH₃], lithiumaluminiumhydride [LiAlH₄], alkylaluminiumhydrides such as (CH₃)AlH₂, (CH₃)₂AlH, (C₂H₅)AlH₂, (C₂H₅)₂AlH, (n-C₃H₇)AlH₂, (n-C₃H₇)₂AlH, (i-C₃H₇)AlH₂, (i-C₃H₇)₂AlH, (n-C₄H₉)AlH₂, (n-C₄H₉)₂AlH, (sec-C₄H₉)AlH₂, (sec-C₄H₉)₂AlH, (1-C₄H₉)AlH₂, (i-C₄H₉)₂AlH[DIBAL],

The reaction can also be performed in substance or in the presence of a solvent or mixtures of solvents. As mentioned above some of the solvents may function as a reactant to form a ligand of the aluminium complex.

Suitable solvents are for example but not limited to:

Organic solvents selected from the group consisting of the chemical class of

-   -   ethers, such as dialkylethers (e.g. diethylether) or cyclic         aliphatic ethers (e.g. tetrahydrofuran),     -   saturated or unsaturated aliphatic hydrocarbons, which may be         unsubstituted or substituted by one or more radicals selected         from the group consisting of halogen, nitro and alkoxy,         preferably (C₁-C₄)alkoxy, i.e. solvents such as alkanes,         alkenes, haloalkanes, nitroalkanes,     -   aromatic hydrocarbons, which may be unsubstituted or substituted         by one or more radicals selected from the group consisting of         alkyl (preferably (C₁-C₄)alkyl), alkoxy (preferably         (C₁-C₄)alkoxy), halogen and nitro, i.e. solvents such as         aromates, alkylaromates, haloaromates, nitroaromates,         alkoxyaromates,     -   alcohols, particularly aliphatic alcohols, such as alkanoles,         ω-dioles or ω-polyoles, which may be unsubstituted or         substituted, preferably unsubstituted or substituted by one or         more radicals from the group consisting of alkoxy (preferably         (C₁-C₄)alkoxy), halogen, nitro, amino, (C₁-C₄)alkylamino, and         di-[(C₁-C₄)alkyl]-amino,     -   heteroaromates, such as heteroaromatic compounds having 5 or 6         ring atoms and 1 or 2 heteroatoms, particularly 1 heteroatom,         selected from the group consisting of N, O and S, such as         pyridine or thiophene,     -   sulfones, such as sulfolane,     -   sulfoxides, such as dimethylsulfoxide and     -   amines, such as monoamines, diamines or polyamines.

Preferred are alcohols or mixtures which include an alcohol or alkoxyalcohol are preferred, such as, propanol, isopropanol, isobutanol, cyclohexanol, 2-ethoxy-ethan-1-ol, 2-methoxy-ethan-1-ol, 2-isopropoxy-ethan-1-ol, 2-methoxy-1-methyl-ethan-1-ol (=1-methoxy-isopropanol), 2-ethoxy-1-methyl-ethan-1-ol (=1-ethoxy-isopropanol).

These solvents may also function as protic additives/solvents which determine the ligands of the aluminium complex.

The process of complex formation can be performed at relatively moderate temperatures such as between 50° C. and 140° C. and preferably between 70° C. and 130° C. and especially between 90 and 120° C.

The complex formation preferably is performed with 0.1 to 10.0 equivalents cyanoguanidine of formula (III), more preferably with 1.0 to 3.0 equivalents cyanoguanidine of formula (III). more preferably with 1.0 to 2.0 equivalents of the cyanoguanidine and especially with 1.0 to 1.6 equivalents of the cyanoguanidine, based on 1 equivalent of compound (II) (amine) or salt thereof.

The complex formation is preferably performed with 0.1 to 10.0 equivalents of the aluminium reagent of the formula (IV), more preferably with 1.0 to 3.0 equivalents of the aluminium reagent of the formula (IV), more preferably with 1.0 to 2.0 equivalents of the aluminium reagent and especially with 1.0 to 1.6 equivalents of the aluminium reagent, based on 1 equivalent of compound (II) or salt thereof.

It is known already from Anorg. Chemie, Org. Chemie, Biochem, Biophys., Biol, 347, 1974 that the unsubstituted aluminium biguanidine complex can be prepared from aluminium chloride (AlCl₃) and biguanidine (C₂N₅H₇). The preparation of substituted complexes has not been known so far.

The compounds of formula (I) or salts thereof (in short “compounds (I)”) are aluminium complexes of biguanides and are suitable as intermediates for the preparation of products which otherwise can be prepared also by reaction of the respective free biguanides.

The compounds (I) are preferably suitable for the preparation of heterocyclic compounds, where the aluminium atom is replaced with an optionally substituted carbon atom or heteroaromatic derivatives thereof, such as s-triazines.

Another object of the invention is thus the use of compounds of formula (I) or salts thereof for the preparation of heterocyclic compounds corresponding to formula (I), wherein the aluminium group Al(X)(Y) is replaced with an optionally substituted carbon atom or s-triazine derivatives thereof.

For example, the latter heterocyclic compounds can be prepared by reacting compounds of formula (I) or salts thereof with ketones, wherein the triazine ring is formed by incorporating the carbon atom of the ketone carbonyl group and the oxygen atom of the carbonyl group of the ketone is replaced with the substituted biguanide moiety contained in the compound of formula (I); see, for example, analogous reaction from biguanide and ketone according to J. Med. Chem. 1985, 28, 1728-1740.

More preferred are preparations of heteroaromatic compounds, particularly s-triazines, using compounds (I) in which R⁵ and R⁶ are hydrogen.

The novel biguanidino-aluminium complexes of formula (I) and salts thereof (=salts, dimers and polymers thereof) are particularly suitable for the preparation of N-substituted 2,4-diamino-s-triazines by the process as described below.

Another object of the present invention is thus a process for the preparation of compounds of the formula (V) or salts thereof,

in which

-   -   R¹, R², R³ and R⁴ are as defined above,     -   and     -   Q is     -   a) hydrogen, (C₁-C₁₂)alkyl, (C₂-C₁₂)alkenyl or (C₂-C₁₂)alkynyl,         more preferably (C₁-C₆)alkyl, (C₂-C₆)alkenyl or (C₂-C₆)alkynyl,         -   wherein each of the last-mentioned six radicals is             unsubstituted or substituted, preferably unsubstituted or             substituted by one or more radicals selected from the group             consisting of halogen, hydroxy, —CN, —NO₂, —OCN, —SCN,             amino, carbamoyl, (C₁-C₆)alkoxy, (C₁-C₆)haloalkoxy,             (C₁-C₆)alkoxy-(C₁-C₆)alkoxy, (C₁-C₆)alkylthio,             (C₁-C₆)alkylsulfinyl, (C₁-C₆)haloalkylsulfinyl,             (C₁-C₆)alkylsulfonyl, (C₁-C₆)haloalkylsulfonyl,             (C₁-C₄)alkyl-amino, di-[(C₁-C₄)alkyl]-amino,             (C₁-C₄)alkylamino-carbonyl,             di-[(C₁-C₄)alkyl]-amino-carbonyl,             (C₁-C₄)alkylamino-carbonylamino and             di-[(C₁-C₄)alkyl]-amino-carbonylamino, oxo, thiooxo, imino,             N—(C₁-C₆)alkyl-imino, N-[phenyl-(C₁-C₄)alkyl]-imino,             N—(C₃-C₆)cycloalkyl-imino,             N—[(C₃-C₆)cycloalkyl-(C₁-C₄)alkyl]-imino,             [(C₁-C₆)alkoxy]-carbonyl, (C₃-C₆)cycloalkyl,             (C₅-C₆)cycloalkenyl, phenyl, naphthyl, heterocyclyl,             benzocondensated heterocycyl, benzo-(C₅-C₆)cycloalkyl,             benzo-(C₅-C₆)cycloalkenyl, (C₃-C₆)cycloalkoxy,             benzo-(C₅-C₆)cycloalkoxy, (C₅-C₆)cycloalkenyloxy,             benzo-(C₅-C₆)cycloalkenyloxy, phenoxy, naphthoxy,             phenylthio, heterocyclyloxy, benzocondensated             heterocyclyloxy, heterocyclylthio, and benzocondensated             heterocyclylthio             -   wherein each of the last-mentioned 19 radicals is                 unsubstituted or substituted in the cyclic moiety by one                 or more radicals selected from the group consisting of                 halogen, hydroxy, —CN, NO₂, —OCN, —SCN, amino,                 carbamoyl, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl,                 (C₁-C₄)alkoxy-(C₁-C₄)alkyl, (C₁-C₆)alkoxy,                 (C₁-C₄)haloalkoxy, (C₁-C₄)alkoxy-(C₁-C₄)alkoxy,                 (C₁-C₄)alkylthio, (C₁-C₄)alkylsulfinyl,                 (C₁-C₄)haloalkylsulfinyl, (C₁-C₄)alkylsulfonyl,                 (C₁-C₄)haloalkylsulfonyl, (C₁-C₄)alkyl-amino,                 di-[(C₁-C₄)alkyl]-amino, (C₁-C₄)alkylamino-carbonyl,                 di-[(C₁-C₄)alkyl]-amino-carbonyl and                 (C₁-C₄)alkylamino-carbonylamino,         -   or, preferably, is hydrogen, (C₁-C₆)alkyl, (C₁-C₆)haloalkyl,             hydroxy-(C₁-C₆)alkyl or (C₁-C₆)alkoxy-(C₁-C₆)alkyl; more             preferably is (C₁-C₄)alkyl or (C₁-C₄)haloalkyl,             hydroxy-(C₁-C₄)alkyl or (C₁-C₄)alkoxy-(C₁-C₄)alkyl; more             preferably is (C₁-C₄)haloalkyl,     -   b) or is (C₃-C₆)cycloalkyl, benzo-(C₅-C₆)cycloalkyl,         (C₅-C₆)cycloalkenyl, benzo-(C₅-C₆)cycloalkenyl, phenyl,         naphthyl, heterocyclyl, benzocondensated heterocycyl,         -   wherein each of the last-mentioned 8 radicals is             unsubstituted or substituted in the cyclic moiety,             preferably unsubstituted or substituted by one or more             radicals selected from the group consisting of halogen,             hydroxy, —CN, —NO₂, —OCN, —SCN, amino, carbamoyl,             (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₁-C₄)alkoxy-(C₁-C₄)alkyl,             (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy,             (C₁-C₄)alkoxy-(C₁-C₄)alkoxy, (C₁-C₄)alkylthio,             (C₁-C₄)alkylsulfinyl, (C₁-C₄)haloalkylsulfinyl,             (C₁-C₄)alkylsulfonyl, (C₁-C₄)haloalkylsulfonyl,             (C₁-C₄)alkyl-amino, di-[(C₁-C₄)alkyl]-amino,             (C₁-C₄)alkylamino-carbonyl,             di-[(C₁-C₄)alkyl]-amino-carbonyl,             (C₁-C₄)alkylamino-carbonylamino and             di-[(C₁-C₄)alkyl]-amino-carbonylamino,             [(C₁-C₆)alkoxy]-carbonyl,         -   (C₃-C₆)cycloalkyl, (C₅-C₆)cycloalkenyl, phenyl, naphthyl,             heterocyclyl, (C₃-C₆)cycloalkoxy, (C₅-C₆)cycloalkenyloxy,             phenoxy, naphthoxy, phenylthio, heterocyclyloxy and             heterocyclylthio,             -   wherein each of the last-mentioned 12 radicals is                 unsubstituted or substituted in the cyclic moiety by one                 or more radicals selected from the group consisting of                 halogen, hydroxy, —CN, NO₂, —OCN, —SCN, amino,                 carbamoyl, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl,                 (C₁-C₄)alkoxy-(C₁-C₄)alkyl, (C₁-C₆)alkoxy,                 (C₁-C₄)haloalkoxy, (C₁-C₄)alkoxy-(C₁-C₄)alkoxy,                 (C₁-C₄)alkylthio, (C₁-C₄)alkylsulfinyl,                 (C₁-C₄)haloalkylsulfinyl, (C₁-C₄)alkylsulfonyl,                 (C₁-C₄)haloalkylsulfonyl, (C₁-C₄)alkyl-amino,                 di-[(C₁-C₄)alkyl]-amino, (C₁-C₄)alkylamino-carbonyl,                 di-[(C₁-C₄)alkyl]-amino-carbonyl and                 (C₁-C₄)alkylamino-carbonylamino,         -   and, in case of heterocyclyl, also oxo attached to             heteroring atoms N or S or in alpha-position of an N-atom as             heteroring atom,     -    or, preferably, is (C₃-C₆)cycloalkyl which is unsubstituted or         substituted by one or more radicals selected from the group         consisting of halogen and (C₁-C₄)alkyl,     -   c) or is COR, COOR, C(═S)R, C(═O)SR, C(═S)OR, C(═S)SR, wherein R         in each of the 6 last-mentioned radicals being (C₁-C₁₈)alkyl,         (C₃-C₆)cycloalkyl or phenyl, the latter three radicals being         unsubstituted or substituted, preferably unsubstituted or         substituted by one or more radicals selected from the group         consisting of halogen, CN, nitro, (C₁-C₆)alkoxy,         (C₁-C₄)haloalkoxy, (C₁-C₄)alkoxy-(C₁-C₄)alkoxy, (C₁-C₄)alkylthio         and in case of cyclic basic radicals also (C₁-C₄)alkyl,         (C₁-C₄)haloalkyl and (C₁-C₄)alkoxy-(C₁-C₄)alkyl, or is CONR′R″         or C(═S)NR′R″, wherein each of R′ and R″ in the two         last-mentioned radicals, independently of each other, being         hydrogen, (C₁-C₁₈)alkyl, (C₃-C₉)cycloalkyl or phenyl, the latter         three radicals being unsubstituted or substituted, preferably         unsubstituted or substituted by one or more radicals selected         from the group consisting of halogen, CN, nitro, (C₁-C₆)alkoxy,         (C₁-C₄)haloalkoxy, (C₁-C₄)alkoxy-(C₁-C₄)alkoxy, (C₁-C₄)alkylthio         and in case of cyclic basic radicals also (C₁-C₄)alkyl,         (C₁-C₄)haloalkyl and (C₁-C₄)alkoxy-(C₁-C₄)alkyl, or         -   R′ and R″ together with the nitrogen atom form a 3 to             6-membered heterocyclic ring which can contain one or two             additional hetero atoms selected from N, O and S, and which             is unsubstituted or substituted by one or more radicals             selected from the group consisting of halogen, CN,             (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₁-C₄)alkoxy-(C₁-C₄)alkyl,             (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy,             (C₁-C₄)alkoxy-(C₁-C₄)alkoxy and (C₁-C₄)alkylthio,     -   characterized in that a compound of the formula (I) or a salt         thereof

in which

R¹, R², R³ and R⁴ are as defined in the compound of formula (V) to be prepared and

R⁵ and R⁶ are hydrogen,

is reacted with a compound of the formula (VI)

Q-W*  (VI)

-   -   in which     -   Q is as defined in the compound of formula (V) to be prepared         and     -   W* is a carbon atom which bears 3 additional bonds to 1, 2 or 3         leaving groups which are linked by hetero atoms, preferably         heteroatoms selected from the group consisting of O, N, F, Cl,         Br, I, S, P, Si and metal atoms, (i.e. the carbon atom is linked         to 3 leaving groups, each via a single bond, linked to two         leaving groups via a single bond and a double bond,         respectively, and is linked to one leaving group via a triple         bond),         -   and is preferably the functional group         -   —CO—X¹ (acid halide group, X¹=F, Cl, Br),         -   —CO—CN (acyl nitrile group),         -   —CO—O—COR* (anhydride, R*=Q or R),         -   —CO—O—X² (O)_(n)(O_(m)R)_(t) (mixed anhydride, X=S, P, B,             n=0, 1, 2, 3, m=0, 1, 2, t=1, 2),         -   —CO—O—R (ester group),         -   —CO—O—N═R (acyloxime group)         -   —CO—NR′R″ (amide group, R′, R″=H, OR, NR, SR or R, or R′ and             R″ form a ring),         -   —CN (nitrile group),         -   —C(═NR′)NR″ (amidine group, R′, R″=H or R, or R and R′ form             a ring),         -   —C(═NH)OR (iminoether, imidacid esters),         -   —C(═NR′)OR (iminiumether R′=R (independently)),         -   —C(═O)SR or —C(═S)OR or —C(═S)SR (thio ester),         -   —C(═S)NR′R″ or —C(═NR′)SR (thio amide or iminothioether R′,             R″=H or R, or R and R′ form a ring or R′ and R″ form a ring)         -   —C(═NR)X¹ (haloimidate group, X═F, Cl, Br),         -   —C(═N⁺RR′)X¹⁻ (haloimidium group, R′═R (independently), or R             and R′ form a ring, X¹⁻=F⁻, Cl⁻, Br⁻),         -   —C(—OR)(—OR′)X¹ (haloacetal group, R′=R (independently or R             and R′ form a ring, X¹=F, Cl, Br),         -   wherein in each subformula group of W* the group R being             (C₁-C₁₈)alkyl, (C₃-C₆)cycloalkyl or phenyl, the latter three             radicals being unsubstituted or substituted, preferably             unsubstituted or substituted by one or more radicals             selected from the group consisting of halogen, CN, nitro,             (C₁-C₆)alkoxy, (C₁-C₄)haloalkoxy,             (C₁-C₄)alkoxy-(C₁-C₄)alkoxy, (C₁-C₄)alkylthio and in case of             cyclic basic radicals also (C₁-C₄)alkyl, (C₁-C₄)haloalkyl             and (C₁-C₄)alkoxy-(C₁-C₄)alkyl,         -   and in case of a ring formed by R and R′ or R′ and R″ the             ring having preferably 3 to 6 ring atoms and being             unsubstituted or substituted by one or more radicals             selected from the group consisting of halogen, CN,             (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₁-C₄)alkoxy-(C₁-C₄)alkyl,             (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy,             (C₁-C₄)alkoxy-(C₁-C₄)alkoxy and (C₁-C₄)alkylthio,             to give the compound of the formula (V) or a salt thereof.

The triazine formation can also be performed in substance or in the presence of a solvent or mixture of solvents, preferably non-aqueous solvent or solvent mixture, for example in an organic solvent or solvent mixture, which have been mentioned above as suitable for the preparation of compounds of formula (I) too.

Preferred as solvents are alcohols or mixtures which include an alcohol, preferably an alcohol such as methanol, ethanol, propanol, isopropanol, butanol, iso-butanol, tert-butanol, pentanol, hexanol and cyclohexanol and mixtures thereof, more preferably methanol, ethanol, propanol or butanol and mixtures thereof.

The triazine formation preferably is performed between −20° C. and 140° C., more preferably between 0° C. and 120° C. and especially between 20° C. and 100° C.

The triazine formation preferably is performed with 1.0 to 10 equivalents, more preferably with 1.0 to 3.0 equivalents of the species Q-W, more preferably with 1.0 to 2.0 equivalents of the species Q-W and especially with 1.0 to 1.6 equivalents of the species Q-W, based on 1 equivalent of compound (I) or salt thereof.

The triazine formation can also be performed without or preferably in the presence of one or more additives selected from the group consisting of bases and compounds having polar functional groups such hydroxy or amino groups the latter two of which are polar but not particularly basic. The additive often helps in speeding up the reaction, improving the yield, providing the reaction to be performed cleaner and/or at a lower temperature compared to the reaction without the additive.

The following bases can be used as additives for example but not limited to:

a) salts such as an alkoxylate (alkoxide), carbonate, hydrogencarbonate, fluoride, phosphate, hydrogenphosphate, dihydrogenphosphate or hydroxide,

where the counter-ion can be a cation of metal derived from metals, for example, alkali metals such as lithium, sodium, potassium, cesium (=caesium), or alkaline earth metals such as magnesium, calcium, or other metals such as aluminium, or the counter-ion can be ammonium, phosphonium, ammonium or phosphonium substituted by organic groups or can be another organic cation,

b) a tertiary or aromatic amine or mixtures thereof,

Reaction mixtures which include one or more alkoxides selected from the group consisting of metal methoxide, metal ethoxide, metal propoxide, metal isopropoxide, metal butoxide, metal iso-butoxide and metal tert-butoxide are especially preferred as base.

The alkoxide, when present, is used preferably in an amount of 0.01 to 5 equivalents and preferably between 0.01 to 2 equivalents, based on 1 equivalent of compound of formula (I) or salt thereof.

The triazine formation can also be performed in the presence of one or more compounds having polar (functional) groups which are of less basic nature than said alkoxides above. Such compounds are preferably selected from the group consisting of polyols, aminoalcohols and polyamines.

Examples for compounds having polar groups are the following compounds including all of their isomers:

ethanediol, propandiol, propantriol, aminoethanol, N-mono- and N,N-disubstituted-aminoethanol, aminopropanol, N-mono- and N,N-disubstituted-aminopropanol, butandiol, butantriol, aminobutanol, N-mono- and N,N-disubstituted-aminobutanol, diethanolamine, N-substituted-diethanolamine, triethanolamine, dipropanolamine, N-substituted-dipropanolamine, ethanediamine, mono-, di-, tri- or tetra-substituted-ethanediamine, propanediamine and mono-, di-, tri- and tetra-substituted-propanediamine, preferably ethanediol, propanediol and butanediol, and mixtures thereof. Especially preferred are 1,2-ethanediol, 1,2-propanediol, 1,2-butanediol and 1-methyl-1,2-propanediol, 1,4-butanediol.

The substance with polar groups, when present, preferably is used in an amount of from 0.01 to 20 equivalents, more preferably of from 0.01 to 10 equivalents and especially of from 0.01 to 5 equivalents, based on 1 equivalent of compound (I) or salt thereof.

The triazine formation can also be performed in the presence of both, one or more base and one or more substances with polar groups, of which mixtures which include one or more of ethanediol, propanediol or butanediol and one or more (metal) methoxide, ethoxide, propoxide, isopropoxide, butoxide, iso-butoxide and tert-butoxide are preferred.

The substance having polar groups, such as the diol, aminoalcohol or diamine, and the (metal) alkoxide often works synergistically resulting in reactions which are quicker and/or cleaner and/or may progress at a lower temperature than may be achieved by either reagent separately.

The triazine formation can also be performed in the presence of an additional salt which may act as a dehydrating agent, for example but not limited to:

sodium sulfate (Na₂SO₄), calcium sulfate (CaSO₄), calcium halides (CaCl₂, CaBr₂), magnesium sulfate (MgSO₄), magnesium halides (MgCl₂, MgBr₂).

The additional salt is preferably used in stoichiometric or sub-stoichiometric quantities based on the amount of compound of formula (I).

The triazine formation can also be performed in the presence of a zeolite, clay or other water absorbing substance which may act as a dehydrating agent.

The triazine formation can also be performed in the presence of one or more of the above mentioned additives.

The amine of the formula (II) can also be used in the form of the free base or as a salt or mixed salt of an acid such as, for example: HF, HCl, HBr, HI, H₂SO₄, H₃PO₄, RSO₃H, RSO₂H, RPO₃H₂, or a complex with AlX₃, BX₃, CO₂, SO₂, SO₃, PX₃, POX₃, PX₅, SiX₄ where X is halogen, a halogen analogue, alkyloxy, aryloxy, alkylamino, alkylarylamino or arylamino or derivatives thereof, where the alkyl groups having 1 to 6 carbon atoms are preferred, and aryl being phenyl is preferred.

The salt of the amine (II) can optionally be used together with the addition of an equivalent amount or less or more than equivalent amount of an organic or inorganic base, preferably a non-aqueous base.

The process for the formation of the triazine can be combined directly with the process for preparing the Al-complex of formula (I) without isolation (or purification) of the compound of formula (I), optionally in a one-pot process.

Preferably, the invention provides a process for the preparation of compounds of formula (V) or salts thereof, characterized in that

(a) a compound of the formula (II) or a salt thereof,

in which R¹ and R² are defined as in the compound of formula (V) to be prepared, is reacted to a compound of the formula (IIIa) or a salt thereof,

in which R³ and R⁴ are defined as in the compound of formula (I) to be prepared,

and an aluminium(II) source, optionally, in the presence of a protic additive or solvent selected from the group consisting of alcohols or amines, preferably an aluminium(III) source selected from

-   -   (i) aluminium salts of the formula (IV),

-   -   in which     -   X and Y are as defined in the compound of formula (I) to be         prepared, and Z, independently of X, is a leaving group selected         from the group of radicals as defined for X or Y, or     -   (ii) aluminium salts of the formula (IV′),

-   -   in which     -   X′, Y′ and Z′ each are selected from the group consisting of         radicals as defined for X, Y or Z, respectively and radicals         which generate said group X, Y or Z, respectively in the         presence of a protic additive or solvent X—H, Y—H or Z—H,         respectively, with the proviso that 1, 2 or 3 of the radicals         X′, Y′ and Z′ are selected from said radicals which generate         radicals X, Y and Z, respectively, in combination with a protic         additive or solvent X—H, Y—H or Z—H wherein each of X, Y and Z         are defined as set forth for X and Y in formula (I), and         addition salts thereof,

to give a compound of the formula (Ia) or a salt thereof,

in which R¹, R², R³ and R⁴, are defined as in the compound of formula (V) to be prepared, and in which Y is as defined in formula (I) further above, and

(b) the compound of formula (I) obtained in step (a), optionally without isolation and purification, is reacted with a compound of the formula (VI)

Q-W*  (VI)

in which Q is defined as for Q in formula (V) to be prepared, and W* is defined formula (VI) defined further above, to give a the compound of the formula (V) or a salt thereof.

The process for the preparation of compounds (V) via compounds (I) proceeds with high yield and purity at moderate reaction conditions.

In the following non-limiting examples the amounts and percentages are related to weight unless defined otherwise specifically.

A) PREPARATION EXAMPLES

Abbreviations used in the examples:

hr(s)=hour(s)

ml=milliliter

mp=melting point

A1) 4-Morpholino-6-[(1S)-1-chloroethyl]-1,3,5-triazine-2-amine

A1a) A mixture of 108 g morpholine, 163 g cyanoguanidine, 347 g aluminium isopropoxide and 267 g 1-methoxy-2-propanol were stirred under nitrogen and heated to 90° C. for 22.5 hrs (see example Ia-1.181 of Table II).

A1b) The reaction mixture obtained in A1a was cooled to 70° C., and 530 g methanol was added carefully. After complete addition 178 g methyl (2S)-2-chloro-propionate was added. After 22 hrs at 70° C. the internal the reaction mixture was added to 2400 ml 10% acetic acid at 70° C. Low boiling solvents were removed under a light vacuum (840 ml). The suspension was then cooled to 30° C., filtered and washed with 2×240 g 10% acetic acid and then 2×480 g water. The solid was then dried in vacuo. Product: 199 g, yield 68%, mp: 177-8° C. (see example V-1 of Table I).

A2) N-Benzyl-6-[(1S)-1-hydroxyethyl]-1,3,5-triazine-2,4-diamine

A2a) 130 g benzylamine, 163 g cyanoguanidine and 347 g aluminium isopropoxide were suspended in 267 g 1-methoxy-2-propanol and heated to 90° C. for 10 hrs (see example Ia-1.182 of Table II).

A2b) The reaction mixture obtained in A2b was cooled to 75° C., and 530 g methanol and 153 g methyl S-lactate were added. After 22 hrs the reaction mixture was added to 2400 g 10% acetic acid which had been pre-heated to 70° C. Up to an internal temperature of 88° C. 740 ml solvent was removed by distillation, the mixture cooled to 20° C. and extracted 3 times with 2000 ml ethyl acetate. The combined organic layers were dried over sodium sulfate, filtered and concentrated in vacuo. The resulting product was an oil. Yield of the product: 260 g, 83% (see example V-2 of Table I).

A3) N-Cyclohexyl-6-methoxymethyl-1,3,5-triazine-2,4-diamine

A3a) 50 g cyclohexylamine, 68 g cyanoguanidine and 144 g aluminium isopropoxide were suspended in 110 g 1-methoxy-2-propanol and heated to 90° C. for 4 hrs (see example Ia-1.183 of Table II).

A3b) The reaction mixture obtained in A3a was then cooled to 75° C., and 220 g methanol and 63.7 g methyl methoxyacetate were added. After 16 hrs the reaction mixture was added to 1000 g 10% acetic acid which had been pre-heated to 70° C. Up to an internal temperature of 88° C. 330 ml solvent was removed by distillation, the mixture cooled to 20° C. and extracted 3 times with 1000 ml toluene. The combined organic layers were dried over sodium sulfate, filtered and concentrated in vacuo. The resulting product was an oil which solidified on standing. Product yield: 101 g (85%), mp: 103-6° C. (see example V-3 of Table I).

A4) N-[(1R)-2,3-Dihydro-6-methyl-1H-inden-1-yl]-6-[(1R)-1-fluoroethyl]-1,3,5-triazine-2,4-diamine

A4a) A mixture of 53.1 g 1R-1-amino-6-methylindane, 56.5 g cyanoguanidine, 127 g aluminium isopropoxide and 75 g isopropanol were stirred under nitrogen and heated to reflux for 22.5 hrs (see example Ia-1.5 of Table II).

A4b) The reaction mixture obtained in A4a was cooled to 75° C., and 70 g 1,2-propandiol and 182 g methanol were added carefully. After complete addition 45.5 g methyl (2R)-2-fluoro-propionate was added. After 23 hrs at 70° C. the internal temperature the reaction mixture was then added to 870 g 10% acetic acid at 70° C. The suspension was then cooled to 20° C., filtered and washed twice with 160 g 5% acetic acid and then twice with 160 g water. The solid was then dried in vacuo. Product yield: 81.7 g (81%), mp: 135-136° C. (see example V-4 of Table I).

A5) 4-[1,2,3,4-tetrahydroisoquinolin-2-yl]-6-[(1R)-1-fluoroethyl]-1,3,5-triazine-2-amine

A5a) A mixture of 48 g 1,2,3,4-tetrahydroisoquinoline, 56.5 g cyanoguanidine, 128 g aluminium isopropoxide and 75 g isopropanol were stirred under nitrogen and heated to reflux for 22 hrs (see example Ia-1.8 of Table II).

A5b) The reaction mixture obtained in A5a was cooled to 75° C., and 70 g 1,2-propandiol and 182 g methanol were added carefully. After complete addition 45.5 g methyl (2R)-2-fluoro-propionate was added. After 23 hrs at 70° C. the internal temperature the reaction mixture was then added to 862 g 10% acetic acid at 70° C. The suspension was then cooled to 20° C., filtered and washed with 2×160 g 5% acetic acid and then twice with 160 g water. The solid was then dried in vacuo. Product yield: 68.5 g (71%), mp: 186-9° C. (see example V-5 of Table I).

A6) N-[1,2,3,4-Tetrahydronaphth-1-yl]-6-[(1S)-1-chloroethyl]-1,3,5-triazine-2,4-diamine

A6a) 136.6 g 1,2,3,4-Tetrahydronaphthaline, 122 g cyanoguanidine and 260 g aluminium isopropoxide were suspended in 203 g 1-methoxy-2-propanol and heated to 90° C. for 24 hrs (see example Ia-1.189 of Table II).

A6b) The reaction mixture obtained in A6a was cooled to 75° C., and 400 g methanol and 134 g methyl (2S)-2-chloropropionate were added. After 23 hrs the reaction mixture was added to 1800 g 10% acetic acid which had been pre-heated to 70° C. Up to an internal temperature of 86° C. 550 ml solvent was removed by distillation, the mixture cooled to 20° C. and filtered and washed twice with 180 g 5% acetic acid and then twice with 180 g water. The solid was then dried in vacuo. Product yield: 209 g (76%), mp: 169-70° C. (see example V-6 of Table I).

A7) 4-[1,2,3,4-tetrahydroisoquinolin-2-yl]-6-isopropyl-1,3,5-triazine-2-amine

A7a) A mixture of 68.7 g 1,2,3,4-tetrahydroisoquinoline, 67.9 g cyanoguanidine and 144 g aluminium isopropoxide were suspended in 111 g 2-ethoxyethanol and heated to 90° C. for 21 hrs (see example Ia-1.224 of Table II).

A7b) The reaction mixture obtained in A7a was cooled to 75° C., and 222 g methanol, 65 g methyl isobutyrate and 90 g 30% sodium methoxide were added. After 23 hrs the reaction mixture was added to 1000 g 10% acetic acid which had been pre-heated to 70° C. Up to an internal temperature of 86° C. 430 ml solvent was removed by distillation, the mixture cooled to 20° C. and filtered and washed with 2×240 g 5% acetic acid and then twice with 240 g water. The solid was then dried in vacuo. Product yield: 107 g (79%), mp: >255° C. (see example V-7 of Table I).

A8) N-[(1R,2S)-2,6-Dimethyl-2,3-dihydro-1H-inden-1-yl]-6-difluoromethyl-1,3,5-triazine-2,4-diamine

A8a) A mixture of 87 g 1R,2S-1-amino-2,6-dimethylindane, 67.9 g cyanoguanidine and 146 g aluminium isopropoxide were suspended in 111 g 1-methoxy-2-propanol and heated to 90° C. for 24 hrs (see example Ia-1.192 of Table II).

A8b) The reaction mixture obtained in A8a was cooled to 70° C. and 222 g methanol, 104 g 1,2 propandiol and 68.9 g methyl difluoropropionate were added. After 23 hrs the reaction mixture was added to 1000 g 10% acetic acid and 1000 ml toluene which had been pre-heated to 70° C. Up to an internal temperature of 87° C. 370 ml solvent was removed by distillation, the mixture cooled to 20° C., the phases separated and the organic phase extracted twice with 500 ml toluene. The combined phases were dried over sodium sulfate and evaporated. The solid was then dried in vacuo. Product yield: 134 g (81%), mp: 87-88° C. (see example V-8 of Table I).

A9) N-[(1R,2S)-2,4,6-Trimethyl-2,3-dihydro-1H-inden-1-yl]-6-[(1S)-1-chloroethyl]-1,3,5-triazine-2,4-diamine

A9a) A mixture of 7.6 g 1R,2S-1-amino-2,4,6-trimethylindane, 5.6 g cyanoguanidine and 12.0 g aluminium isopropoxide were suspended in 8.8 g 1-methoxy-2-propanol and heated to 90° C. for 16 hrs (s. expl. Ia-1.198 of Table II).

A9b) The reaction mixture obtained in A9a was cooled to 70° C., and 18.2 g methanol and 6.1 g methyl (2S)-2-chloropropionate were added. After 22 hrs the reaction mixture was added to 10% 85 g acetic acid which had been pre-heated to 70° C. Up to an internal temperature of 87° C. 20 ml solvent was removed by distillation. The mixture was then cooled to 20° C. and filtered and washed twice with 10 g 10% acetic acid and then twice with 20 g water. The solid was then dried in vacuo. Product yield: 6.3 g (45%), mp: 85-87° C. (see example V-9 of Table I).

A10) N-[(1S,2R)-2,6-Dimethyl-2,3-dihydro-1H-inden-1-yl]-biguanidinoaluminiummethoxyisopropoxide

A mixture of 2.62 g (1S,2R)-1-amino-2,6-dimethylindane, 1.40 g cyanoguanidine, 3.40 g aluminium isopropoxide and 2.54 g 1-methoxy-2-propanol were stirred under nitrogen and heated to 103° C. After 22 hrs the reaction was cooled to 50° C. and concentrated in vacuo. The residue was suspended in toluene 20 ml and re-evaporated. The amorphous solid was then dried in vacuo. Structural confirmation was made with Al²⁷-NMR, H¹-NMR and C¹³-NMR in D₈-Isopropanol (see example Ia-1.199 in Table II).

A11) N-[(1R)-cyclobutyl-2-phenyleth-1-yl]-biguandinoaluminiummethoxyisopropoxide

A mixture of 3.08 g (1R)-cyclobutyl-2-phenyleth-1-yl-amine, 1.42 g cyanoguanidine, 3.40 g aluminium isopropoxide and 2.54 g 1-methoxy-2-propanol were stirred under nitrogen and heated to 103° C. After 22 hrs the reaction was cooled to 50° C. and concentrated in vacuo. The residue was suspended in toluene 20 ml and re-evaporated. The amorphous solid was then dried in vacuo. Structural confirmation was made with Al²⁷-NMR, H¹-NMR and C¹³-NMR in D₈-Isopropanol (see example Ia-1.215 in Table II).

A12) N-pent-3-ylbiguanidinoaluminiummethoxyisopropoxide

A mixture of 1.37 g 3-pentylamine, 1.40 g cyanoguanidine, 3.40 g aluminium isopropoxide and 3 g isopropanol were stirred under nitrogen and heated to 85° C. After 22 hrs the reaction was cooled to 50° C. and concentrated in vacuo. The residue was suspended in toluene 20 ml and re-evaporated. The amorphous solid was then dried in vacuo. Structural confirmation was made with Al²⁷-NMR, H¹-NMR and C¹³-NMR in D₈-Isopropanol (see example Ia-1.33 in Table II).

The compounds of formula (V) of the following Table I were prepared analogously to the preparation examples Al (a, b) to A9 (a, b) and A10 to A12 from respective compounds of formula (I) as shown in Table II.

TABLE I Compounds of formula (Va) (Va)

Cpd. Q NR¹R² NR³R⁴ Additive Solvent V-1 (1S)-1-chloroethyl morpholin-yl NH₂ — CH₃OH V-2 (1S)-1-hydroxyethyl benzylamino NH₂ — CH₃OH V-3 methoxymethyl cyclohexylamino NH₂ — CH₃OH V-4 (1R)-1-fluoroethyl (1R)-2,3-dihydro-6-methyl-1H-inden-1yl-amino NH₂ 1,2-propanediol CH₃OH V-5 (1R)-1-fluoroethyl 1,2,3,4-tetrahydro-isoquinolin-2-yl NH₂ 1,2-propanediol CH₃OH V-6 (1S)-1-chloroethyl (1RS)-1,2,3,4-tetrahydro-napht-1-yl-amino NH₂ — CH₃OH V-7 isopropyl 1,2,3,4-tetrahydro-isoquinolin-2-yl NH₂ NaOCH₃ CH₃OH V-8 difluoromethyl (1R,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NH₂ 1,2-propanediol CH₃OH V-9 (1S)-1-chloroethyl (1R,2S)-2,3-dihydro-2,4,6-trimethyl-1H-inden-1yl-amino NH₂ — CH₃OH V-10 (1R)-1-fluoroethyl (1R,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NH₂ NaOCH₃ CH₃OH V-11 (1S)-1-fluoroethyl (1R,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NH₂ NaOC₂H₅ C₂H₅OH V-12 (1R)-1-fluoroethyl (1R,2S)-2,3-dihydro-2-methyl-1H-inden-1yl-amino NH₂ 1,2-propanediol CH₃OH V-13 difluoromethyl (1R,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NH₂ NaOCH₃ CH₃OH V-14 (1R)-1-fluoroethyl (1RS)-1,2,3,4-tetrahydro-napht-1-yl-amino NH₂ NaOCH₃, CH₃OH 1,2-propanediol V-15 (1R)-1-fluoroethyl 1,2,3,4-tetrahydro-iso-quinolin-2-yl NH₂ NaOCH₃, CH₃OH 1,2-propanediol V-16 (1R)-1-fluoroethyl (1R,2R)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NH₂ NaOCH₃, CH₃OH 1,2-propanediol V-17 difluoromethyl (1R)-2,3-dihydro-6-methyl-1H-inden-1yl-amino NH₂ NaOCH₃, CH₃OCH(CH₃)₂ V-18 difluoromethyl 1,2,3,4-tetrahydro-iso-quinolin-2-yl NH₂ NaOCH₃, CH₃OCH(CH₃)₂ V-19 1-fluoro-1-methylethyl (1R)-2,3-dihydro-6-methyl-1H-inden-1yl-amino NH₂ NaOCH₃, CH₃OCH(CH₃)₂ 1,2-propanediol V-20 1-fluoro-1-methylethyl (1R,S)-1-cyclobutyl-2-phenyleth-1-yl-amino NH₂ NaOCH₃, CH₃OCH(CH₃)₂ 1,2-propanediol V-21 1-fluoro-1-methylethyl (1R)-cyclobutyl-2-phenyleth-1-yl-amino NH₂ NaOCH₃, C₂H₅OC₂H₄OH 1,2-propanediol V-22 (1R)-1-fluoroethyl (1R)-cyclobutyl-2-phenyleth-1-yl-amino NH₂ NaOCH₃, CH₃OCH(CH₃)₂ 1,2-propanediol V-23 (1S)-1-fluoroethyl (1R)-cyclobutyl-2-phenyleth-1-yl-amino NH₂ NaOCH₃, CH₃OCH(CH₃)₂ 1,2-propanediol V-24 1-fluoro-1-methylethyl (2R,S)-1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NH₂ NaOCH₃ CH₃OH V-25 1-fluoro-1-methylethyl (1R)-1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NH₂ NaOCH₃ C₂H₅OC₂H₄OH V-26 1-fluoro-1-methylethyl (1S)-1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NH₂ NaOCH₃ CH₃OH V-27 1-fluoro-1-methylethyl 1,1-dicyclopropylmethyl-amino NH₂ NaOCH₃ CH₃OH V-28 1-fluoro-1-methylethyl pent-3-ylamino NH₂ NaOCH₃ CH₃OH V-29 1-fluoro-1-methylethyl (4RS)-3,4-dihydro-2H-chromen-4-yl-amino NH₂ NaOCH₃ CH₃OH V-30 1-fluoro-1-methylethyl (4R)-3,4-dihydro-2H-chromen-4-yl-amino NH₂ NaOCH₃ CH₃OH V-31 1-fluoro-1-methylethyl (4S)-3,4-dihydro-2H-chromen-4-yl-amino NH₂ NaOCH₃ CH₃OH V-32 1-fluoro-1-methylethyl (3RS,4RS)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NH₂ NaOCH₃, CH₃OCH(CH₃)₂ 1,2-propanediol V-33 1-fluoro-1-methylethyl (3R,4R)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NH₂ NaOCH₃, CH₃OCH(CH₃)₂ 1,2-propanediol V-34 1-fluoro-1-methylethyl (3S,4S)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NH₂ NaOCH₃, CH₃OCH(CH₃)₂ 1,2-propanediol V-35 1-fluoro-1-methylethyl (1RS)-1-cyclopropylethyl-amino NH₂ NaOCH₃ CH₃OH V-36 1-fluoro-1-methylethyl (1R)-1-cyclopropylethyl-amino NH₂ NaOCH₃ CH₃OH V-37 1-fluoro-1-methylethyl (1S)-1-cyclopropylethyl-amino NH₂ NaOCH₃ CH₃OH V-38 1-fluoro-propyl (1RS)-1-(4-chlorphenyl)eth-1-yl-amino NH₂ NaOCH₃ C₂H₅OC₂H₄OH V-39 1-fluoro-propyl (1R)-1-(4-chlorphenyl)eth-1-yl-amino NH₂ NaOCH₃ C₂H₅OC₂H₄OH V-40 1-fluoro-propyl (1S)-1-(4-chlorphenyl)eth-1-yl-amino NH₂ NaOCH₃ C₂H₅OC₂H₄OH V-41 (1S)-1-chloroethyl (1R)-1,2,3,4-tetrahydro-napht-1-yl-amino NH₂ — CH₃OH V-42 (1S)-1-chloroethyl (1S)-1,2,3,4-tetrahydro-napht-1-yl-amino NH₂ — CH₃OH V-43 (1R)-1-fluoroethyl (1R)-1,2,3,4-tetrahydro-napht-1-yl-amino NH₂ NaOCH₃, CH₃OH 1,2-propanediol V-44 (1R)-1-fluoroethyl (1S)-1,2,3,4-tetrahydro-napht-1-yl-amino NH₂ NaOCH₃, CH₃OH 1,2-propanediol V-45 (1S)-1-chloroethyl morpholin-yl NHBz — CH₃OH V-46 (1S)-1-hydroxyethyl benzylamino NHBz — CH₃OH V-47 methoxymethyl cyclohexylamino NHBz — CH₃OH V-48 (1R)-1-fluoroethyl (1R)-2,3-dihydro-6-methyl-1H-inden-1yl-amino NHBz 1,2-propanediol CH₃OH V-49 (1R)-1-fluoroethyl 1,2,3,4-tetrahydro-isoquinolin-2-yl NHBz 1,2-propanediol CH₃OH V-50 (1S)-1-chloroethyl 1,2,3,4-tetrahydro-napht-1-yl-amino NHBz — CH₃OH V-51 (1S)-1-fluoroethyl 1,2,3,4-tetrahydro-isoquinolin-2-yl NHBz NaOCH₃ CH₃OH V-52 difluoromethyl (1R,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NHBz 1,2-propanediol CH₃OH V-53 (1S)-1-chloroethyl (1R,2S)-2,3-dihydro-2,4,6-trimethyl-1H-inden-1yl-amino NHBz — CH₃OH V-54 (1R)-1-fluoroethyl (1R,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NHBz NaOCH₃ CH₃OH V-55 (1S)-1-fluoroethyl (1R,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NHBz NaOC₂H₅ C₂H₅OH V-56 (1R)-1-fluoroethyl (1R,2S)-2,3-dihydro-2-methyl-1H-inden-1yl-amino NHBz 1,2-propanediol CH₃OH V-57 difluoromethyl (1R,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NHBz NaOCH₃ CH₃OH V-58 (1R)-1-fluoroethyl 1,2,3,4-tetrahydro-napht-1-yl-amino NHBz NaOCH₃, CH₃OH 1,2-propanediol V-59 (1R)-1-fluoroethyl 1,2,3,4-tetrahydro-isoquinolin-2-yl NHBz NaOCH₃, CH₃OH 1,2-propanediol V-60 (1R)-1-fluoroethyl (1R,2R)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NHBz NaOCH₃, CH₃OH 1,2-propanediol V-61 difluoromethyl (1R)-2,3-dihydro-6-methyl-1H-inden-1yl-amino NHBz NaOCH₃, CH₃OCH(CH₃)₂ V-62 difluoromethyl 1,2,3,4-tetrahydro-isoquinolin-2-yl NHBz NaOCH₃, CH₃OCH(CH₃)₂ V-63 1-fluoro-1-methylethyl (1R)-2,3-dihydro-6-methyl-1H-inden-1yl-amino NHBz NaOCH₃, CH₃OCH(CH₃)₂ 1,2-propanediol V-64 1-fluoro-1-methylethyl (1RS)-1-cyclobutyl-2-phenyleth-1-yl-amino NHBz NaOCH₃, CH₃OCH(CH₃)₂ 1,2-propanediol V-65 1-fluoro-1-methylethyl (1R)-cyclobutyl-2-phenyleth-1-yl-amino NHBz NaOCH₃, C₂H₅OC₂H₄OH 1,2-propanediol V-66 (1R)-1-fluoroethyl (1R)-cyclobutyl-2-phenyleth-1-yl-amino NHBz NaOCH₃, CH₃OCH(CH₃)₂ 1,2-propanediol V-67 (1S)-1-chloroethyl (1R)-cyclobutyl-2-phenyleth-1-yl-amino NHBz NaOCH₃, CH₃OCH(CH₃)₂ 1,2-propanediol V-68 1-fluoro-1-methylethyl 1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NHBz NaOCH₃ CH₃OH V-69 1-fluoro-1-methylethyl (1R)-1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NHBz NaOCH₃ C₂H₅OC₂H₄OH V-70 1-fluoro-1-methylethyl (1S)-1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NHBz NaOCH₃ CH₃OH V-71 1-fluoro-1-methylethyl 1,1-dicyclopropylmethyl-amino NHBz NaOCH₃ CH₃OH V-72 1-fluoro-1-methylethyl pent-3-ylamino NHBz NaOCH₃ CH₃OH V-73 1-fluoro-1-methylethyl 3,4-dihydro-2H-chromen-4-yl-amino NHBz NaOCH₃ CH₃OH V-74 1-fluoro-1-methylethyl (4R)-3,4-dihydro-2H-chromen-4-yl-amino NHBz NaOCH₃ CH₃OH V-75 1-fluoro-1-methylethyl (4S)-3,4-dihydro-2H-chromen-4-yl-amino NHBz NaOCH₃ CH₃OH V-76 1-fluoro-1-methylethyl (3RS,4RS)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NHBz NaOCH₃ CH₃OH V-77 1-fluoro-1-methylethyl (3R,4R)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NHBz NaOCH₃ CH₃OH V-78 1-fluoro-1-methylethyl (3S,4S)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NHBz NaOCH₃ CH₃OH V-79 1-fluoro-1-methylethyl (1RS)-1-cyclopropylethyl-amino NHBz NaOCH₃ CH₃OH V-80 1-fluoro-1-methylethyl (1R)-1-cyclopropylethyl-amino NHBz NaOCH₃ CH₃OH V-81 1-fluoro-1-methylethyl (1S)-1-cyclopropylethyl-amino NHBz NaOCH₃ CH₃OH V-82 1-fluoro-propyl (1RS)-1-(4-chlorphenyl)eth-1-yl-amino NHBz NaOCH₃ CH₃OH V-83 1-fluoro-propyl (1R)-1-(4-chlorphenyl)eth-1-yl-amino NHBz NaOCH₃ CH₃OH V-84 1-fluoro-propyl (1S)-1-(4-chlorphenyl)eth-1-yl-amino NHBz NaOCH₃ CH₃OH V-85 (1S)-1-chloroethyl (1R)-1,2.3.4-tetrahydro-napht-1-yl-amino NHBz — CH₃OH V-86 (1S)-1-chloroethyl (1S)-1,2,3,4-tetrahydro-napht-1-yl-amino NHBz — CH₃OH V-87 (1R)-1-fluoroethyl (1R)-1,2,3,4-tetrahydro-napht-1-yl-amino NHBz NaOCH₃, CH₃OH 1,2-propanediol V-88 (1R)-1-fluoroethyl (1S)-1,2,3,4-tetrahydro-napht-1-yl-amino NHBz NaOCH₃, CH₃OH 1,2-propanediol V-89 (1S)-1-chloroethyl morpholin-yl NBz₂ NaOCH₃ CH₃OH V-90 (1S)-1-hydroxyethyl benzylamino NBz₂ NaOCH₃ CH₃OH V-91 methoxymethyl cyclohexylamino NBz₂ NaOCH₃ CH₃OH V-92 (1R)-1-fluoroethyl (1R)-2,3-dihydro-6-methyl-1H-inden-1yl-amino NBz₂ NaOCH₃ CH₃OH V-93 (1R)-1-fluoroethyl 1,2,3,4-tetrahydro-iso-quinolin-2-yl NBz₂ NaOCH₃ CH₃OH V-94 (1S)-1-chloroethyl (1RS)-1,2,3,4-tetrahydro-napht-1-yl-amino NBz₂ NaOCH₃ CH₃OH V-95 (1S)-1-fluoroethyl 1,2,3,4-tetrahydro-isoquinolin-2-yl NBz₂ NaOCH₃ CH₃OH V-96 difluoromethyl (1R,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NBz₂ NaOCH₃ CH₃OH V-97 (1S)-1-chloroethyl (1R,2S)-2,3-dihydro-2,4,6-trimethyl-1H-inden-1yl-amino NBz₂ NaOCH₃ CH₃OH V-98 (1R)-1-fluoroethyl (1R,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NBz₂ NaOCH₃ CH₃OH V-99 (1S)-1-fluoroethyl (1R,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NBz₂ NaOCH₃ CH₃OH V-100 (1R)-1-fluoroethyl (1R,2S)-2,3-dihydro-2-methyl-1H-inden-1yl-amino NBz₂ NaOCH₃ CH₃OH V-101 difluoromethyl (1R,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NBz₂ NaOCH₃ CH₃OH V-102 (1R)-1-fluoroethyl (1RS)-1,2,3,4-tetrahydro-napht-1-yl-amino NBz₂ NaOCH₃ CH₃OH V-103 (1R)-1-fluoroethyl 1,2,3,4-tetrahydro-isoquinolin-2-yl NBz₂ NaOCH₃ CH₃OH V-104 (1R)-1-fluoroethyl (1R,2R)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NBz₂ NaOCH₃ CH₃OH V-105 difluoromethyl (1R)-2,3-dihydro-6-methyl-1H-inden-1yl-amino NBz₂ NaOCH₃ CH₃OH V-106 difluoromethyl 1,2,3,4-tetrahydro-isoquinolin-2-yl NBz₂ NaOCH₃ CH₃OH V-107 1-fluoro-1-methylethyl (1R)-2,3-dihydro-6-methyl-1H-inden-1yl-amino NBz₂ NaOCH₃ CH₃OH V-108 1-fluoro-1-methylethyl 1-cyclobutyl-2-phenyleth-1-yl-amino NBz₂ NaOCH₃ CH₃OH V-109 1-fluoro-1-methylethyl (1R)-cyclobutyl-2-phenyleth-1-yl-amino NBz₂ NaOCH₃ CH₃OH V-110 (1R)-1-fluoroethyl (1R)-cyclobutyl-2-phenyleth-1-yl-amino NBz₂ NaOCH₃ CH₃OH V-111 (1S)-1-fluoroethyl (1R)-cyclobutyl-2-phenyleth-1-yl-amino NBz₂ NaOCH₃ CH₃OH V-112 1-fluoro-1-methylethyl 1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NBz₂ NaOCH₃ CH₃OH V-113 1-fluoro-1-methylethyl (1R)-1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NBz₂ NaOCH₃ CH₃OH V-114 1-fluoro-1-methylethyl (1S)-1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NBz₂ NaOCH₃ CH₃OH V-115 1-fluoro-1-methylethyl 1,1-dicyclopropylmethyl-amino NBz₂ NaOCH₃ CH₃OH V-116 1-fluoro-1-methylethyl pent-3-ylamino NBz₂ NaOCH₃ CH₃OH V-117 1-fluoro-1-methylethyl (4RS)-3,4-dihydro-2H-chromen-4-yl-amino NBz₂ NaOCH₃ CH₃OH V-118 1-fluoro-1-methylethyl (4R)-3,4-dihydro-2H-chromen-4-yl-amino NBz₂ NaOCH₃ CH₃OH V-119 1-fluoro-1-methylethyl (4S)-3,4-dihydro-2H-chromen-4-yl-amino NBz₂ NaOCH₃ CH₃OH V-120 1-fluoro-1-methylethyl (3RS,4RS)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NBz₂ NaOCH₃ CH₃OH V-121 1-fluoro-1-methylethyl (3R,4R)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NBz₂ NaOCH₃ CH₃OH V-122 1-fluoro-1-methylethyl (4S,4S)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NBz₂ NaOCH₃ CH₃OH V-123 1-fluoro-1-methylethyl (1RS)-1-cyclopropylethyl-amino NBz₂ NaOCH₃ CH₃OH V-124 1-fluoro-1-methylethyl (1R)-1-cyclopropylethyl-amino NBz₂ NaOCH₃ CH₃OH V-125 1-fluoro-1-methylethyl (1S)-1-cyclopropylethyl-amino NBz₂ NaOCH₃ CH₃OH V-126 1-fluoro-propyl (1RS)-1-(4-chlorphenyl)eth-1-yl-amino NBz₂ NaOCH₃ CH₃OH V-127 1-fluoro-propyl (1R)-1-(4-chlorphenyl)eth-1-yl-amino NBz₂ NaOCH₃ CH₃OH V-128 1-fluoro-propyl (1S)-1-(4-chlorphenyl)eth-1-yl-amino NBz₂ NaOCH₃ CH₃OH V-129 (1S)-1-chloroethyl (1R)-1,2,3,4-tetrahydro-napht-1-yl-amino NBz₂ — CH₃OH V-130 (1S)-1-chloroethyl (1S)-1,2,3,4-tetrahydro-napht-1-yl-amino NBz₂ — CH₃OH V-131 (1R)-1-fluoroethyl (1R)-1,2,3,4-tetrahydro-napht-1-yl-amino NBz₂ NaOCH₃, CH₃OH 1,2-propanediol V-132 (1R)-1-fluoroethyl (1S)-1,2,3,4-tetrahydro-napht-1-yl-amino NBz₂ NaOCH₃, CH₃OH 1,2-propanediol V-133 (1S)-1-chloroethyl (3S,4R)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NH₂ — CH₃OH V-134 (1S)-1-chloroethyl (4R,4S)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NH₂ — CH₃OH V-135 (1R)-1-fluoroethyl (3S,4R)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NH₂ 1,2-propanediol CH₃OH V-136 (1R)-1-fluoroethyl (4R,4S)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NH₂ 1,2-propanediol CH₃OH V-137 1-fluoro-1-methylethyl (3S,4R)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NH₂ NaOCH₃, CH₃OCH(CH₃)₂ 1,2-propanediol V-138 1-fluoro-1-methylethyl (4R,4S)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NH₂ NaOCH₃, CH₃OCH(CH₃)₂ 1,2-propanediol V-139 difluoromethyl (3S,4R)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NH₂ NaOCH₃ CH₃OH V-140 difluoromethyl (4R,4S)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NH₂ NaOCH₃ CH₃OH Abbreviations in Table I: Bz = benzyl NHBz = benzylamino NBz₂ = dibenzylamino Reaction conditions as to examples in Table I: 1) Reaction temperature of 70 to 75° C. in all experiments used 2) Yield generally in the range of percent 70 to 85 of theory, sometimes less yield when additive has been omitted

Compounds of formuIa (Ia-1)

Cpd. no. Y NR¹R² NR³R⁴ Al-source Solvent (Ia-1.1) O-i-Pr morpholin-yl NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.2) O-i-Pr benzylamino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.3) O-i-Pr cyclohexylamino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.4) O-i-Pr (1RS)-2,3-dihydro-6-methyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.5) O-i-Pr (1R)-2,3-dihydro-6-methyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.6) O-i-Pr (1S)-2,3-dihydro-6-methyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.7) O-i-Pr 1,2,3,4-tetrahydro-quinolin-1-yl NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.8) O-i-Pr 1,2,3,4-tetrahydro-isoquinolin-2-yl NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.9) O-i-Pr (1RS)-1,2,3,4-tetrahydro-napht-1-yl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.10) O-i-Pr (1R)-1,2,3,4-tetrahydro-napht-1-yl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.11) O-i-Pr (1S)-1,2,3,4-tetrahydro-napht-1-yl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.12) O-i-Pr (1R,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.13) O-i-Pr (1S,2R)-2,3-dihydro-2,4,6-trimethyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.14) O-i-Pr (1R,2R)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NH₂ Al(CH₃)₃ (CH₃)₂CHOH (Ia-1.15) O-i-Pr (1S,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NH₂ Al(CH₃)₃ (CH₃)₂CHOH (Ia-1.16) O-i-Pr (1R,2S)-2,3-dihydro-2-methyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.17) O-i-Pr (1R,2R)-2,3-dihydro-2-methyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.18) O-i-Pr (1R,2S)-2,3-dihydro-2,4,6-trimethyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.19) O-i-Pr (1S,2R)-2,3-dihydro-2,6-methyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.20) O-i-Pr (3RS,4RS)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.21) O-i-Pr (3R,4R)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.22) O-i-Pr (3S,4S)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.23) O-i-Pr (1RS)-1-cyclopropylethyl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.24) O-i-Pr (1R)-cyclopropylethyl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.25) O-i-Pr (1S)-cyclopropylethyl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.26) O-i-Pr (1RS)-1-(4-chlorphenyl)eth-l-yl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.27) O-i-Pr (1R)-(4-chlorphenyl)eth-1-yl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.28) O-i-Pr (1S)-(4-chlorphenyl)eth-1-yl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.29) O-i-Pr (1RS)-1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.30) O-i-Pr (1R)-1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.31) O-i-Pr (1S)-1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.32) O-i-Pr 1,1-dicyclopropylmethyl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.33) O-i-Pr pent-3-ylamino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.34) O-i-Pr (1RS)-1-cyclobutyl-2-phenyleth-1-yl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.35) O-i-Pr (1R)-cyclobutyl-2-phenyleth-1-yl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.36) O-i-Pr (1S)-cyclobutyl-2-phenyleth-l-yl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.37) —OCH(CH₃)CH₂OCH₃ morpholin-yl NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.38) —OCH(CH₃)CH₂OCH₃ benzylamino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.39) —OCH(CH₃)CH₂OCH₃ cyclohexylamino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.40) —OCH(CH₃)CH₂OCH₃ 2,3-dihydro-6-methyl-1H-inden-1yl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.41) —OCH(CH₃)CH₂OCH₃ (1R)-2,3-dihydro-6-methyl-1H-inden-1yl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.42) —OCH(CH₃)CH₂OCH₃ (1S)-2,3-dihydro-6-methyl-1H-inden-1yl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.43) —OCH(CH₃)CH₂OCH₃ 1,2,3,4-tetrahydro-quinolin-1-yl NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.44) —OCH(CH₃)CH₂OCH₃ 1,2,3,4-tetrahydro-isoquinolin-2-yl NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.45) —OCH(CH₃)CH₂OCH₃ 1,2,3,4-tetrahydro-napht-1-yl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.46) —OCH(CH₃)CH₂OCH₃ (1R)-1,2,3,4-tetrahydro-napht-l-yl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.47) —OCH(CH₃)CH₂OCH₃ (1S)-1,2,3,4-tetrahydro-napht-1-yl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.48) —OCH(CH₃)CH₂OCH₃ (1R,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.49) —OCH(CH₃)CH₂OCH₃ (1S,2R)-2,3-dihydro-2,4,6-trimethyl-1H-inden-1yl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.50) —OCH(CH₃)CH₂OCH₃ (1R,2R)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.51) —OCH(CH₃)CH₂OCH₃ (1S,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.52) —OCH(CH₃)CH₂OCH₃ (1R,2S)-2,3-dihydro-2-methyl-1H-inden-1yl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.53) —OCH(CH₃)CH₂OCH₃ (1R,2R)-2,3-dihydro-2-methyl-1H-inden-1yl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.54) —OCH(CH₃)CH₂OCH₃ (1R,2S)-2,3-dihydro-2,4,6-trimethyl-1H-inden-1yl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.55) —OCH(CH₃)CH₂OCH₃ (1S,2R)-2,3-dihydro-2,6-methyl-1H-inden-1yl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.56) —OCH(CH₃)CH₂OCH₃ (3RS,4RS)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.57) —OCH(CH₃)CH₂OCH₃ (3R,4R)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.58) —OCH(CH₃)CH₂OCH₃ (3S,4S)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.59) —OCH(CH₃)CH₂OCH₃ 1-cyclopropylethyl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.60) —OCH(CH₃)CH₂OCH₃ (1R)-cyclopropylethyl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.61) —OCH(CH₃)CH₂OCH₃ (1S)-cyclopropylethyl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.62) —OCH(CH₃)CH₂OCH₃ 1-(4-chlorphenyl)eth-1-yl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.63) —OCH(CH₃)CH₂OCH₃ (1R)-(4-chlorphenyl)eth-1-yl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.64) —OCH(CH₃)CH₂OCH₃ (1S)-(4-chlorphenyl)eth-1-yl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.65) —OCH(CH₃)CH₂OCH₃ 1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.66) —OCH(CH₃)CH₂OCH₃ (1R)-1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.67) —OCH(CH₃)CH₂OCH₃ (1S)-1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.68) —OCH(CH₃)CH₂OCH₃ 1,1-dicyclopropylmethyl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.69) —OCH(CH₃)CH₂OCH₃ pent-3-ylamino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.70) —OCH(CH₃)CH₂OCH₃ 1-cyclobutyl-2-phenyleth-1-yl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.71) —OCH(CH₃)CH₂OCH₃ (1R)-cyclobutyl-2-phenyleth-1-yl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.72) —OCH(CH₃)CH₂OCH₃ (1S)-cyclobutyl-2-phenyleth-1-yl-amino NHBz Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.73) —OCH₂CH₂OC₂H₅ morpholin-yl NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.74) —OCH₂CH₂OC₂H₅ benzylamino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.75) —OCH₂CH₂OC₂H₅ cyclohexylamino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.76) —OCH₂CH₂OC₂H₅ 2,3-dihydro-6-methyl-1H-inden-1yl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.77) —OCH₂CH₂OC₂H₅ (1R)-2,3-dihydro-6-methyl-1H-inden-1yl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.78) —OCH₂CH₂OC₂H₅ (1S)-2,3-dihydro-6-methyl-1H-inden-1yl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.79) —OCH₂CH₂OC₂H₅ 1,2,3,4-tetrahydro-quinolin-1-yl NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.80) —OCH₂CH₂OC₂H₅ 1,2,3,4-tetrahydro-iso-quinolin-2-yl NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.81) —OCH₂CH₂OC₂H₅ 1,2,3,4-tetrahydro-napht-l-yl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.82) —OCH₂CH₂OC₂H₅ (1R)-1,2,3,4-tetrahydro-napht-1-yl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.83) —OCH₂CH₂OC₂H₅ (1S)-1,2,3,4-tetrahydro-napht-1-yl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.84) —OCH₂CH₂OC₂H₅ (1R,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.85) —OCH₂CH₂OC₂H₅ (1S,2R)-2,3-dihydro-2,4,6-trimethyl-1H-inden-1yl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.86) —OCH₂CH₂OC₂H₅ (1R,2R)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.87) —OCH₂CH₂OC₂H₅ (1S,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.88) —OCH₂CH₂OC₂H₅ (1R,2S)-2,3-dihydro-2-methyl-1H-inden-1yl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.89) —OCH₂CH₂OC₂H₅ (1R,2R)-2,3-dihydro-2-methyl-1H-inden-1yl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.90) —OCH₂CH₂OC₂H₅ (1R,2S)-2,3-dihydro-2,4,6-trimethyl-1H-inden-1yl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.91) —OCH₂CH₂OC₂H₅ (1S,2R)-2,3-dihydro-2,6-methyl-1H-inden-1yl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.92) —OCH₂CH₂OC₂H₅ (3RS,4RS)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.93) —OCH₂CH₂OC₂H₅ (3R,4R)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.94) —OCH₂CH₂OC₂H₅ (3S,4S)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.95) —OCH₂CH₂OC₂H₅ 1-cyclopropylethyl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.96) —OCH₂CH₂OC₂H₅ (1R)-cyclopropylethyl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.97) —OCH₂CH₂OC₂H₅ (1S)-cyclopropylethyl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.98) —OCH₂CH₂OC₂H₅ 1-(4-chlorphenyl)eth-1-yl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.99) —OCH₂CH₂OC₂H₅ (1R)-(4-chlorphenyl)eth-1-yl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.100) —OCH₂CH₂OC₂H₅ (1S)-(4-chlorphenyl)eth-1-yl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.101) —OCH₂CH₂OC₂H₅ 1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.102) —OCH₂CH₂OC₂H₅ (1R)-1-methyl-2-(3,5-dimethylphenylont)eth-1-yl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.103) —OCH₂CH₂OC₂H₅ (1S)-1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.104) —OCH₂CH₂OC₂H₅ 1,1-dicyclopropylmethyl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.105) —OCH₂CH₂OC₂H₅ pent-3-ylamino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.106) —OCH₂CH₂OC₂H₅ 1-cyclobutyl-2-phenyleth-1-yl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.107) —OCH₂CH₂OC₂H₅ (1R)-cyclobutyl-2-phenyleth-1-yl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.108) —OCH₂CH₂OC₂H₅ (1S)-cyclobutyl-2-phenyleth-1-yl-amino NBz₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.109) —OCH(CH₃)C₂H₅ morpholin-yl NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.110) —OCH(CH₃)C₂H₅ benzylamino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.111) —OCH(CH₃)C₂H₅ cyclohexylamino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.112) —OCH(CH₃)C₂H₅ 2,3-dihydro-6-methyl-1H-inden-1yl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.113) —OCH(CH₃)C₂H₅ (1R)-2,3-dihydro-6-methyl-1H-inden-1yl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.114) —OCH(CH₃)C₂H₅ (1S)-2,3-dihydro-6-methyl-1H-inden-1yl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.115) —OCH(CH₃)C₂H₅ 1,2,3,4-tetrahydro-quinolin-1-yl NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.116) —OCH(CH₃)C₂H₅ 1,2,3,4-tetrahydro-isoquinolin-2-yl NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.117) —OCH(CH₃)C₂H₅ 1,2,3,4-tetrahydro-napht-1-yl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.118) —OCH(CH₃)C₂H₅ (1R)-1,2,3,4-tetrahydro-napht-1-yl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.119) —OCH(CH₃)C₂H₅ (1S)-1,2,3,4-tetrahydro-napht-1-yl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.120) —OCH(CH₃)C₂H₅ (1R,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.121) —OCH(CH₃)C₂H₅ (1S,2R)-2,3-dihydro-2,4,6-trimethyl-1H-inden-1yl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.122) —OCH(CH₃)C₂H₅ (1R,2R)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.123) —OCH(CH₃)C₂H₅ (1S,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.124) —OCH(CH₃)C₂H₅ (1R,2S)-2,3-dihydro-2-methyl-1H-inden-1yl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.125) —OCH(CH₃)C₂H₅ (1R,2R)-2,3-dihydro-2-methyl-1H-inden-1yl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.126) —OCH(CH₃)C₂H₅ (1R,2S)-2,3-dihydro-2,4,6-trimethyl-1H-inden-1yl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.127) —OCH(CH₃)C₂H₅ (1S,2R)-2,3-dihydro-2,6-methyl-1H-inden-1yl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.128) —OCH(CH₃)C₂H₅ (3RS,4RS)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.129) —OCH(CH₃)C₂H₅ (3R,4R)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.130) —OCH(CH₃)C₂H₅ (3S,4S)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.131) —OCH(CH₃)C₂H₅ 1-cyclopropylethyl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.132) —OCH(CH₃)C₂H₅ (1R)-cyclopropylethyl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.133) —OCH(CH₃)C₂H₅ (1S)-cyclopropylethyl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.134) —OCH(CH₃)C₂H₅ 1-(4-chlorphenyl)eth-1-yl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.135) —OCH(CH₃)C₂H₅ (1R)-(4-chlorphenyl)eth-1-yl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.136) —OCH(CH₃)C₂H₅ (1S)-(4-chlorphenyl)eth-1-yl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.137) —OCH(CH₃)C₂H₅ 1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.138) —OCH(CH₃)C₂H₅ (1R)-1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.139) —OCH(CH₃)C₂H₅ (1S)-1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.140) —OCH(CH₃)C₂H₅ 1,1-dicyclopropylmethyl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.141) —OCH(CH₃)C₂H₅ pent-3-ylamino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.142) —OCH(CH₃)C₂H₅ 1-cyclobutyl-2-phenyleth-1-yl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.143) —OCH(CH₃)C₂H₅ (1R)-cyclobutyl-2-phenyleth-1-yl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.144) —OCH(CH₃)C₂H₅ (1S)-cyclobutyl-2-phenyleth-1-yl-amino NH₂ Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.145) O-i-Pr morpholin-yl NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.146) O-i-Pr benzylamino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.147) O-i-Pr cyclohexylamino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.148) O-i-Pr 2,3-dihydro-6-methyl-1H-inden-1yl-amino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.149) O-i-Pr (1R)-2,3-dihydro-6-methyl-1H-inden-1yl-amino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.150) O-i-Pr (1S)-2,3-dihydro-6-methyl-1H-inden-1yl-amino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.151) O-i-Pr 1,2,3,4-tetrahydro-quinolin-1-yl NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.152) O-i-Pr 1,2,3,4-tetrahydro-isoquinolin-2-yl NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.153) O-i-Pr 1,2,3,4-tetrahydro-napht-1-yl-amino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.154) O-i-Pr (1R)-1,2,3,4-tetrahydro-napht-1-yl-amino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.155) O-i-Pr (1S)-1,2,3,4-tetrahydro-napht-1-yl-amino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.156) O-i-Pr (1R,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.157) O-i-Pr (1S,2R)-2,3-dihydro-2,4,6-trimethyl-1H-inden-1yl-amino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.158) O-i-Pr (1R,2R)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NHBz Al(CH₃)₃ (CH₃)₂CHOH (Ia-1.159) O-i-Pr (1S,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NHBz Al(CH₃)₃ (CH₃)₂CHOH (Ia-1.160) O-i-Pr (1R,2S)-2,3-dihydro-2-methyl-1H-inden-1yl-amino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.161) O-i-Pr (1R,2R)-2,3-dihydro-2-methyl-1H-inden-1yl-amino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.162) O-i-Pr (1R,2S)-2,3-dihydro-2,4,6-trimethyl-1H-inden-1yl-amino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.163) O-i-Pr (1S,2R)-2,3-dihydro-2,6-methyl-1H-inden-1yl-amino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.164) O-i-Pr (3RS,4RS)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.165) O-i-Pr (3R,4R)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.166) O-i-Pr (3S,4S)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.167) O-i-Pr 1-cyclopropylethyl-amino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.168) O-i-Pr (1R)-cyclopropylethyl-amino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.169) O-i-Pr (1S)-cyclopropylethyl-amino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.170) O-i-Pr 1-(4-chlorphenyl)eth-l-yl-amino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.171) O-i-Pr (1R)-(4-chlorphenyl)eth-1-yl-amino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.172) O-i-Pr (1S)-(4-chlorphenyl)eth-1-yl-amino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.173) O-i-Pr 1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.174) O-i-Pr (1R)-1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.175) O-i-Pr (1S)-1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.176) O-i-Pr 1,1-dicyclopropylmethyl-amino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.177) O-i-Pr pent-3-ylamino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.178) O-i-Pr 1-cyclobutyl-2-phenyleth-1-yl-amino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.179) O-i-Pr (1R)-cyclobutyl-2-phenyleth-1-yl-amino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.180) O-i-Pr (1S)-cyclobutyl-2-phenyleth-1-yl-amino NHBz Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.181) —OCH(CH₃)CH₂OCH₃ morpholin-yl NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.182) —OCH(CH₃)CH₂OCH₃ benzylamino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.183) —OCH(CH₃)CH₂OCH₃ cyclohexylamino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.184) —OCH(CH₃)CH₂OCH₃ 2,3-dihydro-6-methyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.185) —OCH(CH₃)CH₂OCH₃ (1R)-2,3-dihydro-6-methyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.186) —OCH(CH₃)CH₂OCH₃ (1S)-2,3-dihydro-6-methyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.187) —OCH(CH₃)CH₂OCH₃ 1,2,3,4-tetrahydro-quinolinyl NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.188) —OCH(CH₃)CH₂OCH₃ 1,2,3,4-tetrahydro-isoquinolin-2-yl NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.189) —OCH(CH₃)CH₂OCH₃ (1RS)-1,2,3,4-tetrahydro-napht-1-yl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.190) —OCH(CH₃)CH₂OCH₃ (1R)-1,2,3,4-tetrahydro-napht-1-yl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.191) —OCH(CH₃)CH₂OCH₃ (1S)-1,2,3,4-tetrahydro-napht-1-yl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.192) —OCH(CH₃)CH₂OCH₃ (1R,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.193) —OCH(CH₃)CH₂OCH₃ (1S,2R)-2,3-dihydro-2,4,6-trimethyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.194) —OCH(CH₃)CH₂OCH₃ (1R,2R)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.195) —OCH(CH₃)CH₂OCH₃ (1S,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.196) —OCH(CH₃)CH₂OCH₃ (1R,2S)-2,3-dihydro-2-methyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.197) —OCH(CH₃)CH₂OCH₃ (1R,2R)-2,3-dihydro-2-methyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.198) —OCH(CH₃)CH₂OCH₃ (1R,2S)-2,3-dihydro-2,4,6-trimethyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.199) —OCH(CH₃)CH₂OCH₃ (1S,2R)-2,3-dihydro-2-methyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.200) —OCH(CH₃)CH₂OCH₃ (3RS,4RS)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.201) —OCH(CH₃)CH₂OCH₃ (3R,4R)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.202) —OCH(CH₃)CH₂OCH₃ (3S,4S)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.203) —OCH(CH₃)CH₂OCH₃ 1-cyclopropylethyl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.204) —OCH(CH₃)CH₂OCH₃ (1R)-cyclopropylethyl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.205) —OCH(CH₃)CH₂OCH₃ (1S)-cyclopropylethyl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.206) —OCH(CH₃)CH₂OCH₃ 1-(4-chlorphenyl)eth-1-yl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.207) —OCH(CH₃)CH₂OCH₃ (1R)-(4-chlorphenyl)eth-1-yl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.208) —OCH(CH₃)CH₂OCH₃ (1S)-(4-chlorphenyl)eth-1-yl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.209) —OCH(CH₃)CH₂OCH₃ 1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.210) —OCH(CH₃)CH₂OCH₃ (1R)-1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.211) —OCH(CH₃)CH₂OCH₃ (1S)-1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.212) —OCH(CH₃)CH₂OCH₃ 1,1-dicyclopropylmethyl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.213) —OCH(CH₃)CH₂OCH₃ pent-3-ylamino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.214) —OCH(CH₃)CH₂OCH₃ 1-cyclobutyl-2-phenyleth-1-yl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.215) —OCH(CH₃)CH₂OCH₃ (1R)-cyclobutyl-2-phenyleth-1-yl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.216) —OCH(CH₃)CH₂OCH₃ (1S)-cyclobutyl-2-phenyleth-1-yl-amino NH₂ Al(O-i-Pr)₃ HOCH(CH₃)CH₂OCH₃ (Ia-1.217) —OCH₂CH₂OC₂H₅ morpholin-yl NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.218) —OCH₂CH₂OC₂H₅ benzylamino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.219) —OCH₂CH₂OC₂H₅ cyclohexylamino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.220) —OCH₂CH₂OC₂H₅ (1RS)-2,3-dihydro-6-methyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.221) —OCH₂CH₂OC₂H₅ (1R)-2,3-dihydro-6-methyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.222) —OCH₂CH₂OC₂H₅ (1S)-2,3-dihydro-6-methyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.223) —OCH₂CH₂OC₂H₅ 1,2,3,4-tetrahydro-quinlin-1-yl NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.224) —OCH₂CH₂OC₂H₅ 1,2,3,4-tetrahydro-isoquinolin-2-yl NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.225) —OCH₂CH₂OC₂H₅ 1,2,3,4-tetrahydro-napht-1-yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.226) —OCH₂CH₂OC₂H₅ (1R)-1,2,3,4-tetrahydro-napht-1-yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.227) —OCH₂CH₂OC₂H₅ (1S)-1,2,3,4-tetrahydro-napht-1-yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.228) —OCH₂CH₂OC₂H₅ (1R,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.229) —OCH₂CH₂OC₂H₅ (1S,2R)-2,3-dihydro-2,4,6-trimethyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.230) —OCH₂CH₂OC₂H₅ (1R,2R)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.231) —OCH₂CH₂OC₂H₅ (1S,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.232) —OCH₂CH₂OC₂H₅ (1R,2S)-2,3-dihydro-2-methyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.233) —OCH₂CH₂OC₂H₅ (1R,2R)-2,3-dihydro-2-methyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.234) —OCH₂CH₂OC₂H₅ (1R,2S)-2,3-dihydro-2,4,6-trimethyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.235) —OCH₂CH₂OC₂H₅ (1S,2R)-2,3-dihydro-2,6-methyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.236) —OCH₂CH₂OC₂H₅ (3RS,4RS)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.237) —OCH₂CH₂OC₂H₅ (3R,4R)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.238) —OCH₂CH₂OC₂H₅ (3S,4S)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.239) —OCH₂CH₂OC₂H₅ 1-cyclopropylethyl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.240) —OCH₂CH₂OC₂H₅ (1R)-cyclopropylethyl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.241) —OCH₂CH₂OC₂H₅ (1S)-cyclopropylethyl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.242) —OCH₂CH₂OC₂H₅ 1-(4-chlorphenyl)eth-1-yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.243) —OCH₂CH₂OC₂H₅ (1R)-(4-chlorphenyl)eth-1-yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.244) —OCH₂CH₂OC₂H₅ (1S)-(4-chlorphenyl)eth-1-yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.245) —OCH₂CH₂OC₂H₅ 1-methyl-2-(3,5-dimethylphenyloxy)eth-2-yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.246) —OCH₂CH₂OC₂H₅ (1R)-1-methyl-2-(3,5-dimethylphenyloxy)eth-2-yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.247) —OCH₂CH₂OC₂H₅ (1S)-1-methyl-2-(3,5-dimethylphenyloxy)eth-2-yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.248) —OCH₂CH₂OC₂H₅ 1,1-dicyclopropylmethyl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.249) —OCH₂CH₂OC₂H₅ pent-3-ylamino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.250) —OCH₂CH₂OC₂H₅ 1-cyclobutyl-2-phenyleth-1-yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.251) —OCH₂CH₂OC₂H₅ (1R)-cyclobutyl-2-phenyleth-1-yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.252) —OCH₂CH₂OC₂H₅ (1S)-cyclobutyl-2-phenyleth-1-yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.253) —OCH₂CH₂OC₂H₅ (1R,2R)-2,3-dihydro-2,4,6-trimethyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.254) —OCH₂CH₂OC₂H₅ (1S,2S)-2,3-dihydro-2,4,6-trimethyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.255) —OCH₂CH₂OC₂H₅ (1S,2R)-2,3-dihydro-2-methyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.256) —OCH₂CH₂OC₂H₅ (1S,2S)-2,3-dihydro-2-methyl-1H-inden-1yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.257) —OCH(CH₃)C₂H₅ morpholin-yl NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.258) —OCH(CH₃)C₂H₅ benzylamino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.259) —OCH(CH₃)C₂H₅ cyclohexylamino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.260) —OCH(CH₃)C₂H₅ 2,3-dihydro-6-methyl-1H-inden-1yl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.261) —OCH(CH₃)C₂H₅ (1R)-2,3-dihydro-6-methyl-1H-inden-1yl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.262) —OCH(CH₃)C₂H₅ (1S)-2,3-dihydro-6-methyl-1H-inden-1yl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.263) —OCH(CH₃)C₂H₅ 1,2,3,4-tetrahydro-quinolin-1-yl NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.264) —OCH(CH₃)C₂H₅ 1,2,3,4-tetrahydro-isoquinolin-2-yl NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.265) —OCH(CH₃)C₂H₅ 1,2,3,4-tetrahydro-napht-1-yl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.266) —OCH(CH₃)C₂H₅ (1R)-1,2,3,4-tetrahydro-napht-1-yl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.267) —OCH(CH₃)C₂H₅ (1S)-1,2,3,4-tetrahydro-napht-1-yl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.268) —OCH(CH₃)C₂H₅ (1R,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.269) —OCH(CH₃)C₂H₅ (1S,2R)-2,3-dihydro-2,4,6-trimethyl-1H-inden-1yl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.270) —OCH(CH₃)C₂H₅ (1R,2R)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.271) —OCH(CH₃)C₂H₅ (1S,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1yl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.272) —OCH(CH₃)C₂H₅ (1R,2S)-2,3-dihydro-2-methyl-1H-inden-1yl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.273) —OCH(CH₃)C₂H₅ (1R,2R)-2,3-dihydro-2-methyl-1H-inden-1yl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.274) —OCH(CH₃)C₂H₅ (1R,2S)-2,3-dihydro-2,4,6-trimethyl-1H-inden-1yl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.275) —OCH(CH₃)C₂H₅ (1S,2R)-2,3-dihydro-2,6-methyl-1H-inden-1yl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.276) —OCH(CH₃)C₂H₅ (3RS,4RS)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.277) —OCH(CH₃)C₂H₅ (3R,4R)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.278) —OCH(CH₃)C₂H₅ (3S,4S)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.279) —OCH(CH₃)C₂H₅ 1-cyclopropylethyl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.280) —OCH(CH₃)C₂H₅ (1R)-cyclopropylethyl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.281) —OCH(CH₃)C₂H₅ (1S)-cyclopropylethyl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.282) —OCH(CH₃)C₂H₅ 1-(4-chlorphenyl)eth-1-yl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.283) —OCH(CH₃)C₂H₅ (1R)-(4-chlorphenyl)eth-1-yl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.284) —OCH(CH₃)C₂H₅ (1S)-(4-chlorphenyl)eth-1-yl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.285) —OCH(CH₃)C₂H₅ 1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.286) —OCH(CH₃)C₂H₅ (1R)-1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.287) —OCH(CH₃)C₂H₅ (1S)-1-methyl-2-(3,5-dimethylphenyloxy)eth-1-yl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.288) —OCH(CH₃)C₂H₅ 1,1-dicyclopropylmethyl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.289) —OCH(CH₃)C₂H₅ pent-3-ylamino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.290) —OCH(CH₃)C₂H₅ 1-cyclobutyl-2-phenyleth-1-yl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.291) —OCH(CH₃)C₂H₅ (1R)-cyclobutyl-2-phenyleth-1-yl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.292) —OCH(CH₃)C₂H₅ (1S)-cyclobutyl-2-phenyleth-1-yl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.293) —OCH(CH₃)C₂H₅ (3S,4R)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.294) —OCH(CH₃)C₂H₅ (3R,4S)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NHBz Al(O-i-Bu)₃ HOCH(CH₃)C₂H₅ (Ia-1.295) —OCH₂CH₂OC₂H₅ (3S,4R)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.296) —OCH₂CH₂OC₂H₅ (3R,4S)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NH₂ Al(O-i-Pr)₃ HOCH₂CH₂OC₂H₅ (Ia-1.297) —O-i-Pr (3S,4R)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH (Ia-1.298) —O-i-Pr (3R,4S)-3-methyl-3,4-dihydro-2H-chromen-4-yl-amino NH₂ Al(O-i-Pr)₃ (CH₃)₂CHOH Reaction Conditions as to Table II: 1) Reaction temperature of 90 to 100° C. 2) Al-source ised in an amount of 1 to 2 eq based on amine 3) cyanoguanidine used in an amount of 1 to 2 eq based on amine Abbreviations as to Table II: —O-i-Pr = Isopropoxy    Bz = benzyl  NHBz = benzylamino   NBz₂ = dibenzylamino 

1. Compounds of formula (I) or salts thereof,

in which R¹ is (C₁-C₁₈)alkyl, (C₂-C₁₈)alkenyl or (C₂-C₁₈)alkynyl, wherein each of the last-mentioned three radicals is unsubstituted or substituted, or is a group of the formula A¹ or B¹, R² is H, (C₁-C₁₈)alkyl, (C₂-C₁₈)alkenyl or (C₂-C₁₈)alkynyl, wherein each of the last-mentioned three radicals is unsubstituted or substituted, or is a group of the formula A², R³ is H, (C₁-C₁₈)alkyl, (C₂-C₁₈)alkenyl or (C₂-C₁₈)alkynyl, wherein each of the last-mentioned three radicals is unsubstituted or substituted, or is a group of the formula A³, R⁴ is H, (C₁-C₁₈)alkyl, (C₂-C₁₈)alkenyl or (C₂-C₁₈)alkynyl, wherein each of the last-mentioned three radicals is unsubstituted or substituted, or is a group of the formula A⁴, R⁵ is H, (C₁-C₁₈)alkyl, (C₂-C₁₈)alkenyl or (C₂-C₁₈)alkynyl, wherein each of the last-mentioned three radicals is unsubstituted or substituted, or is a group of the formula A⁵, R⁶ is H, (C₁-C₁₈)alkyl, (C₂-C₁₈)alkenyl or (C₂-C₁₈)alkynyl, wherein each of the last-mentioned three radicals is unsubstituted or substituted, or is a group of the formula A⁶, or R¹ and R² or R³ and R⁴ together with the N-atom linked to each other form a N-heterocyclic ring having 3 to 7 ring atoms and optionally having one or more additional hetero atoms selected from the group consisting of N, O and S and which is unsubstituted or substituted, A¹, A², A³, A⁴, A⁵ and A⁶, independently of one another, are (C₃-C₉)cycloalkyl, (C₄-C₉)cycloalkenyl, (C₅-C₉)cycloalkinyl, aryl or heterocyclyl as a basic cyclic moiety, wherein the basic cyclic moiety is unsubstituted or substituted, B¹ is a group as defined for R¹ further linked to the amino group of the group of the formula (I*),

wherein R²*, R³*, R⁴*, R⁵*, X* and Y* are independently as defined in formula (I) for R², R³, R⁴, R⁵, X and Y, respectively, X and Y each, independently of one another, are selected from the group consisting of (i) amino, (ii) a group of the formula NR⁷R⁸ in which R⁷ is a radical selected from the group consisting of radicals as defined for and independently of R¹, and in which R⁸ is a radical selected from the group consisting of radicals as defined for and independently of R², (iii) hydroxy, (iv) (C₁-C₆)alkoxy, (C₁-C₆)haloalkoxy, (C₁-C₆)alkoxy-(C₁-C₆)alkoxy and (C₁-C₆)alkylthio, (v) (C₁-C₆)alkoxy, (C₁-C₆)haloalkoxy, (C₁-C₆)alkoxy-(C₁-C₆)alkoxy and (C₁-C₆)alkylthio, wherein each of the latter 4 radicals is substituted by one or more radicals selected from the group consisting of (C₃-C₆)cycloalkyl, (C₃-C₆)cycloalkoxy, wherein each of the last-mentioned 2 radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxy, carbamoyl, (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy-(C₁-C₆)alkyl, (C₁-C₆)alkoxy, (C₁-C₆)haloalkoxy and (C₁-C₆)alkoxy-(C₁-C₆)alkoxy, aryl and aryloxy, wherein each of the last-mentioned 2 radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxy, nitro, carbamoyl, sulfo, (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy-(C₁-C₆)alkyl, (C₁-C₆)alkoxy, (C₁-C₆)haloalkoxy, (C₁-C₆)alkoxy-(C₁-C₆)alkoxy, (C₁-C₆)alkylthio, (C₁-C₆)alkylsulfinyl, (C₁-C₆)haloalkylsulfinyl, (C₁-C₆)alkylsulfonyl, (C₁-C₆)haloalkylsulfonyl, di-[(C₁-C₄)alkyl]-amino, (C₁-C₄)alkylamino-carbonyl, di-[(C₁-C₄)alkyl]-amino-carbonyl, (C₁-C₄)alkylamino-carbonylamino and di-[(C₁-C₄)alkyl]-aminocarbonylamino, (vi) (C₃-C₆)cycloalkoxy which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxy, carbamoyl, (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy-(C₁-C₆)alkyl, (C₁-C₆)alkoxy, (C₁-C₆)haloalkoxy and (C₁-C₆)alkoxy-(C₁-C₆)alkoxy, (vii) aryloxy which is unsubstituted or substituted, and (viii) acyloxy, acylthio or acylamino, or X and Y together are a divalent group of the formula —U¹-D*-U²— in which D* is a hydrocarbon bridge, optionally interrupted by one or more divalent groups of the formula U³ defined below, and U¹, U² and U³, independently of each other are selected from the group consisting of NH, NR′, O and S, wherein R′ is (C₁-C₆)alkyl, hydroxy-(C₁-C₆)alkyl or (C₁-C₆)alkoxy-(C₁-C₆)alkyl, or X is a radical as defined above and Y is an organic ligand based on a compound of the formula Y′—H, Y′—R^(L) or R^(L)—U³-D**-U⁴—R^(LL) wherein D** is a divalent group as defined for the group D* above, Y′ is a radical as defined for Y, U³ is a divalent group as defined for U¹ above, U⁴ is a divalent group as defined for U² above, each of R^(L) and R^(LL) is a radical group selected from the group consisting of (C₁-C₆)alkyl, hydroxy-(C₁-C₆)alkyl or (C₁-C₆)alkoxy-(C₁-C₆)alkyl, and wherein the organic ligand is coordinated to the aluminium atom of the complex by a free electron pair of a hetero atom contained therein and selected from the group consisting of N, O and S, or X and Y together are a radical of the formula —U-D*-U²—R^(LLL) in which U¹, U² and D* are as defined above, and R^(LLL) is a radical selected from the group consisting of (C₁-C₆)alkyl, hydroxy-(C₁-C₆)alkyl or (C₁-C₆)alkoxy-(C₁-C₆)alkyl, and wherein the radical —U¹-D*-U²—R^(LLL) is additionally coordinated to the aluminium atom of the complex by a free electron pair located at a hetero atom contained in the radical (position represented by Y).
 2. Compound as claimed in claim 1, characterized in that in which R¹ is (C₁-C₁₈)alkyl, (C₂-C₁₈)alkenyl or (C₂-C₁₈)alkynyl, wherein each of the last-mentioned three radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxy, nitro, carbamoyl, sulfo and radicals of the formulae —O—R^(1a), —S—R^(1b), —S(═O)—R^(1c), —S(═O)₂—R^(1d), —NR^(1e)R^(1f), —C(═O)—NHR^(1g), —C(═O)—NR^(1h)R^(1i), —NHC(═O)—NR^(1j)R^(1k) and A^(1a), wherein R^(1a), R^(1b), R^(1c), R^(1d), R^(1e), R^(1f), R^(1g), R^(1h), R^(1i), R^(1j), and R^(1k), independently of one another, are (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy-(C₁-C₆)alkyl or a radical of the formula A^(1b),  or is a group of the formula A¹ or B¹, R² is H, (C₁-C₁₈)alkyl, (C₂-C₁₈)alkenyl or (C₂-C₁₈)alkynyl, wherein each of the last-mentioned three radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxy, nitro, carbamoyl, sulfo and radicals of the formulae —O—R^(2a), —S—R^(2b), —S(═O)—R^(2c), —S(═O)₂—R^(2d), —NR^(2e)R^(2f), —C(═O)—NHR^(2g), —C(═O)—NR^(2h)R^(2i), —NHC(═O)—NR^(2j)R^(2k) and A^(2a), wherein R^(2a), R^(2b), R^(2c), R^(2d), R^(2e), R^(2f), R^(2g), R^(2h), R^(2i), R^(2j), and R^(2k), independently of one another, are (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy-(C₁-C₆)alkyl or a radical of the formula A^(2b),  or is a group of the formula A², R³ is H, (C₁-C₁₈)alkyl, (C₂-C₁₈)alkenyl or (C₂-C₁₈)alkynyl, wherein each of the last-mentioned three radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxy, nitro, carbamoyl, sulfo and radicals of the formulae —O—R^(3a), —S—R^(3b), —S(═O)—R^(3c), —S(═O)₂—R^(3d), —NR^(3e)R^(3f), —C(═O)—NHR^(3g), —C(═O)—NR^(3h)R^(3i), —NHC(═O)—NR^(3j)R^(3k) and A^(3b), wherein R^(3a), R^(3b), R^(3c), R^(3d), R^(3e), R^(3f), R^(3g), R^(3h), R^(3i), R^(3j), and R^(3k), independently of one another, are (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy-(C₁-C₆)alkyl or a radical of the formula A^(3b),  or is a group of the formula A³, R⁴ is H, (C₁-C₁₈)alkyl, (C₂-C₁₈)alkenyl or (C₂-C₁₈)alkynyl, wherein each of the last-mentioned three radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxy, nitro, carbamoyl, sulfo and radicals of the formulae —O—R^(4a), —S—R^(4b), —S(═O)—R^(4c), —S(═O)₂—R^(4d), —NR^(4e)R^(4f), —C(═O)—NHR^(4g), —C(═O)—NR^(4h)R^(4i), —NHC(═O)—NR^(4j)R^(4k) and A^(4a), wherein R^(4a), R^(4b), R^(4c), R^(4d), R^(4e), R^(4f), R^(4g), R^(4h), R^(4i), R^(4j), and R^(4k), independently of one another, are (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy-(C₁-C₆)alkyl or a radical of the formula A^(4b),  or is a group of the formula A⁴, R⁵ is H, (C₁-C₁₈)alkyl, (C₂-C₁₈)alkenyl or (C₂-C₁₈)alkynyl, wherein each of the last-mentioned three radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxy, nitro, carbamoyl, sulfo and radicals of the formulae —O—R^(5a), —S—R^(5b), —S(═O)—R^(5c), —S(═O)₂—R^(5d), —NR^(5e)R^(5f), —C(═O)—NHR^(5g), —C(═O)—NR^(5h)R^(5i), —NHC(═O)—NR^(5j)R^(5k) and A^(5a), wherein R^(5a), R^(5b), R^(5c), R^(5d), R^(5e), R^(5f), R^(5g), R^(5h), R^(5i), R^(5j), and R^(5k), independently of one another, are (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy-(C₁-C₆)alkyl or a radical of the formula A^(5b),  or is a group of the formula A⁵, R⁶ is H, (C₁-C₁₈)alkyl, (C₂-C₁₈)alkenyl or (C₂-C₁₈)alkynyl, wherein each of the last-mentioned three radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxy, nitro, carbamoyl, sulfo and radicals of the formulae —O—R^(6a), —S—R^(6b), —S(═O)—R^(6c), —S(═O)₂—R^(6d), —NR^(6e)R^(6f), —C(═O)—NHR^(6g), —C(═O)—NR^(6h)R^(6i), —NHC(═O)—NR^(6j)R^(6k) and A^(6a), wherein R^(6a), R^(6b), R^(6c), R^(6d), R^(6e), R^(6f), R^(6g), R^(6h), R^(6i), R^(6j), and R^(6k), independently of one another, are (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy-(C₁-C₆)alkyl or a radical of the formula A^(6b),  or is a group of the formula A⁶, or R¹ and R² or R³ and R⁴ together with the N-atom linked to each other form a N-heterocyclic ring having 3 to 7 ring atoms and optionally having one or more additional hetero atoms selected from the group consisting of N, O and S and which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxy, nitro, carbamoyl, sulfo, (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy-(C₁-C₆)alkyl, (C₁-C₆)alkoxy, (C₁-C₆)haloalkoxy, (C₁-C₆)alkoxy-(C₁-C₆)alkoxy, (C₁-C₆)alkylthio, (C₁-C₆)alkylsulfinyl, (C₁-C₆)haloalkylsulfinyl, (C₁-C₆)alkylsulfonyl, (C₁-C₆)haloalkylsulfonyl, di-[(C₁-C₄)alkyl]-amino, (C₁-C₄)alkylamino-carbonyl, di-[(C₁-C₄)alkyl]-amino-carbonyl, (C₁-C₄)alkylamino-carbonylamino, di-[(C₁-C₄)alkyl]-aminocarbonylamino and oxo, A¹, A^(1a), A^(1b), A², A^(2a), A^(2b), A³, A^(3a), A^(3b), A⁴, A^(4a), A^(4b), A⁵, A^(5a), A^(5b), A⁶, A^(6a), and A^(6b), independently of one another, are (C₃-C₉)cycloalkyl, (C₄-C₉)cycloalkenyl, (C₅-C₉)cycloalkinyl, aryl or heterocyclyl as a basic cyclic moiety, wherein the basic cyclic moiety (a) is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxy, nitro, carbamoyl, sulfo, (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy-(C₁-C₆)alkyl, (C₁-C₆)alkoxy, (C₁-C₆)haloalkoxy, (C₁-C₆)alkoxy-(C₁-C₆)alkoxy, (C₁-C₆)alkylthio, (C₁-C₆)alkylsulfinyl, (C₁-C₆)haloalkylsulfinyl, (C₁-C₆)alkylsulfonyl, (C₁-C₆)haloalkylsulfonyl, di-[(C₁-C₄)alkyl]-amino, (C₁-C₄)alkylamino-carbonyl, di-[(C₁-C₄)alkyl]-amino-carbonyl, (C₁-C₄)alkylamino-carbonylamino and di-[(C₁-C₄)alkyl]-amino-carbonylamino and, in case of heterocyclyl, also oxo attached to heteroring atoms N or S or in alpha-position of an N-atom as heteroring atom, or (b) is substituted by or substituted additionally to one or more of the substituents mentioned in (a) by a bridge linked geminal (a 1,1-position), vicinal (a 1,2-position) or in a 1,3-position at the basic cyclic moiety thus forming another carbocyclic or heterocyclic ring together with the part of the basic cyclic moiety between the atoms linked to the bridge, wherein the carbocyclic or heterocyclic ring formed is saturated, partly unsaturated, unsaturated, aromatic or heteroaromatic and wherein the bridge is further unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxy, nitro, carbamoyl, sulfo, (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy-(C₁-C₆)alkyl, (C₁-C₆)alkoxy, (C₁-C₆)haloalkoxy, (C₁-C₆)alkoxy-(C₁-C₆)alkoxy, (C₁-C₆)alkylthio, (C₁-C₆)alkylsulfinyl, (C₁-C₆)haloalkylsulfinyl, (C₁-C₆)alkylsulfonyl, (C₁-C₆)haloalkylsulfonyl, di-[(C₁-C₄)alkyl]-amino, (C₁-C₄)alkylamino-carbonyl, di-[(C₁-C₄)alkyl]-amino-carbonyl, (C₁-C₄)alkylamino-carbonylamino and di-[(C₁-C₄)alkyl]-aminocarbonylamino, B¹ is a group as defined for R¹ further linked to the amino group of the group of the formula (I*),

wherein R²*, R³*, R⁴*, R⁵*, X* and Y* are independently as defined in formula (I) for R², R³, R⁴, R⁵, X and Y, respectively, X and Y each, independently of one another, are selected from the group consisting of (i) amino, (ii) a group of the formula NR⁷R⁸ in which R⁷ is a radical selected from the group consisting of radicals as defined for and independently of R¹, and in which R⁸ is a radical selected from the group consisting of radicals as defined for and independently of R², (iii) hydroxy, (iv) (C₁-C₆)alkoxy, (C₁-C₆)haloalkoxy, (C₁-C₆)alkoxy-(C₁-C₆)alkoxy and (C₁-C₆)alkylthio, (v) (C₁-C₆)alkoxy, (C₁-C₆)haloalkoxy, (C₁-C₆)alkoxy-(C₁-C₆)alkoxy and (C₁-C₆)alkylthio, wherein each of the latter 4 radicals is substituted by one or more radicals selected from the group consisting of (C₃-C₆)cycloalkyl, (C₃-C₆)cycloalkoxy, wherein each of the last-mentioned 2 radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxy, carbamoyl, (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy-(C₁-C₆)alkyl, (C₁-C₆)alkoxy, (C₁-C₆)haloalkoxy and (C₁-C₆)alkoxy-(C₁-C₆)alkoxy,  aryl and aryloxy, wherein each of the last-mentioned 2 radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxy, nitro, carbamoyl, sulfo, (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy-(C₁-C₆)alkyl, (C₁-C₆)alkoxy, (C₁-C₆)haloalkoxy, (C₁-C₆)alkoxy-(C₁-C₆)alkoxy, (C₁-C₆)alkylthio, (C₁-C₆)alkylsulfinyl, (C₁-C₆)haloalkylsulfinyl, (C₁-C₆)alkylsulfonyl, (C₁-C₆)haloalkylsulfonyl, di-[(C₁-C₄)alkyl]-amino, (C₁-C₄)alkylamino-carbonyl, di-[(C₁-C₄)alkyl]-amino-carbonyl, (C₁-C₄)alkylamino-carbonylamino and di-[(C₁-C₄)alkyl]-aminocarbonylamino, (vi) (C₃-C₆)cycloalkoxy which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxy, carbamoyl, (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy-(C₁-C₆)alkyl, (C₁-C₆)alkoxy, (C₁-C₆)haloalkoxy and (C₁-C₆)alkoxy-(C₁-C₆)alkoxy, (vii) aryloxy which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxy, nitro, carbamoyl, sulfo, (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy-(C₁-C₆)alkyl, (C₁-C₆)alkoxy, (C₁-C₆)haloalkoxy, (C₁-C₆)alkoxy-(C₁-C₆)alkoxy, (C₁-C₆)alkylthio, (C₁-C₆)alkylsulfinyl, (C₁-C₆)haloalkylsulfinyl, (C₁-C₆)alkylsulfonyl, (C₁-C₆)haloalkylsulfonyl, di-[(C₁-C₄)alkyl]-amino, (C₁-C₄)alkylamino-carbonyl, di-[(C₁-C₄)alkyl]-amino-carbonyl, (C₁-C₄)alkylamino-carbonylamino and di-[(C₁-C₄)alkyl]-aminocarbonylamino,  and (viii) acyloxy, acylthio or acylamino, each having 1 to 12 carbon atoms, or X and Y together are a divalent group of the formula —U¹-D*-U²—in which D* is a linear alkylene bridge, a linear (C₂-C₁₀)alkenylene bridge, a linear (C₂-C₁₀)alkynylene bridge, a (C₃-C₉)cycloalkylene bridge, a phenylene bridge or a bridge consisting of a combination of two or more of said linear acyclic and cyclic moieties having in total 4 to 24 carbon atoms, wherein the bridge in each case is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxy, nitro, carbamoyl, sulfo, (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy-(C₁-C₆)alkyl, (C₁-C₆)alkoxy, (C₁-C₆)haloalkoxy, (C₁-C₆)alkoxy-(C₁-C₆)alkoxy, (C₁-C₆)alkylthio, (C₁-C₆)alkylsulfinyl, (C₁-C₆)haloalkylsulfinyl, (C₁-C₆)alkylsulfonyl, (C₁-C₆)haloalkylsulfonyl, di-[(C₁-C₄)alkyl]-amino, (C₁-C₄)alkylamino-carbonyl, di-[(C₁-C₄)alkyl]-amino-carbonyl, (C₁-C₄)alkylamino-carbonylamino and di-[(C₁-C₄)alkyl]-aminocarbonylamino, and U¹, U² and U³, independently of each other are selected from the group consisting of NH, NR′, O and S, wherein R′ is (C₁-C₆)alkyl, hydroxy-(C₁-C₆)alkyl or (C₁-C₆)alkoxy-(C₁-C₆)alkyl, or X is a radical as defined above and Y is an organic ligand based on a compound of the formula Y′—H, Y′—R^(L) or R^(L)—U³-D**-U⁴—R^(LL) wherein D** is a divalent group as defined for the group D* above, Y′ is a radical as defined for Y, U³ is a divalent group as defined for U¹ above, U⁴ is a divalent group as defined for U² above, each of R^(L) and R^(LL) is a radical group selected from the group consisting of (C₁-C₆)alkyl, hydroxy-(C₁-C₆)alkyl or (C₁-C₆)alkoxy-(C₁-C₆)alkyl, and wherein the organic ligand is coordinated to the aluminium atom of the complex by a free electron pair of a hetero atom contained therein and selected from the group consisting of N, O and S, or X and Y together are a radical of the formula —U₁-D*-U²—R^(LLL) in which U¹, U² and D* are as defined above, and R^(LLL) is a radical selected from the group consisting of (C₁-C₆)alkyl, hydroxy-(C₁-C₆)alkyl or (C₁-C₆)alkoxy-(C₁-C₆)alkyl, and wherein the radical —U¹-D*-U²—R^(LLL) is additionally coordinated to the aluminium atom of the complex by a free electron pair located at a hetero atom contained in the radical (position represented by Y), preferably located at the heteroatom of the divalent group U².
 3. Compound as claimed in claim 1, characterized in that R¹ is (C₁-C₁₂)alkyl, (C₂-C₁₂)alkenyl or (C₂-C₁₂)alkynyl, wherein each of the last-mentioned six radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxy, nitro, carbamoyl, sulfo and radicals of the formulae —O—R^(1a), —S—R^(1b), —S(═O)—R^(1c), —S(═O)₂—R^(1d), —NR^(1e)R^(1f), —C(═O)—NHR^(1g), —C(═O)—NR^(1h)R^(1i), —NHC(═O)—NR^(1j)R^(1k) and A^(1a), wherein R^(1a), R^(1b), R^(1c), R^(1d), R^(1e), R^(1f), R^(1g), R^(1h), R^(1i), R^(1j), and R^(1k), independently of one another, are (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy-(C₁-C₆)alkyl or a radical of the formula A^(1b),  or is a group of the formula A¹ or B¹,  or R¹ and R² together with the N-atom linked to each other form a N-heterocyclic ring having 5 or 6 ring atoms and optionally having 1, 2 or 3 additional hetero atoms selected from the group consisting of N, O and S and which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxy, nitro, carbamoyl, sulfo, (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy-(C₁-C₆)alkyl, (C₁-C₆)alkoxy, (C₁-C₆)haloalkoxy, (C₁-C₆)alkoxy-(C₁-C₆)alkoxy, (C₁-C₆)alkylthio, (C₁-C₆)alkylsulfinyl, (C₁-C₆)haloalkylsulfinyl, (C₁-C₆)alkylsulfonyl, (C₁-C₆)haloalkylsulfonyl, di-[(C₁-C₄)alkyl]-amino, (C₁-C₄)alkylamino-carbonyl di-[(C₁-C₄)alkyl]-amino-carbonyl, (C₁-C₄)alkylamino-carbonylamino, di-[(C₁-C₄)alkyl]-aminocarbonylamino and oxo, A¹, A^(1a) and A^(1b), independently of one another, are (C₃-C₉)cycloalkyl, (C₄-C₉)cycloalkenyl, (C₅-C₉)cycloalkinyl, aryl or heterocyclyl as a basic cyclic moiety, wherein the basic cyclic moiety (a) is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxy, nitro, carbamoyl, sulfo, (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy-(C₁-C₆)alkyl, (C₁-C₆)alkoxy, (C₁-C₆)haloalkoxy, (C₁-C₆)alkoxy-(C₁-C₆)alkoxy, (C₁-C₆)alkylthio, (C₁-C₆)alkylsulfinyl, (C₁-C₆)haloalkylsulfinyl, (C₁-C₆)alkylsulfonyl, (C₁-C₆)haloalkylsulfonyl, di-[(C₁-C₄)alkyl]-amino, (C₁-C₄)alkylamino-carbonyl di-[(C₁-C₄)alkyl]-amino-carbonyl, (C₁-C₄)alkylamino-carbonylamino and di-[(C₁-C₄)alkyl]-amino-carbonylamino and, in case of heterocyclyl, also oxo attached to heteroring atoms N or S or in alpha-position of an N-atom as heteroring atom, or (b) is substituted by or substituted additionally to one or more of the substituents mentioned in (a) by a bridge linked geminal (a 1,1-position), vicinal (a 1,2-position) or in a 1,3-position at the basic cyclic moiety thus forming another carbocyclic or heterocyclic ring together with the part of the basic cyclic moiety between the atoms linked to the bridge, wherein the carbocyclic or heterocyclic ring formed is saturated, partly unsaturated, unsaturated having 3 to 9 ring atoms or is aromatic or heteroaromatic having 5 or 6 ring atoms and wherein the bridge is further unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxy, nitro, carbamoyl, sulfo, (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy-(C₁-C₆)alkyl, (C₁-C₆)alkoxy, (C₁-C₆)haloalkoxy, (C₁-C₆)alkoxy-(C₁-C₆)alkoxy, (C₁-C₆)alkylthio, (C₁-C₆)alkylsulfinyl, (C₁-C₆)haloalkylsulfinyl, (C₁-C₆)alkylsulfonyl, (C₁-C₆)haloalkylsulfonyl, di-[(C₁-C₄)alkyl]-amino, (C₁-C₄)alkylamino-carbonyl, di-[(C₁-C₄)alkyl]-amino-carbonyl, (C₁-C₄)alkylamino-carbonylamino and di-[(C₁-C₄)alkyl]-amino-carbonylamino and, in case of heterocyclyl, also oxo attached to heteroring atoms N or S or in alpha-position of an N-atom as heteroring atom, or is further benzocondensated wherein the additional annellated benzene ring is unsubstituted or further substituted by one or more radicals as defined for substitution of the bridge which is benzocondensated, B¹ is a group as defined for R¹ further linked to the amino group of the group of the formula (I*),

wherein R²*, R³*, R⁴*, R⁵*, X* and Y* are independently as defined in formula (I) for R², R³, R⁴, R⁵, X and Y, respectively.
 4. Compound as claimed in claim 1, characterized in that R² is H, (C₁-C₄)alkyl, (C₂-C₄)alkenyl or (C₂-C₄)alkynyl, (C₁-C₄)haloalkyl, phenyl, naphthyl, phenyl(C₁-C₄)alkyl or (C₃-C₆)cycloalkyl, wherein each of the last-mentioned 4 radicals is unsubstituted or substituted in the cyclic moiety by one or more radicals as defined for substituents at the cyclic group A², and R³, R⁴, R⁵ and R⁶ each are H,
 5. Compound as claimed in claim 1, characterized in that X and Y, independently of one another, are each selected from the group consisting of (i) amino, (ii) a group of the formula NR⁷R⁸ which is defined as the group NR¹R² in formula (I), (iii) hydroxy, (iv) (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₁-C₄)alkoxy-(C₁-C₄)alkoxy and (C₁-C₄)alkylthio, (v) (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₁-C₄)alkoxy-(C₁-C₄)alkoxy and (C₁-C₄)alkylthio, wherein each of the latter 4 radicals is substituted by one or more radicals selected from the group consisting of (C₃-C₆)cycloalkyl, (C₃-C₆)cycloalkoxy, wherein each of the last-mentioned 2 radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxy, carbamoyl, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₁-C₄)alkoxy-(C₁-C₄)alkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy and (C₁-C₄)alkoxy-(C₁-C₄)alkoxy,  phenyl or phenoxy, wherein each of the last-mentioned 4 radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxy, nitro, carbamoyl, sulfo, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₁-C₄)alkoxy-(C₁-C₄)alkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₁-C₄)alkoxy-(C₁-C₄)alkoxy, (C₁-C₄)alkylthio, (C₁-C₄)alkylsulfinyl, (C₁-C₄)haloalkylsulfinyl, (C₁-C₄)alkylsulfonyl, (C₁-C₄)haloalkylsulfonyl, di-[(C₁-C₄)alkyl]-amino, (C₁-C₄)alkylamino-carbonyl, di-[(C₁-C₄)alkyl]amino-carbonyl, (C₁-C₄)alkylamino-carbonylamino and di-[(C₁-C₄)alkyl]-aminocarbonylamino, (vi) (C₃-C₆)cycloalkoxy which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxy, carbamoyl, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₁-C₄)alkoxy-(C₁-C₄)alkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy and (C₁-C₄)alkoxy-(C₁-C₄)alkoxy,  and (vii) phenoxy, which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxy, nitro, carbamoyl, sulfo, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₁-C₄)alkoxy-(C₁-C₄)alkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₁-C₄)alkoxy-(C₁-C₄)alkoxy, (C₁-C₄)alkylthio, (C₁-C₄)alkylsulfinyl, (C₁-C₄)haloalkylsulfinyl, (C₁-C₄)alkylsulfonyl, (C₁-C₄)haloalkylsulfonyl, di-[(C₁-C₄)alkyl]-amino, (C₁-C₄)alkylamino-carbonyl, di-[(C₁-C₄)alkyl]-amino-carbonyl, (C₁-C₄)alkylamino-carbonylamino and di-[(C₁-C₄)alkyl]-aminocarbonylamino,  and (viii) acyloxy, acylthio or acylamino, wherein acyl in the last-mentioned three groups is formyl, (C₁-C₆)alkylcarbonyl, (C₁-C₆)alkylsulfonyl or phenylsulfonyl, the latter of which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₁-C₄)alkoxy-(C₁-C₄)alkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₁-C₄)alkoxy-(C₁-C₄)alkoxy and (C₁-C₄)alkylthio, or X and Y together are a divalent group of the formula —O-D*-O—, —S-D*-S—, —NH-D*-NH—, —O-D*-NH—, —O-D*-S—, —N(CH₃)-D*-N(CH₃)—, —NH-D*-N(CH₃)—, —N(C₂H₅)-D*-N(C₂H₅)— or —NH-D*-N(C₂H₅)—, wherein D* in each of the last-mentioned 9 divalent groups is a linear alkylene bridge, a linear (C₂-C₁₀)alkenylene bridge, a linear (C₂-C₁₀)alkynylene bridge, a (C₃-C₉)cycloalkylene bridge, a phenylene bridge or a bridge consisting of a combination of two or more of said linear acyclic and cyclic moieties having in total 4 to 18 carbon atoms, wherein the bridge in each case is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxy, nitro, carbamoyl, sulfo, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₁-C₄)alkoxy-(C₁-C₄)alkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₁-C₄)alkoxy-(C₁-C₄)alkoxy, (C₁-C₄)alkylthio, (C₁-C₄)alkylsulfinyl, (C₁-C₄)haloalkylsulfinyl, (C₁-C₄)alkylsulfonyl, (C₁-C₄)haloalkylsulfonyl, di-[(C₁-C₄)alkyl]-amino, (C₁-C₄)alkylamino-carbonyl, di-[(C₁-C₄)alkyl]-amino-carbonyl, (C₁-C₄)alkylamino-carbonylamino and di-[(C₁-C₄)alkyl]-aminocarbonylamino, or X is a radical as defined above and Y is an organic ligand based on a compound of the formula Y′—H, Y′—R^(L) or R^(L)—O-D**-O—R^(LL), R^(L)—S-D**-S—R^(LL), R^(L)—NH-D**-NH—R^(LL), R^(L)—O-D**-NH—R^(LL), R^(L)-O-D**-S—R^(LL), R^(L)—N(CH₃)-D**-N(CH₃)—R^(LL), R^(L)—NH-D**-N(CH₃)—R^(LL), R^(L)—N(C₂H₅)-D**-N(C₂H₅)—R^(LL) or R^(L)—NH-D**-N(C₂H₅)—R^(LL), wherein D** in each of the 9 last-mentioned compounds is a divalent group as defined for the group D* above, Y′ is a radical as defined for Y, and each of R^(L) and R^(LL) is a radical group selected from the group consisting of (C₁-C₆)alkyl, hydroxy-(C₁-C₆)alkyl or (C₁-C₆)alkoxy-(C₁-C₆)alkyl, and wherein the organic ligand is coordinated to the aluminium atom of the complex by a free electron pair of a hetero atom contained therein and selected from the group consisting of N, O and S, or X and Y together are a radical of the formula —O-D**-O—R^(LLL), —S-D**-S—R^(LLL), —NH-D**-NH—R^(LLL), —O-D**-NH—R^(LLL), —NH-D**-O—R^(LLL), —O-D**-S—R^(LLL), —S-D**-O—R^(LLL), —N(CH₃)-D**-N(CH₃)—R^(LL)L, —NH-D**-N(CH₃)—R^(LLL), —N(CH₃)-D**-NH—R^(LLL), —N(C₂H₅)-D**-N(C₂H₅)—R^(LLL), —NH-D**-N(C₂H₅)—R^(LLL) or —N(C₂H₅)-D**-NH—R^(LLL), wherein D* in the 13 last-mentioned radicals is as defined above, and R^(LLL) is a radical selected from the group consisting of (C₁-C₄)alkyl, hydroxy-(C₁-C₄)alkyl or (C₁-C₄)alkoxy-(C₁-C₄)alkyl, and wherein the radical is additionally coordinated to the aluminium atom of the complex by a free electron pair located at a hetero atom contained in the radical (position represented by Y), preferably located at the heteroatom attached to the group R^(LLL) in the divalent group.
 6. Process for the preparation of a compound of formula (I) or salts according to claim 1,

in which R¹ to R⁶ and X and Y are as defined in formula (I), characterized in that a compound (an amine) of the formula (II) or a salt thereof,

in which R¹ and R² are defined as in the compound of formula (I) to be prepared, is reacted to a compound of the formula (III) or a salt thereof,

in which R³, R⁴, R⁵ and R⁶ are defined as in the compound of formula (I) to be prepared, and an aluminium(III) source, optionally, in the presence of a protic additive or solvent selected from the group consisting of alcohols or amines.
 7. Process as claimed in claim 6, characterized in that the aluminium(III) source is selected from (i) aluminium salts of the formula (IV),

in which X and Y are as defined in the compound of formula (I) to be prepared, and Z, independently of X, is a leaving group selected from the group of radicals as defined for X or Y, or (ii) aluminium salts of the formula (IV′),

in which X′, Y′ and Z′ each are selected from the group consisting of radicals as defined for X, Y or Z, respectively and radicals which generate said group X, Y or Z, respectively in the presence of a protic additive or solvent X—H, Y—H or Z—H, respectively, with the proviso that 1, 2 or 3 of the radicals X′, Y′ and Z′ are selected from said radicals which generate radicals X, Y and Z, respectively, in combination with a protic additive or solvent X—H, Y—H or Z—H wherein each of X, Y and Z are defined as set forth for X and Y in formula (I).
 8. A process for the preparation of heterocyclic derivative compounds corresponding to formula (I), wherein the derivatization comprises replacing the aluminium group Al(X)(Y) with an optionally substituted carbon atom, or s-triazine derivatives thereof.
 9. A process for the preparation of compounds of the formula (V) or salts thereof,

in which R¹, R², R³ and R⁴ are as defined in formula (I) according to claim 1, and Q is a) hydrogen, (C₁-C₁₂)alkyl, (C₂-C₁₂)alkenyl or (C₂-C₁₂)alkynyl, wherein each of the last-mentioned three radicals is unsubstituted or substituted, b) or is (C₃-C₆)cycloalkyl, benzo-(C₅-C₆)cycloalkyl, (C₅-C₆)cycloalkenyl, benzo-(C₅-C₆)cycloalkenyl, phenyl, naphthyl, heterocyclyl or benzocondensated heterocycyl, wherein each of the last-mentioned 8 radicals is unsubstituted or substituted in the cyclic moiety, c) or is COR, COOR, C(═S)R, C(═O)SR, C(═S)OR, C(═S)SR, wherein R in each of the 6 last-mentioned radicals being (C₁-C₁₈)alkyl, (C₃-C₆)cycloalkyl or phenyl, the latter three radicals being unsubstituted or substituted, characterized in that a compound of the formula (I) or a salt thereof

in which R¹, R², R³ and R⁴ are as defined in the compound of formula (V) to be prepared and R⁵ and R⁶ are hydrogen, is reacted with a compound of the formula (VI) Q-W*  (VI) in which Q is as defined in the compound of formula (V) to be prepared and W* is a carbon atom which bears 3 additional bonds to 1, 2 or 3 leaving groups which are linked by hetero atoms, to give the compound of the formula (V) or a salt thereof.
 10. Process as claimed in claim 9, characterized in that the compound (I) is prepared according to the process of claim 6 and directly used without isolation for the preparation of the compound of formula (V), optionally in a one-pot process. 